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Glossary of common abbreviations  
AtMCs Adipose tissue derived mesothelial cells  
Bmi1 Proto-Oncogene, Polycomb Ring Finger 
Bra Brachyury 
Cdh1 E-cadherin 
CFDA SE Carboxyfluorescein diacetate succinimidyl ester 
d Days  
Dmp1 Dentin matrix protein 
E/M state Intermediate state  
eControl Whole embryonic rudiment control 
EGF Epidermal growth factor 
EGFR Epidermal growth factor 
EGFRi Epidermal growth factor inhibitor 
EMT Epithelial to mesenchymal transition 
E-state Epithelial state 
FCS Fetal calf serum 
Gapdh Glyceraldehyde 3-phosphate dehydrogenase 
GFP Green fluorescent protein 
h Hours 
Krt8 cytokeratin 8 
MCs Mesothelial cells 
MM Metanephric mesenchyme  
MMT mesothelial to mesenchymal transition 
mRNA Messenger ribonucleic acid 
Msln Mesothelin 
M-state Mesenchymal state  
OMC Omentum cultures 
OMT Omentum tissue 
Pax2 Paired Box 2 
PD Peritoneal dialysis  
PDE Peritoneal dialysis effluents  
PMCs Pleural mesothelial cells  
PNA Peanut agglutinin 
PPARγ Peroxisome proliferator-activated receptor 
rControl Reaggregated rudiment control 
RPMCs Rat peritoneal mesothelial cells  
siSnail2 siRNA Snail2 
Six2 SIX Homeobox 2 
siZeb1 siRNA Zeb1 
siZeb1+2 siRNA Zeb1 + Zeb2 
siZeb2 siRNA Zeb2 
Sox2 SRY (Sex-Determining Region Y)-Box 2 Protein 
Sox9 SRY (Sex-Determining Region Y)-Box 9 Protein 
Sparc Secreted Protein Acidic And Cysteine Rich 
TGF-β Transforming growth factor β 
TβRI Transforming growth factor β receptor I 
TβRi Transforming growth factor β receptor I inhibitor 
TβRII Transforming growth factor β receptor II 
UB ureteric bud 
UtMCs uterine derived mesothelial cells  
Vim Vimentin 
Wt1 Wilms tumor 1 
ZO1 zona occuldens protein 1 
αSMA α smooth muscle actin 
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Abstract 
Mesothelial cells have been described to possess progenitor characteristics and 
contribute to regeneration through differentiation. However, it is not clear what the 
effects of prolonged culture have on the mesothelial cell properties and relative 
plasticity; as long-term cultures have not yet been established as a result of early 
senescence. Understanding the effects of time in culture is crucial for the 
development of novel therapies.  
In this thesis, we demonstrated that mesothelial cell cultures isolated from murine 
omentum could be cultured for more than 40 passages and showed relatively stable 
population doubling times. While initially, the cells did down-regulated the 
expression of mesothelial markers Wilm’s tumor protein 1 (Wt1) and mesothelin and 
epithelial genes; their mesenchymal profile was maintained. This along with the 
increased Snail2 expression suggested the cells were progressing through the 
mesothelial to mesenchymal (MMT) transdifferentiation programme. TGF-β and 
more recently EGF are known mediators of MMT. Targeting signalling through these 
receptors with small molecule inhibitors LY364947 and PD153035, slowed the rate 
of gap closure, in vitro and increased zonula occludens 1 accumulation at cell-cell 
contacts. Which seemed to be mediated through the MEK5/ERK5 pathway. 
Furthermore, siRNA-mediated transient knockdown of Zeb1 and Zeb2 transcription 
factors also achieved attenuated the rate of migration.  
Next, we moved onto to accessing the progenitor properties of the mesothelial cells 
with time in culture. The expression of stem cells markers Bmi1 (Proto-Oncogene, 
Polycomb Ring Finger), Sox9 ((Sex Determining Region Y)-Box 9) and CD34 were 
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downregulated with repeated passaging. However, the low passage mesothelial cells 
exhibited clonogenicity and could differentiate into osteoblasts and adipocytes. 
Finally, in an embryonic kidney rudiment assay, we could show that the mesothelial 
cells co-existed with the embryonic kidney cells and allowed renal structures to form 
in their presence.  
Ultimately, we have demonstrated that the mesothelial cells from the omentum 
maintain some mesothelial characteristics with prolonged culturing. The cells 
showed clonogenic and multi-lineage potential and expressed a number of stem cell 
genes. The MMT programme is complex and could be partly reversed by targeting 
TGF-βR1 and EGFR tyrosine kinases, which along with transiently silencing the Zeb 
transcriptional factors seem likely key targets in ameliorating pathological fibrosis.  
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Chapter 1 Introduction 
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Synopsis 
The mesothelium is a monolayer of mesothelial cells that line the surface of internal 
organs, and cavity walls. As well as having roles in providing a frictionless barrier and 
immunomodulatory functions, studies have also suggested that mesothelial cells 
have progenitor properties. They have been shown to transdifferentiate from a more 
epithelial state to a myofibroblastic cell via a phenomenon known as mesothelial to 
mesenchymal transition and aid in the wound healing process. Furthermore, 
mesothelial cells have been demonstrated to have the ability to differentiate along 
other cell lineages including osteocytes and adipocytes. These multipotential 
properties may be advantageous in treating debilitating fibrosis and sclerosis that 
arise from insult to the mesothelium induced through surgical and non-surgical 
methods. In the third chapter, we will address the effects of culturing on mesothelial 
characteristics. Then in the fourth chapter of this thesis will attempt to address the 
progenitor properties of mesothelial cells and the influence of cell passage on these 
characteristics. Before finally presenting work which aimed to elucidate the 
regulatory MMT networks that control the status of the mesothelial cells. The 
findings from this thesis could help develop strategies that could harness the 
regulatory MMT networks.  
This chapter will provide an overview of the current literature on aspects relevant to 
the subsequent experiments described in the forthcoming chapters. Particular 
emphasis will be placed on the relation between mesothelial progenitor properties 
and their contribution to regeneration and development within in vitro and ex vivo 
settings.  We will also review relevant literature on the cellular and molecular 
mechanisms that contribute to wound repair following insult to mesothelium with 
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emphasis on the role of MMT in modulating this and evidence for its pathological 
contributions.      
1.1 Mesothelium structure and functions 
1.1.1 Morphology of the mesothelium 
The mesothelium is a membrane composed of a monolayer of specialized epithelial-
like mesothelial cells that are situated on a thin basement membrane and line the 
walls of the coelomic cavities (pleural, pericardial, and peritoneal) and the surfaces 
of visceral organs (Figure 1.1) (Herrick and Mutsaers, 2004, Lua and Asahina, 2016).  
 
Figure 1.1 Mesothelial membrane. The mesothelium is composed of a monolayer of 
epithelial-like cells that sit on a thin basement membrane and line the surfaces of 
internal organs and cavity walls.   
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Microscopically, mesothelial cells from different serosal sites and different 
mammalian species are considered morphologically similar (Lachaud et al., 2015, 
Herrick and Mutsaers, 2004). However, ultrastructurally the mesothelial cells located 
at the parietal and visceral sites differ (Mutsaers and Wilkosz, 2007, Lachaud et al., 
2015). The parietal mesothelium lining the coelomic cavities are a flattened sheet of 
larger mesothelial cells and have a lower abundance of intracellular organelles 
(Mutsaers et al., 2015). By contrast, the mesothelial cells located on the visceral 
organs (visceral mesothelium), are more densely compacted and have a higher 
intracellular organelle content which suggests a more active metabolic cell state 
(Mutsaers and Wilkosz, 2007, Lachaud et al., 2015). The differences between the 
visceral and the parietal mesothelial cells are summarized in table 1.1.  
Table 1.1: A summary of the ultrastructural differences between the visceral and parietal 
mesothelial cells (Michailova et al., 1999, Yung and Chan, 2007) 
 
  
 Visceral mesothelium Parietal mesothelium 
Overall Morphology Cuboidal Flatter, longer cells 
Nucleus Rounded Elongated 
Mitochondria +++++ ++ 
RER (Rough endoplasmic reticulum) +++++ + 
Golgi body Well developed Poorly developed 
Vesicles ++++ ++ 
Microfilaments +++++ +++ 
Metabolic cell state  Active Resting  
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1.1.2 Mesothelial cell barrier function  
Previously, the mesothelium was postulated to just function as a protective barrier 
against abrasions and provide a frictionless surface for intracoelomic movement 
(Lachaud et al., 2015, Lua and Asahina, 2016, Mutsaers and Wilkosz, 2007). The 
mesothelium maintains the lubricated non-adhesive barrier through its ability to 
secrete surfactants, proteoglycans, and glycosaminoglycans that are 
electrochemically entrapped between their microvilli (Lachaud et al., 2015, Mutsaers 
et al., 2015) 
However, the mesothelium is now recognized as having more diverse physiological 
functions (Mutsaers and Wilkosz, 2007). It serves as a semi-permeable membrane 
barrier that maintains homeostatic osmolarity and ionic activity between the fluid 
filled serosal cavities and the blood vessels and lymphatic systems that run in the 
submesothelial connective tissues. This function is mediated through the presence 
of aquaporin (AQP) and transmembrane ATPase pumps (Lachaud et al., 2015, 
Mutsaers and Wilkosz, 2007, Yung and Chan, 2007). Whereby the knockout of AQP1 
in mice showed significantly reduce transcellular water transport (Zhang et al., 2016). 
1.1.3 Mesothelial cells modulate inflammation 
The mesothelium is also the first line of defense for the serosa from insult induced 
by surgery, and continuous exposure to bio-incompatible and infectious agents 
(Herrick and Mutsaers, 2007). Mesothelial cells have the capacity to modulate 
inflammation through immunosuppressive mechanisms and the ability to recruit 
innate immune cells (Eigenbrod et al., 2008a, Lachaud et al., 2015). For example, in 
response to IL-1α stimulation released by neighboring necrotic cells, the mesothelial 
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cells secrete CXCL1, a neutrophil recruiting chemokine, through the activation of the 
IL-1R/MyD88/NFκB (interleukin 1 receptor/ Myeloid differentiation primary 
response gene 88/ nuclear factor-kappaB) pathway (Eigenbrod et al., 2008a). 
Mesothelial cells have also been demonstrated to modulate the pro-inflammatory 
response by suppressing the proliferation of γδ T cells through the secretion of TGF-
β (transforming growth factor β) (Lin et al., 2013).  
Finally, a new player in the modulation of mammalian immunity has emerged. 
Arginase-1 is an enzyme that metabolizes L-arginine to L-ornithine and its presence 
is associated with the suppression of T cell responsiveness as well as increasing tissue 
regeneration (Kitayama et al., 2014, Munder, 2009). CD90+/CD45- mesothelial cells 
derived from peritoneal fluid highly expressed this enzyme and significantly reduced 
T cell proliferation, in vitro (Kitayama et al., 2014).  
Overall mesothelial cells show the capacity to ameliorate and contribute to 
inflammatory-induced fibrosis following insult from infectious agents, trauma and 
chemical agents (Mutsaers and Wilkosz, 2007, Yung and Chan, 2007). The 
mechanisms by which this is orchestrated are diverse and complex and are 
summarized in table 1.2.  
 
  
9 
 
Table 1.2: A summary of the proteins secreted by mesothelial cells in regulation of 
inflammation  
   
Molecules  Stimulus  Biological function Reference  
Cytokines  
IL-1α/β 
LPS, TNF-α, 
IL-1α 
Amplification of the initial inflammatory 
response regulates growth and cytokine 
release by mesothelial cells  
(Douvdevani 
et al., 1994)  
IL-6 
Peritoneal 
dialysis 
effluents 
(PDE)  
effluents ,  IL
-1β and IL-
1α  
Promotes of B-cell differentiation and 
immunoglobulin production and is a 
reliable predictor of peritoneal solute 
transport rate  
(Witowski et 
al., 1996, Cho 
et al., 2014)  
IL-15 
PD  
effluents , IL-
2 and IFN-γ 
A potent T-cell activator (CD4+, CD8+, and 
B and natural killer cells)  
(Hausmann 
et al., 2000)  
Chemokines  
IL-8 
PDE, TNF-α, 
IL-1β, IFN-γ 
Leukocyte chemotaxis during peritonitis  
(Topley et al., 
1993, Man et 
al., 2003)  
MCP-1 
RANTES 
CXCL1 PDE, IL-1α  Neutrophil recruitment via IL-1R/MyD88  
(Eigenbrod et 
al., 2008b)  
Growth Factors 
TGF-β IL-1β  Master regulator of fibrosis  
(Offner et al., 
1996)  
bFGF IL-1β   
Promotes PAI-1 expression which functions 
to suppress fibrinolysis  
(Cronauer et 
al., 1999)  
HB-EGF  IL-1, TNF-α 
Promotes mesothelial cell migration and 
adhesion through MMT and therefore has 
a role in fibrosis 
 (Faull et al., 
2001)  
HGF 
Autocrine 
secretion  
Promotes mesothelial cell motility and 
proliferation during wound repair 
(Warn et al., 
2001)  
ECM Molecules 
Collagen I 
PDE, IL-1 β, 
IL-13, TNF-α, 
EGF, PDGF, 
TGF-β  
Laid down during tissue remodelling 
process by ECM producing myofibroblasts. 
They are markers of fibrosis  
  
  
 (Strippoli et 
al., 2016) 
  
  
  
  
Collagen III 
Collagen IV 
Fibronectin 
Elastin 
Vitronectin 
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1.1.4 Mesothelial cell response to injury    
Soft tissue repair is essentially composed of four overlapping phases; bleeding, 
inflammation, proliferation and remodelling (Foley-Comer et al., 2002b). Under 
physiological conditions in the serosa, there is a fine balance between fibrin 
deposition and breakdown and the mesothelial cells are known contributors to 
fibrinolysis (Mutsaers et al., 2015). The mesothelium is the main source of tPA (tissue 
plasminogen activator) in the serosa (Eigenbrod et al., 2008a, Lin et al., 2013). tPA 
activates the serine protease plasmin that in turn degrades fibrin (Falk et al., 2000, 
Rougier et al., 1998). An imbalance in the fibrinolysis through the presence of 
inflammatory mediators TGFβ, TNFα and IL-1 promote serosal adhesions by 
depleting tPA mRNA and protein levels and stimulating plasminogen activator 
inhibitor-1 expression in mesothelial cells resulting in increased overall fibrin 
deposition (Falk et al., 2000, Rougier et al., 1998). The mesothelial cells also 
contribute to the deposition of a number of extracellular matrix (ECM) molecules 
that have important roles in serosal membrane function and repair (Herrick and 
Mutsaers, 2004, Mutsaers et al., 2015). The rate of ECM deposition can be further 
stimulated by the presence of peritoneal effluents and a number of growth factors 
and cytokines highlighted in table 1.2 (Herrick and Mutsaers, 2004, Mutsaers et al., 
2015). Moreover, the turnover of ECM is regulated by mesothelial cells through the 
synthesis of matrix-degrading metalloproteinase (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) (Mutsaers et al., 2015). A more detailed description of 
the role of mesothelial cells in injury and disease is provided later, in the context of 
molecular mechanisms (section 1.4).  
11 
 
As well as synthesizing and releasing a number of proteases, basement membrane 
molecules and signaling  factors to aid repair to the serosa; free floating mesothelial 
also contribute to the wound healing process through implantation and proliferation 
(Foley-Comer et al., 2002b). Using a testicular thermal injury rat model, labeled 
mesothelial cells were injected into the wounded serosa and monitored for 
incorporation 3, 5 and 8 days post-injury through confocal imaging.  The mesothelial 
cells showed evidence of implantation and proliferation in the serosa through the 
expression of the tight junction-associated protein, zonula occludens-1 (ZO1) and 
proliferating cell nuclear antigen (Foley-Comer et al., 2002b). Similarly, Chen and 
colleagues showed through inducible genetic fate mapping that the injured 
peritoneum was repaired and replaced by intrinsic surviving Wt1-RFP+ mesothelial 
cells, and not by submesothelial fibroblasts (Chen et al., 2014). 
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1.2 Mesothelial to mesenchymal transition  
Mesothelial cells originate from the mesoderm however they show characteristics 
analogous to both mesenchymal and epithelial cells (see figure 1.3) (Foley-Comer et 
al., 2002b). Recent evidence suggests that the mesothelial cells can undergo 
phenotypic changes following activation from an epithelial-like state to a more 
mesenchymal morphology in a process similar to EMT (epithelial to mesenchymal 
transition) and EndMT (endothelial to mesenchymal transition). The process has 
been coined mesothelial to mesenchymal transition (MMT) in mesothelial cells (Liu 
et al., 2015, Mutsaers et al., 2015). This led to the notion that a population of 
mesothelial progenitor cells exists within the mesothelium which constitutes the 
proposed origin of myofibroblasts during organogenesis and peritoneal fibrosis 
(Lachaud et al., 2015, Liu et al., 2015, Mutsaers et al., 2015). 
1.2.1 What is MMT?  
MMT is a dynamic cellular process that occurs during development, tissue repair, 
fibrosis and metastasis (Liu et al., 2015, Pez-Cabrera, 2014). MMT is characterized by 
the gradual loss of cell-cell adhesion networks through the repression of adherence 
and tight junctional proteins; E-cadherin (Cdh1) and ZO1 respectively (Liu et al., 2015, 
Mutsaers et al., 2015). This, in turn, results in mesothelial cell detachment from the 
basal lamina and a loss in apical-basal cell polarity and a gain in front-back polarity 
following cytoskeletal rearrangement (Liu et al., 2015, Mutsaers et al., 2015). The end 
result is a Vim/ αSMA expressing transdifferentiated myofibroblastic mesothelial cell 
with migratory and invasive capacity (Liu et al., 2015, Mutsaers et al., 2015) (Figure 
1.2).  
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MMT is activated by a diverse number of proangiogenic and morphogenic growth 
factors (TGFβ, EGF, bFGF and PDGF-bb) and by exposure to bio-incompatible 
peritoneal dialysis (PD) fluids through receptor-mediated signaling  (Liu et al., 2015, 
Mutsaers et al., 2015). These, in turn, activate a plethora of intracellular signaling  
effectors that orchestrate mesothelial transdifferentiation (Pez-Cabrera, 2014) 
(Figure 1.2).  
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Figure 1.2: A summary of the biochemical and morphological changes associated with MMT following stimulation. 
Inducers of MMT Proteins Activated Proteins Upregulated Proteins Downregulated Cellular Changes 
 TGF-β 
 EGF 
 IL-1 
 IL-6 
 HB-EGF 
 HGF 
 MAPK 
 PI3-K 
 NFκB 
 Smad2/3 
 
 αSMA 
 Vim 
 Cdh2 
 Snail1/2 
 Twist1 
 Zeb1/2 
 Fibronectin 
 Collagen I/III 
 MMP2/9 
 PAI-1 
 Cdh1 
 Cytokeratins 
 Claudins 
 Occludins 
 Desmoplakins 
 ZO1 
 tPA 
 Gain a front back 
polarity 
 Increased migration and 
invasion 
 Reduced fibrinolysis 
 Increased ECM 
deposition 
 
Epithelial Mesenchymal 
MMT 
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1.2.2 MMT spectrum  
Mesothelial cells isolated from peritoneal effluents have revealed that MMT is not a 
binary process, rather it houses a whole spectrum of intermediate cell states that 
simultaneously co-express epithelial and mesenchymal characteristics at varying 
degrees (Figure 1.3) (Lee et al., 2014, Zhang et al., 2013, Li and Kang). It also rarely 
results in the complete loss of epithelial genes (Lee et al., 2014, Zhang et al., 2013, Li 
and Kang). Yáñez-Mó and colleagues described three MMT state phenotypes; 
epithelial-like (E-state), intermediate (E/M state) and fibroblastic-like (M-state), in 
mesothelial cells isolated from the effluents of peritoneal dialysis patients (Yáñez-Mó  
et al., 2003). The length of exposure to PD fluids (dwelling time) seemed to influence 
the relative progression through the MMT (Lee et al., 2014). Patients exposed to PD 
>6 months had significantly lower Cdh1 and higher Vim, fibronectin and collagen 1 
protein and mRNA expression compared to patients that had just started PD 
treatment (Zhang et al., 2013). Logistic regression analysis further supported these 
findings and showed that persistent PD treatment for 24 h induced the highest rate 
of full MMT, characterized by reduced Cdh1mRNA and protein (Lee et al., 2014).  
Moreover, the MMT spectrum was also reported in healthy mesothelial cells derived 
from adipose and uterine tissues (Lachaud et al., 2014, Lachaud et al., 2013). Over 
the course of the 15 d culture period in a high glucose medium supplemented with 
EGF, the mesothelial cells initially showed a cobblestone-like morphology and 
accordingly expressed high intercellular levels of β-catenin, ZO1 and E-cadherin 
(Lachaud et al., 2014, Lachaud et al., 2013). By 3 – 5 d the mesothelial cells displayed 
transitional E/M morphologies characterized by disrupted ZO1 localization and 
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increased WT1 and αSMA expression (Lachaud et al., 2014, Lachaud et al., 2013). At 
15 d the cells adopted the M-state phenotype and that was consistent with increased 
expression of αSMA and Vim and a reduction in all epithelial and mesothelial markers 
including Wt1 and mesothelin (Lachaud et al., 2014, Lachaud et al., 2013). These 
gradual changes in the protein and mRNA expression are summarized in figure 1.3.  
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Figure 1.3: MMT spectrum of transitory states. The MMT transdifferentiation programme produces cells that reside in a spectrum of intermediate 
states, where they progressively lose epithelial genes and gradually gain mesenchymal features. These intermediate states are associated with 
plasticity (MMT transitionary mesothelial cells images were taken from (Abelardo Aguilera, 2013, Lachaud et al., 2014, Lachaud et al., 2013). 
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The E/M state of EMT provides relative benefits over complete transdifferentiation 
into a myofibroblastic cell, as it allows cells to move collectively and is a hallmark of 
tissue remodeling during embryonic development, wound repair and metastasis 
(Jolly et al., 2015b, Savagner, 2015). This increases the efficiency of epithelial cell 
migration as it removes the need for all cells to identify and respond to an external 
stimulus (Jolly et al., 2015b, Savagner, 2015).  
The E/M phase has also been associated with stemness (Jolly et al., 2015b, Savagner, 
2015). Lachaud and colleagues showed through RT-PCR and western blotting that 
UtMCs transiently upregulated the expression of stem and progenitor genes Nanog, 
Sox2 and c-Kit during the  E/M phase of MMT, and this expression was reduced once 
the cells had fully differentiated into myofibroblasts (Figure 1.4A-C) (Lachaud et al., 
2013).  Overall the E/M state is a developing concept that still needs to be better 
characterized in mesothelial cells (Figure 1.4D).   
MMT is also reversible (mesenchymal to mesothelial transition) during the early 
stages of transdifferentiation when the MMT signal is removed or through the 
presence of a number of signaling and scaffolding proteins (Vargha et al., 2006, Pez-
Cabrera, 2014). When E-state and M-state mesothelial cells were cultured for 7 days 
in the presence of MMT-inducing TGF-β or the antifibrotic cytokine bone 
morphogenic protein 7 (Bmp7), respectively, they showed a reversal in cell 
morphologies (Vargha et al., 2006). Furthermore, transfection with an adenoviral 
BMP-7 vector or treatment with BMP-7 peptide reversed the M-state morphology 
and attenuated peritoneal fibrosis in animal models of PD (Yu et al., 2009). Moreover, 
HGF (hepatocyte growth factor) treatment protected the peritoneum from PD-
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induced damage by counteracting TGF-β1 signaling (Yu et al., 2009, Loureiro et al., 
2010, Liu et al., 2015). Caveolin 1 (Cav1) has recently been identified as a regulator 
of MMT (Strippoli et al., 2015). This putative scaffolding protein has diverse 
physiological functions, including the regulation of cholesterol homeostasis, cell 
adhesion, and vesicular trafficking. Cav1-/- mice showed thickened peritoneal 
membranes, increased fibrosis and heightened activation of the Mek-Erk1/2-Snail1 
pathway, under both basal and peritoneal dialysis treated conditions (Strippoli et al., 
2015). Overexpression of Cav1 protein in HPMC isolated from the effluents of PD 
patients reversed MMT (Strippoli et al., 2015).     
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Figure 1.4: UtMCs cultured in smooth muscle differentiating medium transdifferentiate via 
MMT and temporally upregulate stem/ progenitor markers. A) Time course staining 
showing the gradual gain in αSMA and loss of β-catenin as the cells progress through the 
MMT program. B) RT-PCR products analysis and C) western blot analysis of time course study 
for mesothelial (cytokeratin-18 (CK-18), WT1, E-cadherin), MMT (Twist, Snail, Slug) and 
pluripotent (Oct 3/4, Sox2, Nanog) marker. During the MMT programme the UtMCs 
temporally upregulated the expression of Sox2, Nanog, and Wt1. D) MMT is not a binary 
process and the E/M and M/E states are associated with stemness (Figure A-C was taken 
from (Lachaud et al., 2013).  
  
A 
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1.3 Signalling pathways regulating MMT 
TGF-β and EGF initiate downstream signaling events through their own respective 
receptors, however, recent reports show that many of the downstream components 
of their signaling pathways may be shared (Figure 1.5) (Jia and Souchelnytstkyi, 2011). 
Understanding the mechanisms by which TGF-β and EGF interact to induce MMT is 
important for the development of the reversal of pathological MMT. 
1.3.1 TGF-β induced MMT  
TGF-β is regarded as the master molecule of the fibrotic process in all organs as it is 
the main signaling pathway activated and perpetuated during the wound healing 
process (Strippoli et al., 2016). Therefore its involvement in the promotion of MMT 
is not surprising. The TGF-β ligand exerts its functions by binding to the constitutively 
active TGF-β receptor II (TβRII) which subsequently recruits, and activates the type I 
receptor (TβRI/ ALK5) (Xu et al., 2009, Strippoli et al., 2016). The activated TβRI then 
mediates downstream signaling  through serine/ threonine kinase activity, by binding 
and phosphorylating members of the Smad and non-Smad signaling  proteins (Xu et 
al., 2009, Strippoli et al., 2016).  
The TGF-β/Smad signaling cascade induces MMT following phosphorylation of 
Smad2 and/or Smad3 signaling mediators. These form a heteromultimeric complex 
with Smad4 and translocate into the nucleus where to directly bind DNA and activate 
downstream gene targets that act to repress Cdh1 and upregulate αSMA/ Vim 
expression (Xu et al., 2009, Strippoli et al., 2016). Biopsies from patients receiving 
continuous ambulatory peritoneal dialysis (CAPD) showed sub-mesothelial 
thickening and increased TGF-β/Smad2/3 signaling  (Duan et al., 2014). However, the 
roles of Smad2 and Smad3 in MMT differ (Xu et al., 2009). The peritoneum of Smad3 
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knockout mice was resistant to fibrosis following prolonged treatment with 
peritoneal dialysis effluents (Duan et al., 2014). Similarly, Smad3 deficient peritoneal 
mouse cells also showed resistance to MMT following TGF-β stimulation (Duan et al., 
2014). In contrast, the transient knockdown of Smad2 promoted MMT by 
upregulating αSMA and collagen I expression and repressing Cdh1 in a time-
dependent manner. It also resulted in exacerbated fibrosis in Smad2 conditional 
knockout mice (Duan et al., 2014). 
While the Smad protein complexes can directly regulate MMT alone, their activity is 
low in comparison to other transcription factors (Heldin et al., 2012, Strippoli et al., 
2016). Rather the majority of their EMT/MMT regulatory transcriptional activity 
occurs in tandem with other MMT- transcription factors (MMT-TF), co-activators and 
co-repressors (Heldin et al., 2012, Strippoli et al., 2016). Therefore, the Smad 
signaling  pathway is not the only means for TGF-β induced MMT (Javelaud and 
Mauviel, 2005). Pathways including the mitogen-activated protein kinase (MAPK)(Xu 
et al., 2003), NFκB and the phosphoinositide 3- kinase (PI3K/ AKT) pathways are also 
activated by TGF-β in mesothelial cells and can also modulate MMT alone, through 
cross-talk with Smad signalling , or by converging onto Smad proteins to regulate 
their activity (Javelaud and Mauviel, 2005, Derynck et al., 2014). 
MAP kinases are a family of serine/threonine kinases that mediate downstream 
transcriptional activity in response to extracellular signals through a cascade of 
phosphorylation events (Javelaud and Mauviel, 2005). There are four major groups 
of MAPKs that are associated with MMT (Javelaud and Mauviel, 2005, Derynck et al., 
2014). These include the extracellular signal-regulated kinases 1/2 (ERK1/2 or p42/44 
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MAPK), ERK5 (big MAPK), p38 MAPKs and the c-Jun N-terminal kinases/stress-
activated protein kinases (JNK/SAPKs) (Javelaud and Mauviel, 2005, Son et al., 2011). 
Each of these MAPK cascades involves at least three tiers of kinases phosphorylation 
events: MAP3K which activates MAP2K that in turn phosphorylates and activates 
MAPK to finally modulate target gene expression (Son et al., 2011, Gui et al., 2012).  
The ERK1/2 signaling  cascade is the major pathway involved in promoting 
mitogenesis, differentiation, cell survival and, if dysregulated, cell transformation 
(Son et al., 2011, Gui et al., 2012). Upon binding of the TGF-β ligand to its receptors, 
Shc/Grb2/Sos/Ras complexes are recruited and assembled on the TβRI platform (Son 
et al., 2011, Gui et al., 2012). The GTP-binding protein Ras subsequently activates and 
recruits Raf kinase which in turn activates and recruits MAPK/ERK kinase 1 (MEK1) 
and MEK2, which are the upstream activators of ERK1/2 respectively (Son et al., 2011, 
Gui et al., 2012).  
The JNK and the P38 MAPK pathways are activated in response to stress signals (such 
as pro-inflammatory cytokines, ultraviolet radiation, and reactive oxygen species) 
and mediate apoptosis and in some cell systems proliferation and differentiation 
(Son et al., 2011, Gui et al., 2012). JNK members are activated by MKK4/MKK7 that 
in turn are substrates for TAK1. This kinase also activates MKK3/6 kinases that are 
upstream MAP2K activators p38 MAPK (Son et al., 2011, Gui et al., 2012). Finally TGF-
β ligands have recently been shown to activate ERK5 through the phosphorylation of 
MKK2/3 that then activate MEK5 a specific MAP2K for ERK5, with downstream roles 
in stabilizing Snail1 expression and therefore enhancing EMT in hepatocytes (Gui et 
al., 2012, Marchetti et al., 2008, Browne et al., 2008).     
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Perhaps the best-characterized interactions between TGF-β and MAPK signalling  in 
mesothelial cells are the JNK and p38 MAPK cascades (Liu et al., 2008). In vitro 
stimulation of rat, peritoneal mesothelial cells (RPMCs) with TGF-β activated both 
JNK and Smad2/3 proteins 5 and 10 minutes post-treatment respectively and 
induced MMT (Liu et al., 2008). The use of SP600125, a small molecule inhibitor of 
JNK, prevented TGF-β induced Smad3 activation and effectively suppressed the high 
expression of αSMA and collagen I, and prevented the downregulation in Cdh1 (Liu 
et al., 2008). 
Conversely, the p38 MAPK was described as a gatekeeper of MMT in human 
omentum-derived mesothelial cells (Strippoli et al., 2010). The loss of p38 either 
through the use of pharmacological inhibitors (SB203580 and BIRB796) or shRNA, 
knockdowns resulted in upregulated TAK1-NFκB signaling  that in turn resulted in the 
loss of Cdh1 and the upregulation in the mesenchymal marker Vim (Strippoli et al., 
2010). Furthermore, p38 MAPK activation was shown to promote Snail1 expression 
and Twist1 repression (Strippoli et al., 2010).  
ERK1/2 signaling has been shown to play an important role in driving the TGF-β 
response towards MMT (Strippoli et al., 2008, Jin et al., 2016). Pre-treatment of 
rodent and human mesothelial cells in U0126, an inhibitor of MEK1/2 prevented TGF-
β IL-1β/IL-6 induced MMT, by decreasing NFκB translocation into the nucleus and 
Snail1 expression (Strippoli et al., 2008, Jin et al., 2016). Furthermore, the ex vivo 
culture of mesothelial cells isolated from the PD effluents in U0126 restored the 
epithelial phenotype of the mesothelial cells (Strippoli et al., 2008). Some studies 
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have indicated that ERK1/2 may be capable of regulating the Smad signaling pathway 
by activating Smad2 (Jin et al., 2016).    
The role in ERK5 modulating the epithelial cells remodeling and transdifferentiation 
has only recently been shown (Drew et al., 2012). ERK5 was required for the 
expression of Snail2 in human keratinocytes, and its loss decreased the gap closure 
rate in a wound healing assay (Arnoux et al., 2008). TGF-β is thought to mediate ERK5 
activation through the activation of Raf, as Raf overexpression increased MEK5 
signaling  (Drew et al., 2012). Hepatocytes treated with TGF-β showed Snail1 
stabilization through ERK5 mediated inactivation of GSK3β signaling (Marchetti et al., 
2008). Silencing ERK5 enhanced Akt/GSK3β signaling and Snail1 expression, in turn, 
promoting EMT (Chen et al., 2012). Finally collagen I synthesis by mesangial cells is 
regulated by ERK5 activation (Dorado et al., 2008). While the role ERK5 plays in 
modulating MMT has not been described it would, however, seem that ERK5 may 
antagonize ERK2 induced MMT signaling, which could have implications in 
mesothelial cell regulation of MMT (Derynck et al., 2014). 
1.3.2 EGF-induced MMT 
In many epithelial cells and mesothelial cells, EGF has been demonstrated to induce 
EMT/MMT through its receptor tyrosine kinases, by activating downstream MAPKs, 
with the Ras–Raf–MEK–ERK and the MEK5-ERK5 MAPK pathways being the most 
activated. In vitro culture of UtMCs cultured in EGF for 15d promoted MMT and gave 
rise to functioning vascular smooth muscle cells (Lachaud et al., 2013). Adipose tissue 
derived mesothelial cells (AtMCs) also showed MMT capacity in the presence of EGF 
for 15d, since EGF stimulation resulted in the phosphorylation of AKT, ERK1/2, and 
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Smad-2 (Lachaud et al., 2014). In a rodent model of peritoneal fibrosis induced by 
chlorhexidine gluconate treatment, the administration of Gefitinib, selective 
inhibitor of EGFR tyrosine kinase, post injury halted fibrosis development and 
progression; and in vitro quashed TGF-β induced MMT (Marchetti et al., 2008). 
Gefitinib mediated its anti-MMT effects by decreasing overall EGFR, Smad3 and NFκB 
phosphorylation (Marchetti et al., 2008). Taken together it seems that EGF can 
augment epithelial cell differentiation into myofibroblasts in the presence of TGF-β. 
  
27 
 
 
Figure 1.5: Intracellular cross-talk between TGF-β and EGF signaling pathways. The 
MAPK and PI3K/Akt pathways are linkers of TGF-β and EGF-mediated MMT. MAPKs 
and Akt modulate MMT either by directly modulating MMT associated genes or 
indirectly through R-Smad activity.  
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1.3.3 MMT transcription factors  
Downstream of the signaling pathways, the process of MMT is tightly controlled by 
three transcription factor (MMT-TF) families; the Snails (Snail1 and Snail2), Zebs 
(Zeb1 and Zeb2) and basic helix-loop-helix (bHLH) transcription factors (Twist1) 
(Lamouille et al., 2014). These master regulators are activated early on in the MMT 
pathway, and therefore have central roles in the transdifferentiation of mesothelial 
cells (Lamouille et al., 2014). Specifically, these transcription factors are activated in 
a hierarchical manner, whereby the Snail TFs are the first to be induced, and they can 
cooperate with Twist to activate Zeb expression (Hugo et al., 2011, Garg, 2013). This 
is important for maintaining the mesenchymal phenotype as Snail proteins were 
shown to have relatively short half-lives (Lamouille et al., 2014, Hugo et al., 2011). 
Snail transcription factors  
The Snail superfamily of transcriptional repressors are essential for complete 
gastrulation during development, whereby the loss of these EMT modulators is 
embryonic lethal (Carver et al., 2001). In adult mesothelial cells, both Snail1 and 
Snail2 mediate MMT by transcriptionally repressing the expression of E-cadherin 
(Strippoli et al., 2008, Jang et al., 2013, Morishita et al., 2016). However, the forced 
expression of E-cadherin alone is not enough to reverse the mesenchymal phenotype 
back to an epithelial morphology, suggesting that these transcription factors also act 
on other epithelial gene targets. Both Snail1 and Snail2 were shown to also target 
cytokeratins (Strippoli et al., 2008) and occludins (Morishita et al., 2016) and in other 
cells, they have been demonstrated to upregulate the expression of vimentin (Vim) 
and fibronectin (Nieto, 2002, Garg, 2013).  
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Snail1 and Snail2 show differential expression patterns in cases of peritoneal dialysis 
and TGF-β induced MMT, suggesting that they play different roles in MMT which 
could be associated with the difference in the binding affinities of these MMT-TF to 
target genes (Loureiro et al., 2011, Villarejo et al., 2014).  
Twist1 transcription factor  
Twist 1 has been documented to be upregulated in the mesothelial cells isolated from 
the peritoneal effluents of patients undergoing PD (Li et al., 2012). Furthermore, the 
overexpression of Twist1 in mesothelial cells in vitro, induced full MMT (He et al., 
2015). Twist1 can mediate EMT and MMT alone and in combination with other 
transcription factors (He et al., 2015, Zhang and Klymkowsky, 2009). Twist1 induces 
epithelial cells to transdifferentiate into myofibroblasts by binding of its bHLH 
domain to the E-cadherin E-box promoter (Garg, 2013). Twist1 and Snail2 were 
shown to be functionally linked both in development and metastasis, whereby the 
loss of Snail2 to a decrease in Twist1 mRNA level and vice versa (Zhang and 
Klymkowsky, 2009). Twist1 was also demonstrated to bind to Snail2 E-box promoter 
and activates its expression (Casas et al., 2011, Zhang and Klymkowsky, 2009). The 
loss of TWIST1 in human peritoneal mesothelial (HPMCs) treated in high glucose 
medium inhibited MMT and the overexpression promoted it (He et al., 2015).   
Zeb transcription factors 
The Zeb (zinc finger E-box-binding homeobox) transcription factors have been shown 
to mediate epithelial transdifferentiation by targeting and repressing E-cadherin 
expression at the E-box promoter (Garg, 2013). Several studies have identified that 
Zeb transcription factors are significantly upregulated in malignant pleural 
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mesotheliomas (MPM) that show hallmarks of MMT through the downregulation of 
epithelial genes and upregulation of vimentin and fibroblast-specific marker 1 (FSP1 
or S100A4) (Fassina et al., 2012, Merikallio et al., 2013). Targeting the knockdown of 
just ZEB1 alone was not enough to suppress proliferation and reverse MMT (Horio et 
al., 2011). Rather studies that targeted and suppressed both ZEB1 and ZEB2 with miR-
205 reversed the MMT phenotype back to an epithelial cell morphology and also 
inhibited migration and invasion (Fassina et al., 2012). These results suggested that 
both proteins need to be targeted for effective reversal of MMT (Reid, 2015, Horio 
et al., 2011). 
The expression of these MMT-TF in mesothelial cells is context specific (Liu et al., 
2008). Compared to Snail1, Snail2 is only weakly activated, while Twist1 is not 
induced following stimulation with TGF-β1 (Strippoli et al., 2016). The 
pharmacological inhibition of Smad3, MEK/ERK1/2, and NFκB signaling molecules 
downregulates Snail1 expression in rodent peritoneal mesothelial cells (Duan et al., 
2014, Jin et al., 2016, Strippoli et al., 2010, Strippoli et al., 2008). Whereas the 
inhibition of p38 parallels Snail inhibition in MCs, where the induction of Twist is 
observed (Strippoli et al., 2010). A summary of the MMT-TF functions during MMT 
progression are collated in table 1.3.  
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Table 1.3: MMT is driven by Snail, Twist1, and Zeb transcription factors. The MMT-TF are 
activated through Smad-dependent and -independent pathways and act to repress epithelial 
genes and upregulate mesenchymal genes.  
 
 Induction Repression Regulatory Signaling Pathways 
Sn
ai
l1
/2
 
 Twist1 
 Zeb1/2 
 Cdh2 
 Fibronectin 
 Collagen 
 
 Cdh1 
 Cytokeratins 
 Claudins 
 Occludins 
 Desmoplakins 
 
 TGF-β-Smad3 
 PI3K-AKT 
 EGF 
 NFκB 
 bFGF 
Tw
is
t1
 
 Cdh2 
 Fibronectin 
 SPARC 
 Cdh1 
 Claudins 
 Occludins 
 Desmoplakins 
 
 MAPK 
Ze
b
1
/2
 
 Cdh2 
 MMPs 
 
 Cdh1 
 ZO1 
 TGF-β-Smad3 
 Ras-MAPK 
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 1.4 The role of MMT in disease  
Mesothelial cells are a source of fibrogenic cells that arise as a result of aberrant pro-
MMT signalling during serosal inflammation, pleural and peritoneal fibrosis and 
adhesion formation (Strippoli et al., 2016, Batra and Antony, 2015).    
1.4.1 Peritoneal dialysis induced fibrosis  
PD is a form of renal replacement therapy for patients with end-stage renal failure 
(Leypoldt, 2002). It takes advantage of the semi-permeable membrane function of 
the peritoneum which separates the fluid-filled cavities from the capillaries. PD fluids 
are introduced into the abdomen via a catheter and uremic toxins are replaced by 
electrolytes and small molecules (Leypoldt, 2002). The high glucose concentration 
present in the PD fluids drives osmotic pressure for ultrafiltration. Meanwhile, 
solutes are exchanged by diffusion and absorption (Leypoldt, 2002). At the end of the 
PD treatment, the fluids are drained and disposed   (de Lima et al., 2013, López-
Cabrera, 2014)  However, long-term exposure to the bio-incompatible PD fluid agents 
(low pH, high glucose and lactate) results in peritoneal damage and subsequently 
dialysis induced fibrosis (Akira Onishi, 2011, Strippoli et al., 2016). Peritoneal fibrosis 
develops in most patients within 2 years of treatment and is associated with 
increased peritoneal membrane thickness, reduced mesothelial cell viability, the loss 
of the mesothelial monolayer and eventually the complete loss in the membrane 
ultrafiltration capacity (Akira Onishi, 2011, Strippoli et al., 2016). The histological 
examination of peritoneal tissue biopsies taken from patients and mice exposed to 
PD identified myofibroblastic cells in the fibrotic tissue (Strippoli et al., 2015, 
Margetts et al., 2005). Lineage tracing studies showed that mesothelial cells which 
were triggered to undergo MMT contributed to fibrosis following their invasion into 
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the sub-mesothelial stroma (Chen et al., 2014). A number of pro-MMT signalling 
factors are secreted as a result of peritoneal wounding that contributes to peritoneal 
fibrosis. As discussed earlier, TGF-β1 is a known master molecule in the induction of 
fibrosis in several tissues and organs and has also been shown to be upregulated in 
the effluents of patients diagnosed peritoneal fibrosis (Gangji et al., 2009). Further 
evidence to support the role of TGF-β in mediating peritoneal fibrosis comes from 
Margetts and colleagues who showed that transient overexpression of TGF-β gene in 
the intraperitoneal membrane significantly increased expression of MMT related 
genes including collagen type I, αSMA and Snail1, and induced fibrosis (Margetts et 
al., 2005). Furthermore, peritoneal fibrosis was inhibited through the delivery of TGF-
β1-siRNA-nano particle complex or by TGF-β1 blocking peptides in mice that were 
receiving PD fluids (Yoshizawa et al., 2015, Loureiro et al., 2011). Recently the growth 
factor EGF that has already established roles in promoting EMT in other tissue types 
was also shown to promote MMT (refer to section 1.3.2 for more details) and as a 
result induce peritoneal fibrosis through cross-talk with TGF-β between Smad3 and 
NFκB signalling  cascades (Wang et al., 2015).  
1.4.2 Pleural fibrosis  
Pleural fibrosis is progressive irreversible lung disorder that is characterized by the 
presence of localized lesions and diffuse thickening and fibrosis in the pleural 
membrane (Batra and Antony, 2015). The alterations in the pleural cavity are the 
result of increased deposition of ECM components and the increased presence of 
αSMA expressing myofibroblasts (Batra and Antony, 2015, Zolak et al., 2013). A 
number of agents including exposure to tuberculosis effusions, radiation, and 
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inhalation of inorganic particles such as talc and asbestosis fibres are known to 
induce pleural fibrosis (Batra and Antony, 2015, Zolak et al., 2013).  
Human and mouse derived pleural mesothelial cells (PMCs) were demonstrated to 
transdifferentiate via MMT into myofibroblasts in vitro in response to TGF-β 
stimulation via Smad-dependent and independent pathways (Nasreen et al., 2009, 
Zolak et al., 2013, Batra and Antony, 2015). These mesenchymal mesothelial cells 
showed increased αSMA, NADPH oxidase 4 and fibroblast-specific protein-1 
expression, higher contractility, haptotaxis, and increased production of ECM 
component, collagen I (Nasreen et al., 2009, Zolak et al., 2013, Batra and Antony, 
2015). Furthermore, histological analysis of TGF-β induced pleural fibrosis revealed 
that GFP-labelled PMCs injected into the pleural space trafficked into the lungs 
following their transformation into αSMA expressing myofibroblasts (Zolak et al., 
2013). Moreover, WT1 and mesothelin-expressing human PMCs were found in the 
fibrotic lesions of idiopathic pulmonary fibrosis lung explants (Mubarak et al., 2012, 
Zolak et al., 2013).  
1.4.3 Liver fibrosis  
The liver parenchyma is covered by a monolayer of squamous mesothelial cells that 
have active roles in liver development and fibrosis (Lua and Asahina, 2016). Liver 
fibrosis is defined by scarring following excessive fibrin deposition (Lua and Asahina, 
2016). This is brought about by excessive alcohol consumption, hepatitis infections, 
cirrhosis and obesity (Lua and Asahina, 2016). Under basal conditions mouse liver 
mesothelial cells expressed high levels of mesothelin, Wt1, podocalyxin-like protein 
1 (Podxl), uroplakin 1b and epithelial and mesenchymal genes Krt8, Krt19 and Vim 
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respectively (Li et al., 2013b, Lua et al., 2016). Furthermore, they showed poor Cdh1 
and Snail1 expression (Li et al., 2013b). In a carbon tetrachloride (CCl4) and bile duct 
ligation models of liver injury, GFP-tagged liver mesothelial cells transformed into 
αSMA expressing myofibroblasts and invaded the liver (Lua et al., 2016). In vitro 
treatment of liver-derived mouse mesothelial cells for 4 days with TGF-β, induced 
MMT and as a consequence upregulated collagen 1 synthesis, through 
phosphorylation of Smad3 (Li et al., 2013b). Targeting the TGF-β signalling  pathway 
with pharmacological inhibitors against Smad3, TGF-β receptor II (TGF-βRII) or 
conditional knockouts for this receptor blocks MMT induction in mesothelial cells (Li 
et al., 2013b, Li et al., 2016, Lua et al., 2015).  
1.4.4 Postoperative adhesions 
Postoperative adhesions manifests as fibrous tissue bands that form between the 
opposing tissues and organs following insult from surgery, ischemia, and infections 
(Lua and Asahina, 2016, Jin et al., 2016). It is a common disorder that affects up to 
93% of patients that have undergone abdominopelvic surgery and can cause small 
bowel obstruction in two-thirds of patients, chronic pelvic pain, infertility in women 
and repeat hospital admission (Lua and Asahina, 2016, Jin et al., 2016). The 
mesothelium synthesizes and secretes lubricants that mediate anti-adhesive 
functions between abdominal viscera (Lua and Asahina, 2016, Jin et al., 2016). 
Trauma to the mesothelium lining the liver was shown to provoke mesothelial cells 
denudation from the opposite intact liver lobe. That in turn induced fibrin deposition 
and adhesion formation between the liver lobes (Suzuki et al., 2015).  
1.5 Plasticity and translational potential of mesothelial cells  
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Developmentally, mesothelial cells contribute to the vasculature of the forming heart, 
liver, intestine and lungs by transdifferentiating into vascular smooth muscle, 
possibly via MMT (Wilm et al., 2005, Que et al., 2008, Zhou et al., 2008, Asahina et 
al., 2011, Rinkevich et al., 2012). The potential to give rise to the mural part of the 
vasculature is maintained in adult mesothelial cells (Lachaud et al., 2013, Kawaguchi 
et al., 2007). In vitro UtMCs transdifferentiated into functional vascular smooth 
muscle-like cells that expressed the contractile cell marker smoothelin-B, following 
stimulation (Lachaud et al., 2013). Furthermore, both adult human and rodent 
mesothelial cells were capable of differentiating along the osteocyte, adipocyte and 
chondrocyte lineages following stimulation in inductive medium (Lansley et al., 2011, 
Lachaud et al., 2014, van Tuyn et al., 2007). In vivo lineage tracing also supported this, 
by showing Wt1 expressing adult mesothelium that lined the visceral fat depots were 
the progenitor source of adipocytes (Chau et al., 2014).   
Due to this reported capacity, a number of studies have attempted to harness this 
regenerative potential in vivo.  The transplantation of mesothelial cell sheets on to a 
fibrotic peritoneum contributed to the regeneration of the peritoneal surface within 
3 days (Hekking et al., 2003). Furthermore, activated omentum that was wrapped 
around rat kidneys that had undergone 5/6 nephrectomy, slowed the rate of chronic 
kidney disease and Wt1-expressing cells were shown to contribute to repair (Garcia-
Gomez et al., 2014). Moreover, transplantation of genetically modified mesothelial 
cells that over-expressed proteins critical for wound repair also contributed 
positively to the wound healing process (Nagy et al., 1995). However, recent studies 
have shown the contrary, where mesothelial cell transplantation actually aggravated 
the inflammatory response, further promoting tissue damage through the increased 
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secretion of pro-inflammatory factors TGF-β, VEGF and MMP-2 (Kanda et al., 2014). 
The MMT state of mesothelial cell influences therapeutic outcome (Kitamura et al., 
2014). E-state and M-state cells were transplanted into the peritoneal cavity of 
previously injured mice (Kitamura et al., 2014). The E-state cells attenuated 
peritoneal membrane thickening and adhesion formation, contrary to the M-state 
cells (Kitamura et al., 2014).  
Taken together mesothelial cell transplantation by direct injection or via a matrix 
grafting have therapeutic potential. Also, the availability of a number of mesothelial 
cell sources (including the omentum, mesenteric membranes and peritoneal 
effluents) and the advantages of autologous transplantation are what make 
mesothelial cells an ideal source of cells for transplantation therapies (Kanda et al., 
2014, Kitamura et al., 2014, Mutsaers et al., 2015). Nevertheless, a clearer 
understanding of the mechanisms regulating MMT and a better understanding of 
mesothelial cell plasticity are necessary factors for the development of novel 
therapeutic strategies.   
1.6 Thesis aims 
Based on this we wanted to further explore the plasticity and MMT regulatory 
networks of mesothelial cells in culture. To do this we aimed to address the following 
points:  
1) Assess the effect of repeated passaging on mesothelial cell characteristics, 
including MMT state and differentiation potential  
2) Characterise mesothelial cell progenitor properties by studying stem cell gene 
expression and assessing clonogenic potential 
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3) Study the potential contribution of mesothelial cells to kidney development 
using an ex vivo embryonic kidney rudiment assay  
4) Determine the role of EGF and TGF-β in controlling the E/M state of 
mesothelial cells  
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Chapter 2: Materials and 
methods 
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2.1 Dissection of embryos, tissues, and organs 
2.1.1 Animal Husbandry  
Animal handling and experimentation were conducted in accordance with the UK 
Home Office under the Animal (Scientific Procedures) Act, 1986. CD1 female mice at 
6-12 weeks of age (Charles River, Margate, UK) were housed in ventilated 
environment chambers, with a 12 hour (h) light-dark schedule and free access to food 
and water. Animals were culled by asphyxiation with an automated CO2 chamber, 
followed by cervical dislocation to confirm death.  
2.1.2 Dissection of tissues and organs from adult mice  
Animal coats were sprayed with 70% ethanol to reduce hair dispersion during 
subsequent steps. The abdominal cavity was exposed and the stomach and spleen 
complex were harvested into DMEM medium supplemented with 10% FCS and 1% 
penicillin and streptomycin (v/v). The omentum was carefully freed under a 
stereoscopic microscope (Leica MZFLIII) using Dumont fine scissors and fine forceps, 
size 5 (Dumont, Switzerland). Any residual blood vessels and fat droplets were 
removed. For the establishment of mesothelial cell lines, the tissue was compacted 
and cut into smaller fragments using disposable scalpels, size 11 (12387999, Fisher 
Scientific) and seeded into 35 mm dishes (D7804, Nunc) containing fresh standard 
full growth medium (FGM) (see section 2.15.1). Approximately 8 to 13 explants were 
routinely isolated from one omentum tissue and on average 90% of the explants 
attached from which mesothelial cells moved out within 48 h.   
For RNA isolation the freshly cleaned omental tissue was placed into TRIzol® Reagent 
(see section 2.12.1). For RNA extraction from kidneys and gonadal white adipose 
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tissues, the organs were harvested using sterilized stainless steel fine forceps and 
scissors and processed as described (section 2.12.1).  
2.1.3 Dissection of embryonic kidney rudiments 
Kidney rudiments were isolated and dissociated from CD1 mouse embryos at 
embryonic day 13.5 (E13.5) based on the Unbekandt and Davies (2010) protocol. For 
this, adult time mated CD1 mice (8-12 weeks old) were sacrificed by asphyxiation and 
the uterine horns were transferred into ice-cold MEME (M5650, Sigma) 
supplemented with 1% FCS (v/v). Using fine forceps (Dumont) the embryos were 
cleaned from extra-embryonic membranes and decapitated. The caudal parts were 
transferred into fresh ice cold 1% FCS MEME medium. The rudiments were isolated 
by turning the caudal part onto its dorsal side and cutting down the sagittal plane 
under a stereoscopic microscope (MZFLIII, Leica). The rudiments dissected using this 
protocol were either cultured in vitro or re-aggregated with labeled MCs, following 
dissociation for the chimeric rudiment assay (see section 2.10.1) or samples were 
subjected to RNA extraction (section 2.12.1).  
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Figure 2.1: Kidney rudiment dissection from mouse embryos at embryonic day 13.5. A. 
E13.5 embryo isolated from the uterine horns of the CD1 mothers. B. Following decapitation, 
the embryos were turned over and the kidneys were isolated from the back of the caudal 
parts. C, D. The kidney rudiments (highlighted) were separated from the gonads  
 
  
1.5 mm 1.5 mm 
1.5 mm 750 µm 
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2.2 Primary cells and stem cell lines  
2.2.1 Primary Mesothelial cells isolation and establishment 
Following the attachment of the omentum explants to the tissue culture dish, the 
standard growth medium was carefully replaced, with fresh medium provided every 
3-4 days. Radial outgrowths of mesothelial cells could be seen as early as 24 hours 
post seeding. Culturing the explants for a period greater than 14 days resulted 
generally in the loss of epithelial features and the appearance of a large, flattened, 
terminally differentiated fibroblastic phenotype. To generate stable primary 
mesothelial cell cultures, the explants and outgrowths were rinsed in CaCl2 and MgCl2 
free Dulbecco’s phosphate-buffered saline (DPBS, D8537, Sigma) and dissociated in 
500 µl of trypsin (10x trypsin, T4174, Sigma) for 30 minutes, at 37°C with gentle 
agitation every 10 minutes (min). Once the cells had detached, the cell suspension in 
trypsin was added to 3.5 ml of fresh standard growth medium and equally distributed 
into 4 wells of a 12 well plate (BC011, Corning). The cells were left to attach overnight 
and the medium was changed the next day and subsequently replaced every 2-3 days 
with conditioned media (section 2.15.2). A homogeneous population of mesothelial 
cells with cobblestone appearance was usually achieved at passage 4 (P4) and at this 
point the cells could reach up to 80-90% confluence and be passaged into a larger 
dish (section 2.3.1). During the course of this project, twelve mesothelial cell lines 
were generated from independent biological samples with similar phenotypes. The 
data presented in this study were from 3 independent lines unless otherwise stated.  
Established mesothelial cells were routinely subcultured every 3-4 days when they 
had reached 80-90% confluence.  
44 
 
2.2.2 Mesenchymal stem cells   
The mouse mesenchymal stem cell (MSC) line D1 (ORL UVA [D1] (ATCC® CRL-12424)) 
was selected as a positive control for assessment of mesodermal lineage 
differentiation, due to their multipotential properties. The cells were maintained in 
standard growth medium (section 2.15.1) and were passaged at 70% confluence 
(section 2.3.1). The D1 cells were used between passages 19 and 32.  
2.2.3 H6 clonal kidney stem cell line  
The mouse kidney stem cell (KSC) line H6, is a clonally derived cell line from the 
kidneys of 2-6 day old neonate CD1 pups. This cell line was established by Dr. Cristina 
Mora (2009) and kindly gifted to us from the Murray lab. The cells were included as 
a positive control for stem cell gene profiling and comparison. The cells were also 
maintained in standard growth medium (section 2.15.1) and sub-cultured at 80% 
confluence. The H6 clonal lines were used between passages 21 and 24.  
2.3 Routine tissue culture techniques 
The cells used in this study were of mouse origin and were cultured in a humidified 
environment at 37°C with 5% CO2. 
2.3.1 Cell passaging 
The same passaging protocol was used on all the adherent cells used in this study. 
The culture medium was aspirated off the cells and residual medium and debris were 
washed away in DPBS (D8537 Sigma). Next, the cells were incubated in an 
appropriate trypsin-EDTA (10x trypsin, T4174, Sigma) volume to cover the cells for 30 
seconds (s) to 5 min at 37°C in a humidified environment. Gentle tapping of the tissue 
culture dishes was used at regular intervals to encourage cell detachment. To 
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neutralize the trypsin solution, 5 ml of pre-warmed standard culture medium was 
added to the dishes. The cell solution was transferred to a 15 ml centrifuge tube 
(188271, Greiner Bio-One) and cells were pelleted at 1000 rpm for 5 min. Following 
on from this, the supernatant was removed, the cell pellet was re-suspended in 1 ml 
of pre-warmed standard culture medium (section 2.15.1) and cells were counted 
twice in an automated cell counter (TC20™, BioRad) using the trypan blue (T8154, 
Sigma) exclusion assay. The H6 KSCs and MSCs were split at a 1:5 ratio, meanwhile 
the mesothelial cells were passaged at a higher ratio of 1:6 to 1:10 due to their fast-
growing nature.  
2.3.2 Cell freezing protocol  
The cells in this study were frozen down using standard protocols. In short, the cell 
medium was aspirated and the cells were washed once with DPBS to remove debris. 
Following the described passaging protocol (see section 2.3.1) the cells were 
trypsinized, pelleted and counted. The cell medium solution was once again pelleted 
at 1000 rpm and the supernatant was discarded. For every 1x106 cells, 1 ml of 
freezing solution (section 2.15.5) was added and transferred into 2 ml cryovials 
(BC163, Corning) and left to slowly freeze down overnight at -80°C in a freezing 
container (5100-0001, ThermoFisher Scientific). The cryovials were transferred into 
liquid nitrogen containers for long-term storage.  
2.3.3 Cell thawing protocol  
To limit cell death during the thawing procedure, the cryovials were quickly 
transferred from the liquid nitrogen tanks into a 37°C water bath, where they were 
continuously agitated to speed the process of cell thawing.  For every 1 ml of cells in 
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freezing solution, 10 ml of pre-warmed cell growth medium was pipetted into a 100 
mm dish (430167, Corning). The cells were pipetted in a drop by drop fashion into 
the culture medium and were left to adhere overnight in standard culture 
environments. The medium was replaced the following day to remove the traces of 
dimethyl sulfoxide (DMSO, D8418 Sigma).  
2.4 Generation of Mesothelial Cell clones  
Mesothelial cell clones (MC clones) were generated by standard dilution cloning 
assays. P5 mesothelial cells were pelleted and counted following the outlined 
protocols (section 2.3.1). The starting cell density was 2x103 cells, which were serially 
distributed across the 96 well plate (4616-7008, Nunc) using a multichannel pipette 
(F14403, GILSON). The next morning, the wells which contained single cell colonies 
were scored and had their medium replaced with fresh pre-warmed conditioned 
media. The medium was changed every 3-4 days and the clonal cells were sub-
cultured into a 48 well plate once they had reached 90% confluence. The clonal cells 
were maintained in conditioned medium for a further passage until they were 
transferred into a 100 mm dish (430167, Corning) where they were maintained in 
standard culture medium. Three clonally derived cell lines were generated from 
independent biological samples. The process was imaged using an inverted 
microscope (TS100-F, Nikon Eclipse).  
2.5 Population doubling Studies  
2.5.1 Trypan blue exclusion study 
P4 mesothelial cells were the earliest passage assessed for the cell doubling time due 
to the heterogeneous nature of the cells at earlier passages. The cells for this study 
were trypsinized at 90% confluence, counted using the trypan blue (T8154, Sigma) 
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and seeded at a density of 6x105 in a 100 mm dish (664160, Greiner Bio-One).  The 
population doubling time (PDT) was calculated by  dividing  the time  in  culture (t)  
by  the log  of  the cell number at the end of the experiment (N1) over the log of the 
cell number at the start of the incubation (N0): PDT = t*ln(2)/(ln(N1)-ln(N0)). The 
experiment was repeated three times (n=3).  
2.5.2 Cytokinetics analysis by CCK-8 
Mesothelial cells at P7 – P12 were seeded in triplicates, in 24 well plates at 2.5x102, 
5.0 x103, 1.0x104, 2.0x104, 5.0x104, 7.5x104 and 1.0x105 cells per well in 100 µl of 
media, to generate a standard curve relating to cell and optical density values. The 
same cells were also seeded at 2.5 x 102 cells/ well density. The samples were assayed 
at 0, 24 and 48 h to test the effects of the pharmacological small molecule inhibitors 
on cell viability. In which the standard growth medium  was removed and replaced 
with 100 µl of fresh medium containing 10% CCK-8 solution (96992, Sigma). The cells 
were incubated in the CCK-8 containing medium for 3 h at 37⁰C. Next, the optical 
density values were measured by transferring 100 µl of the CCK-8 containing cell 
medium mix to a clean 96 well plate and measuring against a reagent blank at a test 
wavelength of 460 nm (FLUOSTAR Omega plate reader).  From the standard curves, 
the cell number was extrapolated based on the OD readings. From which PDT was 
calculated using the same formula stated in section 2.5.1 and the percentage cell 
viability was derived through PCV = (treated PDT / untreated PDT) *100.   
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2.6 Mesodermal Differentiation assays  
2.6.1 Mesothelial cells  
The ability of mesothelial cells to differentiate along the mesodermal lineages was 
assessed over time by studying early (P5), mid-passage cells (P13) and late passage 
cells (P26). Due to the cells’ highly proliferative nature, they were seeded at 1000 
cells/well in a 12 well culture dish (3513, Corning) overnight and stimulated the next 
day. The adipogenic and osteogenic inductive media (section 2.15.4 and 2.15.5 
respectively) were changed every 2-3 days and the cells were sub-cultured for 2 
weeks, before either their RNA was harvested (section 2.12.1) or they were stained 
to identify calcium deposits (section 2.6.3) or fat droplets (section 2.6.4). Each 
treatment group had its own controls, which were cells sub-cultured in standard 
growth medium; and each condition for each passage was done as 3 independent 
biological replicas for both RNA collection and staining.  
2.6.2 MSCs 
The MSCs are an already established multipotential cell line and were incorporated 
as positive controls of differentiation. The cells were seeded at 1000 cells/well in a 
12 well culture dish (3513, Corning) and left to reach 70% confluence in full growth 
medium. Next, the cells were treated in the inductive mediums for 7 days, with 
regular media changes every 2-3 days. The cells were stained for calcium mineral 
deposits (section 2.6.3) and fat droplets (section 2.6.4) and also had their RNA 
harvested (section 2.12.1) for mRNA quantification.   
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2.6.3 Visualization and quantification of mineral deposits through Alizarin red S 
staining: 
At the end of the inductive period, the treated cells and their respective controls 
were fixed in 4% paraformaldehyde solution in PBS (PFA; P6148, Sigma) for 10 min 
and stained for 2 min in 2% Alizarin red S solution, pH4.5 (see section 2.16.7). 
Samples were washed 3 times with 2 ml of double distilled water per well, to remove 
the excess stain. Positive cultures stained orange-red and mineral deposits were 
visible with the naked eye. Samples were imaged on the inverted microscope 
(DM2500, Leica) connected to the DFC350FX camera.  
2.6.4 Visualization and quantification of lipid formation through Oil red staining 
Following the two-week treatment period in the adipogenic medium, the cells were 
fixed in 4% PFA and washed twice in 2ml of 60% isopropanol for 5 min at room 
temperature. The cells were incubated in 1ml of 0.3% oil red solution for 10 min. This 
was followed by 4 washes in double distilled water for 5 min, before being viewed on 
Leica DM2500 microscope and imaged DFC350FX camera.  
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2.7 EMT studies 
2.7.1 Small molecule inhibitors and growth factor studies 
Mesothelial cells were seeded at 5x105 viable cells per well in a 24 well culture plates 
for mRNA, western blot, and immunolabelling studies. After the establishment of a 
cell monolayer at 24 h, the cells were serum starved for 24 h in 1% FCS DMEM 
medium and then exposed to the agents of interest diluted in the 1% FCS DMEM for 
a 48 h period (see table 2.1 and 2.2for the list of agents). Treatment conditions 
applied are denoted in the relevant chapters. In all experimental sets, controls were 
included of untreated cells cultured in full growth medium and in low serum medium.  
Table 2.1: A list of the small molecule inhibitors used in this study.  
Product 
name 
Reference 
throughout the 
thesis as 
Mode of action Final 
concentrations 
Product 
details 
LY364947 TβRi A selective, ATP-
competitive inhibitor 
of TGFβ type I receptor 
kinase 
5 – 20 µM L629, 
Sigma 
PD153035 
hydrochloride 
EGFRi A potent and selective 
ATP-competitive 
inhibitor of the EGF 
receptor tyrosine 
kinase 
5 – 20 µM SML056, 
Sigma 
PD184352 MEKi A potent and selective 
non-competitive MEK 
inhibitor 
5 µM PZ0181, 
Sigma 
Bix02189 MEK5i Selective MEK5 and 
ERK5 inhibitor 
1.25 – 5 µM 4842, 
Tocris 
XMD8-92 ERK5i Selective ERK5/BMK1 
inhibitor 
1.25 – 5 µM 4132, 
Tocris 
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Table 2.2: Growth factors used in this study  
Product name Mode of action Final 
concentrations 
Product 
details 
TGFβ Role in inducing EMT 50 ng/ml 100-21C, 
R&D 
EGF Role in augmenting EMT 50 ng/ml 236-EG, 
R&D 
 
2.7.2 Transient siRNA knockdown of EMT effectors 
Cells were seeded in 12 well plates at a density of 8×104 cells/well and reached 80% 
confluence 16 h later. They were transfected with siRNAs at a final concentration of 
40 nM using Lipofectamine® 2000 transfection reagent (11668027, ThermoFisher 
Scientific) in Opti-MEM™ (31985070, ThermoFisher Scientific) according to the 
manufacturer’s instructions. The cells were then cultured for 48 h to allow the 
knockdown to have full effect. Total RNA was harvested and the relative knockdown 
levels were calculated against control lipofectamine-treated cells. The siRNAs used 
were predesigned and purchased from Sigma Mission® siRNA (see table).  
Table 2.3: a list of siRNA target sequences 
Gene Name Product Gene ID # siRNA ID Target sequences 
5’ – 3’ 
Snail2 NM_011415 SASI_Mm01_00143833 GGAUCACAGUGGUUCAGAA 
UUCUGAACCACUGUGAUCC 
Zeb1 NM_011546 SASI_Mm02_00320896 CAUAGUGGUUGCUUCAGGA 
UCCUGAAGCAACCACUAUG 
Zeb2 NM_015753 SASI_Mm01_00062546 GUAUGCAUGUGACUUAUGU 
ACAUAAGUCACAUGCAUAC 
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2.8 In vitro wound healing assay 
2.8.1 Small molecule inhibitors and growth factors studies   
Mesothelial cells between passages 13 to 23 were seeded at 4x105 viable cells per 
well of a 24 well culture plate and serum starved in 1% FCS in DMEM medium for 24 
h. To investigate the effect of inhibitors and growth factors on cell migration, cells 
were pre-treated for the next 24 h in low serum media containing the inhibitors/ 
growth factors listed in tables 2.1 and 2.2 respectively.  Next, the cell layer was gently 
wounded using a 1 ml tip, and the wells were washed twice with DPBS to remove cell 
debris. Fresh medium containing the growth factors or inhibitors were added to the 
cells at 37° C for a further 24 h. Gap closure was imaged at 0, 4 and 12 h using the 
(DM2500, Leica) microscope and the DFC350FX camera.  
2.8.2 In vitro wound healing assay in the presence of mitomycin C 
To more accurately determine the contribution the growth factors and inhibitors had 
on cell migration, similar experiments in the presence of the mitomycin C were 
performed. In brief, 5x105 mesothelial cells were seeded and serum starved as 
described in section X. The cells were treated with mitomycin C (10 µg/ml) for 4 h 
and washed 3 times to inhibit cell proliferation. The treatments were added and the 
cells were incubated for 24 h at 37° C, 5% CO2. An artificial wound was created with 
a 1 ml pipette tip at 0 h and unattached MCs were removed by a DPBS wash. Images 
of the experimental groups were acquired at 0 h, 4 h, 12 h and 24 h, using an inverted 
light microscope (Leica DMIL).  
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2.8.3 Wound healing assay on siRNA transfected Cells  
Mesothelial cells at 8×104 were plated in each well of a 12 well plate. Following 
overnight incubation, the cells were transfected with 40 nM siRNA for 6 h and then 
allowed to recover overnight. The cell monolayers were serum starved for 16 h in 1% 
FCS DMEM and wounded by scraping with a 1 ml tip. They were washed several times 
with DPBS to remove dislodged cells and placed back in low serum medium. Images 
were captured using a phase-contrast microscope immediately and at, 6 and 24 h 
after wounding.  
2.8.4 Gap closure analysis  
The TScratch software is an automated image analysis tool for the objective and 
reproducible quantification of open wound areas. The default threshold settings 
were able to detect the cell boundaries. However in the cases of the later time points, 
where the open areas were small, the areas were manually adjusted down to a single 
cell. The software computed out the percentage open area per time point. These 
values were transferred into Excel and the percentage wound closure was calculated 
as % WCR = (Original gap – gap at indicated time)/ (original gap) *100. Next the fold 
change in migration was calculated where FCM = (% WCR treated) / (% WCR 
untreated). Experiments were performed as at least 2 independent biological 
replicas.   
2.9 Cell labelling  
To be able to monitor the cells within the chimeric kidney rudiment assay, three 
labelling techniques were individually employed. These three techniques are as 
follows:  
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A) The carboxyfluorescein diacetate succinimidyl ester (CFDA SE) Cell Tracer Kit 
(C1157, ThermoFisher Scientific) utilises amine-reactive probes that covalently bind 
to cytosolic components of cells once they penetrate and are metabolized [REF].  
B) The PKH67 (PKH67GL, Sigma) is a lipophilic dye that stains the plasma membrane 
of cells through lateral diffusion [REF].  
C) Cells were transduced with a lentivirus vector expressing green fluorescent protein 
(GFP).  
The dye labelling kits were applied to the mesothelial cells following the standard 
recommended manufacturer’s instructions. Optimisation of dye loading 
concentrations was first identified, based on the brightest signal and limited impact 
on cell viability. The fluorescence intensity of all 3 labelling techniques was 
monitored over the course of 7 days via flow cytometry (BD Biosciences FACSCalibur, 
BD Biosciences), through the FL1 channel (530±30 nm). Meanwhile, cell death was 
determined by the trypan blue staining and cell counting using the automated cell 
counter.  
2.9.1 PHK67  
The mesothelial cells were washed twice in DPBS, before being detached, centrifuged 
at 1000 rpm in growth medium and counted. 1x106 cells were transferred to fresh 15 
ml centrifuge tubes, washed and pelleted. The supernatant was aspirated off leaving 
no more than 25 μl of residual fluid, and 500 μl of diluent C was added to evenly re-
suspend the cells. Since cell membrane staining is nearly instantaneous, a 2x working 
stock solution of 2 µM was made by adding 1 µl of 1 mM PKH67 dye (PKH67GL, Sigma) 
to 500 µl of diluent C in a fresh 1.5ml tube and vortexed. This was immediately 
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transferred onto the cells in suspension and mixed by pipetting to ensure uniform 
labeling. The cells were incubated with the probe at room temperature for 3 min, 
after which 1 ml FBS was added to stop dye uptake into cell membranes, followed by 
a further 1 min incubation step. The cells were pelleted at 1000 rpm for 10 mins, the 
supernatant removed, and the cells were washed a further 2 times in full growth 
medium before they were either plated out into 6 well plates for dye fading 
experimental monitoring; or co-cultured in the ex vivo rudiment assay.   
2.9.2 CFDA SE 
A 10 mM stock solution of the CFDA SE (C1157, ThermoFisher Scientific) was 
prepared prior to use by dissolving component A of the kit in 90µL DMSO. 
Mesothelial cells at passages 5 to 10 were used in this study and labeled in 
suspension. Firstly, the mesothelial cells were washed, pelleted and the supernatant 
was removed.  A final concentration of 5 µM probe was added to the cells in pre-
warmed DPBS and the cells were incubated for 15 mins at 37°C, 5% CO2 in a 
humidified environment. The cells were re-pelleted at 1000 rpm for 5 mins and re-
suspended 1 ml of FCS/ 1x106 cells and left to incubate for a further 30 min at 37°C, 
5% CO2 to ensure complete probe modification. Finally, the cells were re-pelleted at 
1000 rpm for 5 min and were either seeded in a 6 well culture plate (10119831, Nunc) 
for probe monitoring via flow cytometry or co-cultured in the chimeric rudiment 
assay (see section 2.10.1).    
2.9.3 GFP lentivirus-labelled MCs 
Mesothelial cells had been previously transduced by Dr. Anne Herman and Kelly 
Ward (Wilm group, 2011). Briefly, this involved culturing the mesothelial cells to 60% 
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confluence for transduction. Culture medium was aspirated and replaced with 
OptiMEM® (11058021 ThermoFisher Scientific)-based lentiviral infecting medium 
containing polybrene (8 µg/ml) and lentivirus particles based on the pLNT-SFFV-GFP 
vector for overnight incubation. The medium was replaced 24 h after transduction 
and the cells were cultured for a further 72 h at 37°C in 5% CO2. Finally, an 88% GFP 
positive stable mesothelial cell line was achieved through fluorescence-activated cell 
sorting (FACs) using the 488nm laser of the FACSAria II 
2.10 Metanephric kidney culture  
2.10.1 Kidney re-aggregation chimera assay 
The embryonic kidney re-aggregation assay used in this study was based on the 
Unbekandt and Davies (2010) protocol (Unbekandt and Davies, 2010). As described 
in section 2.1.3, kidneys rudiments were harvested from E13.5 CD1 mouse embryos. 
The rudiments were held on ice throughout sample harvest and preparation. The 
rudiments were transferred into a 15 ml centrifuge tube and washed with 3 ml of 
DPBS for 3 times with gentle, pulse centrifugation, to remove any traces of blood. 
The DPBS was carefully aspirated and the rudiments were incubated in 3 ml 5 x 
trypsin/ DPBS (T4174, Sigma) for 10 min, with intermittent gentle agitation at 37°C in 
5% CO2. The trypsin was neutralized in 10 ml of full growth rudiment culture medium 
containing 10% FCS, for 5 min at 37°C. The dissociated embryonic kidney cells were 
collected by centrifugation at 3000 rpm for 2 min and re-suspended in 1 ml the fresh 
full growth rudiment medium. Both the embryonic kidney cells and the labeled 
mesothelial cells were counted using trypan blue – exclusion assay. The embryonic 
kidney cells were either co-cultured by mixing with labeled mesothelial cells at a 1:10 
ratio; or were seeded alone to form pellets of 2x105 cells. To achieve this, the cell 
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mixtures were spun down at 3000 rpm for 2 min in 1.5 ml centrifuge tubes 
(10509691, Eppendorf).  The re-aggregated control rudiments (rControl), the 
chimeric rudiments (MC rudiments) or whole embryonic rudiments (eControl) which 
had not been dissociated, were transferred using a 200 µl pipette tip onto 1.5 µm 
membrane filters (RTTP02500, Millipore) placed on 0.4 mm holes metal grids (Inoxia 
Ltd) at a liquid-air-interface at 37°C, 5% CO2. The samples were cultured in kidney 
rudiment medium containing 5 µM Rho kinase inhibitor (Y-27632, Millipore) for the 
first 24 h, and subsequently cultured in kidney rudiment medium without Rho kinase 
inhibitor. Samples were harvested at days 4 and 7 for confocal image analysis. GFP 
labeled mesothelial cells at passages 22-32 were used throughout the kidney 
rudiment study, and the assay was successfully repeated on 7 independent 
occasions. Labelling with the CFDA SE and PKH67 probes was performed on younger 
mesothelial cells between passages 7 and 10. Each dye labeling technique was 
assayed using 3 independent biological samples. Figure 2.2 shows a schematic 
representation of the kidney rudiment assay culture technique. 
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2.10.2 Isolation of GFP+ MCs from the chimeric rudiment assay  
GFP labeled mesothelial cells between passages 30 and 32 that had incorporated into 
the chimeric rudiments, were isolated for qPCR analysis as follows: The pellets were 
first collected in a 15 ml centrifuge tube to be disassociated in 5x trypsin/ DPBS for 
10 min with intermittent and gentle agitation at 37°C. The cells were pelleted at 1000 
rpm for 5 min and re-suspended in ice-cold 10% FBS/DPBS and held on ice. Using the 
BD FACS ARIA III, GFP+ mesothelial cells were harvested from the single cell mix of 
embryonic and adult cells through a number of gating parameters that were initially 
set up using non-aggregated GFP-labelled mesothelial cells. The dead cells and debris 
were gated out using side scatter (SSC-A) against forward scatter (FSC-A). The cell 
clusters were next gated out by plotting FSC-A vs FSC-H and SSC-W vs SSC-H. GFP+ 
cells were then selected by plotting the signal detected with the 488-nm laser (GFP 
FITC-A log) vs SSC-A. A histogram was finally plotted with count vs GFP FITC-A 
parameters to select cells with the brightest fluorescence cells. 
2.11 Immunofluorescence techniques 
2.11.1 Immunofluorescence staining of cultured cells  
For the characterisation of protein distribution in cells, mesothelial cells, and the 
clones were seeded at 4x104 cells/ well in 8 well chamber slides (Lab-Tek™ II, Nunc) 
and cultured to 80% confluence. Omentum explants were analyzed by seeding 2 
explant pieces per chamber and left to culture for 14 d. Finally, cells that were either 
stimulated with growth factors, or were cultured in small molecule inhibitors for 48 
h, were seeded into 24 well plates, plated at 5x104, and by the end of the treatment 
had reached 90% confluence. Finally, the mesothelial cells that were involved in the 
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siRNA-mediated transcription factor knockdown were plated in 12 well plates at 
6x104 and for 72 h post treatment.  
Subsequently, the medium was aspirated from the cell monolayer or explant pieces 
and the cells were quickly rinsed twice in DPBS. Following a 15 min fixation in 4% PFA 
(section 2.16.5), the cells were once again washed in DPBS for 5 min at RT. Next, the 
cells were permeabilized in 0.25% Triton-X/PBS (93426, Fluka) for 10 min. Following 
a 5 min DPBS wash, the cells were blocked with 2% bovine serum albumin (BSA) 
(BPE9701, ThermoFisher Scientific) for one hour at RT. This was followed by an 
overnight incubation with primary antibody solution in 2% BSA at 4°C in a humid 
chamber (see table 2.4). The following day the cells were washed 3 times for 15 min. 
Cells cultured in chamber slides were subsequently incubated with secondary 
antibody solution in 2% BSA for 1 h at RT in the dark. Samples were imaged using a 
Leica DMR-HC microscope with Leica DFC350FX camera and Leica application 
software. Meanwhile, cells cultured in the 24 - 12 well plates were incubated in the 
secondary antibody solution overnight at 4°C with gentle rocking. The cells were 
extensively washed for an hour in DPBS. Samples that were cultured on the glass 
chamber slides were mounted in anti-fade mounting medium Gelmount (1798510, 
Biomedia). Meanwhile, cells cultured in the 12 and 24 well plates were left hydrated 
in DPBS and documented using the Leica DM IRBE inverted microscope. Experiments 
were performed with 3 - 4 independent biological samples. 
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2.11.2 Immunofluorescence of intact kidney rudiments and kidney chimeras 
In this study, both the rControl (re-aggregated kidneys), and the eControl (whole 
embryonic kidneys) as well as the chimeric rudiments, were transferred from the 
grids into a 48 well plate, while attached to the membrane filters. They were quickly 
and gently rinsed in PBS, before being fixed in 4% PFA for 30 min. After a 10 min wash 
in PBS, the samples were blocked in 10% goat serum/PBS containing 0.1% Triton 
X100/ PBS. Since the pellets were quite large, the samples were incubated in 300 µl 
of primary antibody containing the same 10% goat serum block, with 0.1% triton 
X100/PBS; overnight at 4°C with gentle rocking. The following morning, the samples 
were carefully washed 3 times in PBS for 15 min, as not to flush the pellets off the 
membranes. Next, 300 µl of secondary antibodies in the same blocking solution were 
added to the rudiments and incubated for 2 hours at RT in the dark. Finally, the 
rudiments were washed 3 more times in PBS, for 15 min, before being mounted onto 
glass slides with 80% glycerol (section 2.16.6). Rudiments were imaged using the 
Zeiss LSM 510 Multiphoton confocal microscope.  
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Table 2.4: Details of the primary antibodies used throughout this study.  
Antibody Type Concentration Supplier 
Bmi1 Rabbit Ig, 
polyclonal 
1:50 AP8756a, Abgent 
GFP Rabbit IgG, 
polyclonal 
1:5000 ab290; Abcam 
Laminin α1β Rat IgG, 
monoclonal 
1:200 MAB1905, Millipore 
Megalin Mouse IgG1, 
monoclonal 
1:200 DM3613P, Acris 
Pan-Cytokeratin Rabbit IgG, 
polyclonal 
1:200 Z0622, Dako 
Pax2 Rabbit IgG, 
polyclonal 
1:200 PRB-276P, 
Biolegend 
PECAM Rat IgG2a, 
monoclonal 
1:100 550274, BD 
Pharmingen 
Six2 rabbit IgG, 
polyclonal 
1:200 11562-1-
AP/Proteintech 
Sox9 Rabbit IgG, 
polyclonal 
1:100 SC-20095, Santa 
Cruz 
Vimentin Goat IgG, 
polyclonal 
1:200 64740, ICN 
Biomedicals Inc. 
Wt1 Mouse  IgG1, 
monoclonal 
1:100 05-753, Millipore 
ZO1 Rabbit IgG 
polyclonal 
1:200 40-2200, Life 
Technologies 
α1 Sodium Potassium ATPase 
- Plasma Membrane Marker 
Mouse IgG1, 
monoclonal 
1:200 Ab7671, Abcam 
α-smooth muscle actin Mouse IgG2a, 
monoclonal 
1:200 A2547, Sigma 
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Table 2.5: Details of the secondary antibodies and nuclear stain used throughout this study.  
Antibody Type Concentration Supplier 
Anti-goat, AlexaFluor 546 Donkey 
IgG 
1:1000 A11056, ThermoFisher 
Scientific 
Anti-mouse AlexaFluor 
488 
goat IgG 1:1000 A11001, ThermoFisher 
Scientific 
Anti-mouse AlexaFluor 
594 
goat IgG1 1:1000 A21125, ThermoFisher 
Scientific 
Anti-mouse AlexaFluro 
594 
goat IgG 1:1000 A11032, ThermoFisher 
Scientific 
Anti-rabbit AlexaFluro 
488 
goat IgG 1:1000 A11008, ThermoFisher 
Scientific 
Anti-rabbit AlexaFluro 
647 
goat IgG 1:1000 A21245, ThermoFisher 
Scientific 
Anti-rabbit, AlexaFluor 
488 
Donkey 
IgG 
1:1000 A21206, ThermoFisher 
Scientific 
Anti-rat AlexaFluro 594 goat IgG 1:1000 A11007, ThermoFisher 
Scientific 
Nuclear counterstain 
DAPI 
---- 1:1000 D1306, ThermoFisher 
Scientific 
 
2.12 Molecular biology techniques 
2.12.1 TRIzol® based RNA extraction:  
Total RNA was extracted from cells and tissue samples using TRIzol® reagent 
(15596018, ThermoFisher Scientific) according to the manufacturer’s instructions. 
Samples were washed with DPBS to flush away debris and media, and then 
appropriate TRIzol® volumes and cell lysis techniques were employed according to 
sample type, as described in table 2.6.  
Table 2.6: homogenization techniques  
Sample type Action 
Tissues Whole omentum tissue and adult and embryonic kidney organs were 
directly homogenized in 1, 4 and 2 ml of TRIzol®, respectively, using a 
power homogenizer (15-340-145, Fischer Scientific). The samples were 
then filtered using 0.45 µM pore-size filter units (F8273-50EA, Sigma). 
Adherent Cells 
(monolayers) 
Cells in a 10 cm dish were incubated in 1 ml of TRIzol® for 5 min, at RT; 
before being further lysed by pipetting.  
Cells harvested 
from the FACS 
1ml of TRIzol® was added to the pelleted FACS GFP+ MC. The cells were 
mechanically lysed by pipetting, following a 5 min incubation period at 
RT.  
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The lysed samples were transferred into a 1.5 ml microcentrifuge tube and per 250 
µl of TRIzol® reagent used, 50 µl of chloroform was added and the homogeneous 
mixtures were vigorously shaken for 15 s. Following a 15 min centrifugation at 13000 
rpm, three phases could be distinguished. The RNA in the aqueous phase was 
pipetted into a clean 1.5 ml tube and an equal volume of isopropanol was added. The 
solution was inverted 6 times and left to stand at RT for 10 min before being 
centrifuged at 13000 rpm for 10 min to obtain an RNA pellet. The supernatant was 
discarded and the pellet was washed twice with 75% ethanol at a slower speed of 
7500 rpm for 5 min. Before the pellets could be re-suspended in 11-50 µl of DNAse 
and RNase-free distilled water, the ethanol was removed and the pellets were left to 
air dry. The RNA concentration (ng/µl) and quality (260/280nm where the ratio value 
lies between1.8-2.0) were determined spectrophotometrically (ND1000, NanoDrop).  
Meanwhile, the RNA integrity was determined on a 1% agarose gel.  
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2.12.2 DNase treatment  
An RQ1 DNase digestion (M6101, Promega) was performed to remove residual DNA 
from the RNA samples prior to qPCR applications, as it is vital to maintain RNA 
integrity when obtaining meaningful gene expression data. A single DNase digestion 
reaction was composed of 1.4 µg of RNA in 8 µl of DNase/ RNase-free water, 1 µl of 
10X reaction buffer and RQ1 endonuclease. The samples were incubated at 37°C for 
30 min, in a thermocycler (ABgene). The reaction was terminated by incubating the 
samples with 1 µl Stop buffer at 37°C for 15 min.  
2.12.3 cDNA synthesis  
The Superscript III kit (18080-044, ThermoFisher Scientific) was used for the first-
strand complementary DNA (cDNA) synthesis of 200 ng/µl template RNA. To 
denature the secondary structures of the RNA and any hexamer duplexes, 4 µl of 
DNase-treated RNA was incubated with 2 µl random hexamers (100 ng/µl) and 1 µl 
10 mM dNTP mix, for 5 min, 65°C and cooled on ice for 1 min. Next, 4 µl of the 5x 
buffer, 2 µl of DTT (0.1 M) and 1 µl Superscript III polymerase (200 U/µl) were also 
added and the samples were collected at the bottom of the tube by pulse 
centrifugation. To facilitate random primer annealing, the reaction tubes were 
heated for 5 min to 25°C. The reaction mixture was heated to 50°C, for 60 min, for 
the DNA polymerase to catalyze cDNA synthesis. Finally, the enzyme was inactivated 
at 70°C for 15 min.  
2.12.4 Primers  
The primers used in this study were designed in-house to detect sequences that are 
common across all the alternative splicing variants. The primers also spanned across 
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multiple exons (2 or more) to reduce the risk of false positives from contaminating 
genomic DNA amplification. The oligonucleotides were purchased from Sigma-
Aldrich as a lyophilized product and reconstituted in nuclease-free water to a stock 
concentration of 100 µM. Primer specificity was validated in several ways. The 
optimal annealing temperature was determined via a thermal gradient qPCR assay 
using cDNA of a positive control sample know to express the target gene of interest. 
The temperature giving the lowest cycle threshold (Ct) without any amplicons was 
selected. Meanwhile, the presence of secondary nonspecific products and primer-
dimers was determined via melt curve and 1% agarose gel analysis, and if detected, 
the respective primers were discarded from the study.  
2.12.5 Quantitative polymerase chain reaction 
Quantitative polymerase chain reactions (qPCR) were used to assess the relative 
changes in gene expression of samples after culture and in specific stimulation 
studies. Each reaction comprised of 7.5 µl of SYBR® Green Jumpstart™ Taq 
readymix™ (S4438, Sigma), 1.5 µl of the forward primer (250 nM final concentration), 
1.5 µl of the reverse primer (250 nM final concentration) and the diluted cDNA (4.5 
ng/ µl final concentration), and the volume was adjusted to 15 µl with nuclease free 
PCR grade water. The samples were vortexed to mix the cDNA with the SYBR green 
and were plated into hard shell white-coated 96 well plates (HSP-9645, BioRad). The 
qPCR was run on the CFX Connect Real-Time PCR (BioRad), using 2 step amplification 
settings. A melt curve was generated at the end of the amplification. The cycling 
programme used is shown in table 2.7. All samples were run as triplicates for each 
gene per reaction plate. Target experimental values were normalized to 2 
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housekeeping genes using the relative quantification method with 3 independent 
biological samples per condition. 
Table 2.7: qPCR cycling conditions  
qPCR conditions for the characterization studies Wt1 isoform qPCR study  
Cycles Description Cycles Description 
1 cycle 95oC for 3 min 1 cycle 95oC for 3 min 
50 
cycles 
Denaturation at 95oC for 10 sec 
Annealing and extension at 60/ 62oC 
for 30 sec 
40 
cycles 
Denaturation at 95oC for 10 
sec 
Annealing 58oC for 20 sec 
Extension 72oC for 1 min 
1 cycle Melt curve: 65oC to 95 oC, in 0.5 oC 
increments for 5 sec 
1 cycle Melt curve: 65oC to 95 oC, in 
0.5 oC increments for 5 sec 
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Table 2.8: Details of primer sequences and product length are shown below  
Gene Forward primer Reverse primer Melting 
temperatu
re 
Product 
length 
Housekeeping genes 
Gapdh CATCTTCCAGGAGCGAGA
CC 
GAAGGGGCGGAGATGATGA
C 
60°C/ 62°C 150 
β-actin GTACCCAGGCATTGCTGA
CA 
CTGGAAGGTGGACAGTGAG
G 
60°C/ 62°C 145 
EMT markers/ mediators 
TGF-β1 GCCTGAGTGGCTGTCTTTT
G 
CAGTGAGCGCTGAATCGAA
A 
60°C/ 62°C 93 
TβRI TCCAAACCACAGAGTAGG
CAC 
GTCAGCGCGTTTGAAGGATT
C 
60°C/ 62°C 97 
TβRII GTGAGACTGTCCACTTGC
GA 
TGTCGTTCTTCCTCCACACG 60°C/ 62°C 112 
EGFR CACATGCAAAGACACCTG
CC 
TCGTAGTAGTCAGGCCCACA 60°C/ 62°C 117 
Cell-junctional markers 
Krt8 GATGAACCGCAACATCAA
CCG 
GGTCTGGGCATCCTTAATGG
C 
60°C 127 
Cdh1 GCTCTCATCATCGCCACAG
A 
GCAGTAAAGGGGGACGTGT
T 
60°C 197 
ZO1 TGCCATTACACGGTCCTCT
G 
AGGGACTGGAGATGAGGCT
T 
60°C 175 
Vcl CCGCTGCTCGGATCTTACT
G 
CAATAGCCTCGTCCACCAGC 60°C 123 
Msln ATGTACTCCCACGGAGGT
CT 
GCCACAAATTTCCCAGGCAG 60°C 145 
Mesenchymal markers 
Cdh2 CGCAAAGACCTTGTGGAG
GG 
AGGCGTTTCAAGTCTGCCAC 60°C 149 
Vim TCTGCCTCTGCCAACCTTT
T 
ACCTGTCCATCTCTGGTCTCA 60°C 126 
S100A4 AGCTACTGACCAGGGAGC
TG 
ATCTGGGCAGCCCTCAAAGA 60°C 179 
Acta2 AGAGGCACCACTGAACCC
TA 
CACCATCTCCAGAGTCCAGC 60°C 158 
 Stem cell genes 
Sox9 CAAGACTCTGGGCAAGCT
CT 
CCGGGGCTGGTACTTGTAAT
C 
60°C 124 
Bmi1 GCTCCAATGAAGACCGAG
GA 
ATTGCTGCTGGGCATCGTAA 60°C 178 
Sox2 CACATGTGAGGGCTGGAC
TG 
TCCTCTTTTTGCACCCCTCC 60°C 146 
CD34 TCATCTTCTGCTCCGAGTG
C 
GCCTCAGCCTCCTCCTTTTC 60°C 176 
  Transcription factors 
Wt1  CCAAATGACCTCCCAGCTT
GA 
TGCTCTGCCCTTCTGTCCAT 58°C/ 60°C 116 
Twist 1* AGCGGGTCATGGCTAACG GGACCTGGTACAGGAAGTC
GA 
60°C 162 
Zeb1 GGGGAAACCGCAAGTTCA
AG 
AGCCAGAATGGGAAAACCG
T 
60°C 141 
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Zeb2 TCAAGTACCGCCACGAGA
AG 
CTTGCGGTTACCTGCTCCTT 60°C 155 
Snail 1 AGCCCAACTATAGCGAGC
TG 
GTAGGGCTGCTGGAAGGTG
A 
60°C 112 
Snail 2 CGAACCCACACATTGCCTT
G 
GTGAGGGCAAGAGAAAGGC
T 
60°C/62°C 117 
                                                                                Kidney markers 
Ret TGAAGACAGGCCACAGGA
TG 
CAGCAAACACTGGCCTCTTG 62°C 108 
CD10 CAGCCTCAGCCGAAACTA
CA 
CATAAAGCCTCCCCACAGCA 60°C 140 
AqpI CACCTGCTGGCGATTGACT
A 
CACCTTCATGCGGTCTGTGA 60°C 195 
AqpII CCCTGCTCTCTCCATTGGT
T 
AGGGGAACAGCAGGTAGTT
G 
60°C 200 
Synaptopo
din 
TTCCTTCTCCACCCGGAAT
G 
CTCCACGAGGGGGACATTG 62°C 207 
Wnt4 CGAGGAGTGCCAATACCA
GTT 
CCTTGTGTCACCACCTTCCC 62°C 90 
Wnt6 GATGTGGACTTCGGGGAT
GA 
GTTGCACCAATGCACGGATA 62°C 88 
Eya1 CAATAATCCCTCCCCTCCC
C 
CCGTATCTGTTGGCGTAGGA 62°C 117 
Wt1 AATGCGCCCTACCTGCCCA CCGTCGAAAGTGACCGTGCT
GTAT 
60°C/ 62°C 116 
Notch2 TGTGACAGCCCTTATGTGC
C 
GGGCAGTCGTCGATATTCCG 62°C 143 
Sdf1 GCTCTGCATCAGTGACGG
TA 
TCAGATGCTTGACGTTGGCT 62°C 98 
Fgf7 AAGACTGTTCTGTCGCACC
C 
CAATTCCAACTGCCACGGTC 62°C 122 
Igf11 ACCTCAGACAGGCATTGT
GG 
TCTTGGGCATGTCAGTGTGG 62°C 137 
FoxC1 GAAGGACGCAGTGAAGG
ACAA 
ACACGTACCGTTCTCCGTCTT 62°C 178 
Pax2 TCCAGGCATCAGAGCACA
TC 
GGCCGATGCAGATAGACTG
G 
62°C 104 
Sal1 TTTCCAATCCGACCCCGAA
G 
CCACAGACATGGGCATCCTT 62°C 105 
Bmp7 CTCGATACCACCATCGGG
AG 
CAGCAAGAAGAGGTCCGAC
T 
62°C 188 
Gdnf CGCTGACCAGTGACTCCA
AT 
AAACGCACCCCCGATTTTTG 62°C 222 
                                                                                Adipocyte markers 
Fatp1 CAGTGCGTCATCTACGGG
TT 
AGGTAGCGGCAGATTTCACC 60°C 125 
Fatp4 CAGCCTCAGCCGAAACTA
CA 
CATAAAGCCTCCCCACAGCA 60°C 140 
Glut4 CATTGTCGGCATGGGTTTC
C 
GGCAGCTGAGATCTGGTCAA 60°C 151 
Pparγ ATTGAGTGCCGAGTCTGT
GG 
GCAAGGCACTTCTGAAACCG 60°C 191 
                                                                                Osteoblast markers 
Igfbp3 CACAATGCTGGGAGTGTG
GA 
TGTCCTCCATTTCTCTGCGG 60°C 185 
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Fgf23 CCGCTGCTGCATTTCTACA
C 
CTCGCGAGAGCAGGATACA
G 
60°C  1
35 
Dmp1 TCCTTGTGTTCCTTTGGGG
G 
CCAGATTCACTGCTGTCCGT 60°C 199 
Sparc TGTTGGCCCGAGACTTTG
AG 
CGTGTGGTGCAATGTTCCAT 60°C 160 
Alpl CCGGCTGGAGATGGACAA
AT 
CTCATTGCCCTGAGTGGTGT 60°C 184 
Mesodermal markers 
Brachyury TCCCCACCTGAAGACAGG
AA 
CAGGATGGGTCTGGATCAC
G 
60°C 155 
Fgf5 AAGTCAATGGCTCCCACG
AA 
TCCTCGTATTCCTACAATCCC
CT 
60°C 88 
FoxF1 CCAAAACAGTCACAACGG
GC 
TCACACACGGCTTGATGTCT 60°C 191 
FoxC2 GAAGAAGGATGTGCCCAA
GGA 
CCGCCTCGCTCTTAACCAC 60°C 146 
Nodal CAAGCCTGTTGGGCTCTAC
TC 
CCGGTCACGTCCACATCTTG 60°C 179 
Wnt3a GCTCTGCCATGAACCGTCA CACCAGCAGGTCTTCACTTC
A 
60°C 118 
Wnt8a GGGAACGGTGGAATTGTC
CT 
CAGCCGCAGTTTTCCAAGTC 60°C 163 
Osr1 GCCCCCAAAAAGGAGAGA
GT 
AGCCACAGCTCATCCTTTACC 60°C 161 
 
 
Table 2.9 Wt1 primer sequences for isoform studies 
 
 
 
 
WT1 variant Primer sequence 
EX5(-)fwd GAGCCA CCTTAAAGGGCCA 
EX5(+)fwd ATGGACAGAAGGGCAGAGCA 
KTS(-)-rvs GCTGAAGGGCTTTTCACCTGTA 
KTS(+)-rvs CTGAAGGGCTTTTCACTTGTTTTAC 
 
Wt1 isoforms 
detected 
Primer sequence combination Product 
length 
Wt1 A EX5(-)fwd KTS(-)-rvs 455 
Wt1 B EX5(+)fwd KTS(-)-rvs 460 
Wt1 C EX5(-)fwd KTS(+)-
rvs 
463 
Wt1 D EX5(+)fwd KTS(+)-
rvs 
468 
(Kramarzova et al., 2012) 
71 
 
2.12.6 qPCR data analysis  
Following completion of the qPCR runs, each experimental study set had the baseline 
threshold adjusted consistently through the Biorad CFX manager software. All cycle 
threshold values (CT) were then transferred into an excel spreadsheet for the 
calculation of fold change. The CT corresponds to the cycle number at which the 
fluorescent signal crosses the threshold. In order to assess the difference in 
expression between treated and control samples, the following steps were 
performed:  
Firstly, the average CT of the target gene of interest (GOI) was normalized against the 
average combined CT of each sample’s internal housekeeping genes (HKG) to 
calculate the dCT, using the following equation: dCT=CT (GOI) - CT (HKG). Since each 
experiment was performed on 3 independent biological replicas, the mean dCT was 
ascertained. Following on, the ddCts were calculated relative to the control group 
with the following formula: ddCt =dCT (Control group) - dCT (Target group). Finally, the relative 
fold change in gene expression was determined by the equation: 2-(ddCT).  
2.13 Biochemistry  
2.13.1 Cell Lysis 
The cells were washed in ice-cold PBS, supplemented with protease inhibitors and 
sonicated in 120 µl ice-cold cell extraction buffer (section 2.16.1). The lysates were 
transferred into a 1.5 ml centrifuge tube and centrifuged at 13,000 rpm for 10 min at 
4°C. The clear lysates were aliquoted into fresh tubes for protein quantification.  
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2.13.2 Protein quantification 
Protein concentrations were quantified using the Pierce™ BCA Protein Assay Kit 
(23225, ThermoFisher Scientific), following manufacturer’s instructions. Briefly, a 
protein standard curve was generated by serially diluting a 1 mg/ml BSA stock 
solution in distilled water to values between 0 - 1000 µg/ml. These and the unknown 
protein samples were added to the preformed BCS solution which consists of a 50:1 
mixture of Reagent A (Bicinchoninic acid solution) and Reagent B (copper sulfate 
solution). The samples were incubated at 37°C for 30 min and absorbance was read 
at 562 nm using the FLUOstar Omega spectrophotometer. 
2.13.3 Resolving proteins with western blotting  
Samples were denatured at 90°C for 5 min before 15 µg of total cell lysates were 
loaded onto a 4-12% Bis-Tris gel (NP0335BOX, NuPAGE®, ThermoFisher Scientific) for 
electrophoresis in MOPs running buffer (section 2.16.2) at 200 V constant for 50 min. 
Following protein separation, the contents were transferred onto an activated PVDF 
0.2 µm pore blotting membrane (ISEQ00010, Merk Millipore) using wet transfer 
apparatus (XCell II™ Blot Module, EI9051, ThermoFisher Scientific) for 1 h at 3 V. The 
membranes were blocked for 1 h at RT in Western Blocker Solution (W0138, Sigma), 
before being incubated overnight with the primary antibody solutions on a rocker at 
4°C. The membranes were washed for 30 min the following morning in Tris-buffered 
saline with Tween (section 2.16.4). The secondary antibodies were added to the 
membranes for 1 h on a rocker at RT. Following a 45 min TBST wash, the proteins 
were visualized using Pierce ECL (32109, ThermoFisher Scientific) or the more 
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sensitive Amersham ECL prime (GERPN2232, GE Healthcare) on Amersham Hyperfilm 
(28906835, GE Healthcare).   
2.13.4 Quantification of the fold change in relative protein expression   
Following film development, the samples were quantified using imageJ application 
software. The target protein values were normalized to their own loading control and 
the fold change in expression was compared against the untreated control samples. 
Meanwhile, the proportion of phosphorylated proteins was calculated as follows: 
[(phosphoprotein/β-actin)/total protein/β-actin]. Experiments were performed as 2 
independent biological samples.  
  
74 
 
Table 2.9: western primary antibodies  
Antibody Type 
1°Ab 
Concentration 
2°Ab 
Concentration 
Supplier 
β-actin (8H10D10) 
 
Mouse 
monoclonal 
1:10000 1:20000 3700, CST 
Slug (C19G7) 
 
Rabbit 
monoclonal 
1:1000 1:5000 9585, CST 
α-smooth muscle 
actin 
Rabbit 
polyclonal 
1:500 1:5000 ab5694 
ZO1 
Rabbit IgG 
polyclonal 
1:200 1:5000 
40-2200, Life 
Technologies 
 
Vimentin 
Goat IgG, 
polyclonal 
1:200 1:5000 
64740, ICN 
Biomedicals 
Inc. 
 
Phospho-Erk5 
(Thr218/Tyr220) 
Rabbit 
monoclonal 
1:2000 1:5000 3371, CST 
Erk5 (D23E9) 
 
Rabbit 
monoclonal 
1:1000 1:5000 3552, CST 
Phospho-p44/42 
MAPK (Erk1/2) 
(Thr202/Tyr204) 
(D13.14.4E) XP® 
Rabbit 
monoclonal 
1:2000 1:5000 4370, CST 
p44/42 MAPK 
(Erk1/2) (3A7) 
Mouse 
monoclonal 
1:1000 1:5000 9107, CST 
 
Table 2.10 western secondary antibodies  
Antibody Type Supplier 
Peroxidase-
AffiniPure 
Goat Anti-Rabbit 
IgG 
111-035-144-JIR, Jackson 
ImmunoResearch 
Peroxidase-
AffiniPure 
Goat Anti-Mouse 
IgG 
115-035-003-JIR, Jackson 
ImmunoResearch 
Peroxidase-
AffiniPure 
Donkey Anti-Goat 
IgG 
705-035-003-JIR, Jackson 
ImmunoResearch 
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2.14 Statistical analysis  
The data from each experiment were first averaged and presented as means with 
standard error bar (SEM). The statistical analysis was performed using either a 
student T test or a one-way ANOVA to determine statistical significance between 
groups. This was followed by a Sidak multiple-comparison test to determine 
significance between individual groups (unless otherwise stated). A p value of <0.05 
was considered significant. All statistical data was analysed using GraphPad Prism 
version 6.00 for Windows. 
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2.15 Medium composition  
2.15.1 Mesothelial cell standard growth medium 
DMEM (D5796, Sigma) containing 10% (v/v) FBS (F6178, Sigma), and 1% (v/v) 
streptomycin - penicillin (P4333, Sigma)  
2.15.2 Conditioned medium 
The medium was aspirated off the cultured mesothelial cells and was pelleted to 
collect the debris. The conditioned medium was then transferred to a fresh tube and 
mixed with fresh standard full growth medium at a 1:1 ratio. 
2.15.3 Kidney rudiment medium  
MEME (M5650, Sigma) containing, 10% (v/v) FCS and 1% (v/v) 200mM L-glutamine 
(G7513, Sigma) 
2.15.4 Adipogenic medium  
Standard FGM supplemented with 100nM dexamethasone (D4902, Sigma), 500nM 
3-isobutyl-1-methylxanthine (I7018, Sigma), 50μM indomethacin (I7378, Sigma) and 
1μg/ml insulin (I6634, Sigma)  
2.15.5 Osteogenic medium  
MC FGM supplemented with 100nM dexamethasone, 10mM β-glycerophosphate 
(G9422, Sigma) and 25μg/ml of 2-Phospho-L-ascorbic (49752, Sigma).  
2.15.6 Cell Freezing solution  
The freezing solution was composed of 90% fetal bovine serum (FBS; (F6178, Sigma)) 
and 10% dimethyl sulphoxide (DMSO; D2438, Sigma).    
2.16 Buffers, solutions, and dyes 
2.16.1 Cell lysis buffer 
 4.733 ml Cell Extraction Buffer (FNN0011, ThermoFisher Scientific) 
 17 µl phenylmethanesulfonyl fluoride or phenylmethylsulfonyl fluoride 
(PMSF) (1 mM final concentration) 
 250 µl Protease inhibitor cocktail that is composed of AEBSF (2 mM), 
Aprotinin (0.3 μM), Bestatin (116 μM), E-64 (14 μM), Leupeptin (1 μM) and 
EDTA (1 mM) (P-2714, Sigma). 
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2.16.2 MOPS buffer  
 950 ml dH2O 
 50 ml NuPAGE® MOPS SDS Running Buffer (20X) (NP0001, ThermoFisher 
Scientific) 
2.16.3 Transfer buffer  
 849 ml dH2O 
 50 ml NuPAGE® MOPS SDS Running Buffer (20X) (NP0001, ThermoFisher 
Scientific) 
 1 ml NuPAGE® antioxidant (NP0005, ThermoFisher Scientific)  
 100 ml analytical grade methanol  
2.16.4 TBST  
 50 ml Pierce™ 20X TBS Tween™ 20 Buffer (28360, ThermoFisher Scientific) 
 1 ml Tween-20 (0.1% final concentration)  
 949 ml dH2O 
2.16.5 4% PFA  
 20 g PFA (Sigma)  
 500 ml PBS  
PFA powder was dissolved on a heated magnetic stirrer at 60°C. The solution’s pH 
was then adjusted to 7.4-7.6, filtered and stored long-term storage at -20°C.  
2.16.6 Kidney rudiment mounting solution  
 80 ml glycerol (G5516, Sigma)  
 20 ml dH2O  
 Autoclaved before use  
2.16.7 Alizarin S red dye 
 2 g Alizarin Red S (C.I. 58005)  
 100 ml distilled water   
Adjust pH to 4.1~4.3 with 10% ammonium hydroxide.  
2.16.8 Oil red dye 
 0.5 g oil red O (CI 26125, Sigma)       
 100.0 ml isopropanol 
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Chapter 3: Isolation and 
characterisation of 
mesothelial cells in long-
term culture 
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3.0 Introduction and aims 
There is accumulating evidence pointing towards the presence of a population of 
progenitor cells within the peritoneum that under certain cues become activated to 
drive regeneration processes through differentiation. Such properties may explain 
the healing potential of omentum transpositions, however, the mechanisms 
underpinning this remain elusive.  
The overall goal of this chapter was to assess the phenotype of cultured mouse 
omentum-derived mesothelial cells in vitro. 
Specifically, we aimed to characterize the cell morphology of the isolated mesothelial 
cells and assess the effect of repeated passaging and prolonged culturing on 
mesothelial cell characteristics. We aimed to investigate these effects by studying 
changes in gene expression signatures relative to the omentum cultures. We 
analyzed at a molecular level the regulatory mechanisms that resulted in any changes 
observed in the culture of mesothelial cells; furthermore, we wondered which 
implications these changes in cultured mesothelial cells had on regenerative 
therapeutic outputs.    
Lastly, we also aimed to explore the plasticity of mesothelial cells by studying their 
potential clonogenic properties and the expression of stem cell markers.   
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3.1 Isolation and culture of mesothelial cells  
The mouse omentum is a peritoneal - fold of tissue composed of two mesothelium 
layers which connect the stomach, spleen and the pancreas (Fig 3.1). The mesothelial 
cells are the predominant cell type in this fenestrated membrane-like structure, and 
due to the relative ease of access, the omentum it is an ideal source of mesothelial 
cells (Fedorko et al., 1971).  
 
Figure 3.1: CD1 mouse omentum (OMT) is located between the stomach (st) and spleen 
(sp) complex.  
 
Previously published work by our group demonstrated the culture of omentum 
explants for 5 d, with mesothelial cells emerging 2 d post seeding (Kawaguchi et al., 
2007). In the current study, we were able to replicate this, showing epithelial sheets 
of mesothelial cells migrating radially from the explanted tissues within 4 d of seeding 
(Fig 3.2A). Prolonged omentum explant culture (OMC) for more than 14 d resulted in 
Sp 
St 
OMT 
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the appearance of longer, spindle-shaped cells. These cells occurred initially at the 
leading edge of the epithelial sheet before spreading more widely (Fig 3.2B). In order 
to avoid that subsequent passaged mesothelial cultures contained the spindle-
shaped cells, we treated the omentum cultures by 14 d to generate passage 1 (P1) 
mesothelial cell lines.  The explant cultures were sensitive to physical detachment 
protocols such as scraping and vigorous pipetting, and as a result, we could not 
establish mesothelial cell lines through these techniques. Instead, we found that 
prolonged exposure to enzymatic treatment resulted in the complete dissociation of 
the omentum-derived cells and the eventual establishment of a mesothelial cell line. 
Cell density was not a limiting factor in the establishment of murine mesothelial cell 
cultures. However, typically it took up to 4 passages to achieve a homogeneous 
monolayer as the cells needed to be serially expanded. This is contrary to other 
primary cultures established from human and rat peritoneum (Książek, 2013, Jiang 
et al., 2010).  
Following trypsin incubation, detachment and seeding as P1 cells, subconfluent 
mesothelial cells had a slightly elongated phenotype (Fig 3.2C), however, the 
cobblestone phenotype was restored upon confluence in P1 cells (Fig 3.2D). From 
passage 4 onwards, the mesothelial cells adopted a less cobblestone phenotype, 
which was largely maintained even at higher passages (Fig 3.2D-E). Throughout this 
research project, 12 biologically independent mesothelial cell cultures were 
successfully generated through this procedure and the cells were successfully sub-
cultured to P40.  
 
82 
 
 
 
Figure 3.2: Generation of the mesothelial cell line. [A] The omentum culture explants (OMC) 
that were cultured for 4 d were surrounded by a sheet of epithelial-like mesothelial cells 
(arrowheads). [B] Prolonged cultured led to the appearance of fibroblastic mesothelial cells 
(M) that bordered (dashed line) the few remaining epithelial cells (E). [C] Following 
subculture, the sub-confluent P1 cells adopted an elongated morphology (arrowheads), 
however, the cobblestone appearance returned upon confluence [D]. With time in culture, 
the cells became slightly more elongated (arrows) but the general phenotype remained 
stable from P4 [E] to P24 MCs [F]. Images are representative of n≥3 independent biological 
replicates.  
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3.2 Long-term cultured mesothelial cells displayed a capacity to proliferate 
in even high passages  
Since we were able to successfully culture mesothelial cells up to P40, we aimed to 
investigate the effects of repeated passaging had on the population doubling times 
(PDT). The trypan blue exclusion assay is a simple technique for calculating the rate 
of cell proliferation and the percentage of viable cells because the dye easily diffuses 
across cell membranes of dead or dying cells only (Berridge et al., 2005). The PDT of 
mesothelial cells was monitored between passages 5 through to 18. The cells were 
grown to 90% confluence before harvesting and staining with trypan blue to quantify 
cell death. We had chosen to start the assay at P5 which was the lowest 
homogeneous passage available following isolation from the omentum explants. Our 
analysis showed that the PDT of P5 to P18 cells ranged from 20 to 40 h, stabilizing at 
about 24 h between P8 and P16 (Fig 3.3). The mesothelial cells could be passaged to 
P40 and even at the higher passages, they did not show signs of senescence as they 
shared a similar cell morphology and maintained the capacity to proliferate.   
Figure 3.3: Population doubling times of mesothelial cells throughout passages. The PDT 
for mesothelial cells was performed using the trypan blue exclusion assay. The PDT ranged 
from 20 –40 h. Figure A is representative of 2 independent biological replicates.   
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3.3 Long-term cultured mesothelial cells expressed the mesothelial markers 
Wt1 and Msln  
To assess whether the mesothelial cells maintained their characteristics throughout 
culture, OMC (P0 cells) through to P24 cells were studied for their expression of the 
classical mesothelial markers Wilms tumor protein 1 (Wt1) and mesothelin (Msln).   
Immunolabeling studies revealed that Wt1 was expressed in the nuclei of OMC (Fig 
3.4A-B), P4 (Fig 3.4D-E), P12 (Fig 3.3G-H) and P24 mesothelial cells (Fig 3.4J-K). 
Mesothelin, a cell surface glycoprotein (Lua et al., 2016), was localized on the cell 
membranes of the P4 (Fig 3.4F), P12 (Fig 3.3I) and P24 cells (Fig 3.4L). However, 
mesothelin staining in the OMC was diffuse and punctate (Fig 3.4C).   
Next, we performed quantitative gene expression analysis to study the effects of 
mesothelial long-term culture on the levels of mRNA transcripts of these two 
mesothelial markers, relative to the OMC. Freshly isolated omentum tissue (OMT) 
was also included in the analysis to see if placing the tissue in culture had an effect 
on these key mesothelial markers. Wt1 mRNA was detected in all samples, and more 
or less maintained between the OMT and the OMC. However, with cell passaging we 
saw a more than 4000 - fold drop in expression at passage 5 (P<0.001) relative to the 
OMC (Fig 3.5A). The expression level of Wt1 was maintained in the P10 and P25 cells 
compared to the P5 mesothelial cells; suggesting that the Wt1 transcript levels were 
stabilized once the cells were passaged. Of note, the delta Ct values for Wt1 
expression in passaged cells were in the range between 17-19, while in the range 
between 3-6 in OMT and OMC, suggesting that very high levels of Wt1 expression 
was strongly attenuated in the cells from passage 5 onwards (table 3.1). Interestingly, 
with culturing the OMC downregulated Msln expression ~80 - fold relative to the 
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OMT. Then, with repeated passaging the mesothelial cells upregulated Msln mRNA 
levels 5 - fold by passages 5-10 (P<0.001), and a further 16 - fold increase was seen 
in the P25 cells (p<0.01) (Fig 3.5B) relative to the OMC. Overall, these results show 
that the process of isolating and establishing mesothelial cell cultures altered the 
expression levels of the two mesothelial cell markers analyzed.  
 
Figure 3.4: Mesothelial cells expressed Wt1 and Msln. Mesothelial cells at P4-P24 were 
seeded into 8 well glass chamber slides and left to reach 80% confluence, while 2-3 pieces of 
omentum explants were cultured for 14 d. Samples were fixed and stained for mesothelial 
markers Wt1 and Msln. Mesothelial cells consistently expressed Wt1 in the nuclei of cells [A-
B, D-E, G-H and J-K]. Msln was localized to the membranes of P4-P24 cells [F, I and L]. The 
OMC cell (P0) staining was diffuse and punctate [C]. Representative images from 3 
biologically independent samples, per passage, are shown.    
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Figure 3.5: Relative expression of Wt1 and Msln in omentum tissue, omentum cultures and 
MC of different passages. RNA from omentum tissue (OMT), omentum cultures (OMC) and 
P5, P10 and P25 mesothelial cells was harvested for relative - fold change in gene expression 
of Wt1 [A] and Msln [B]. Data presented as 3 independent biological replicates per condition. 
Compared to the OMC, ***p < 0.001, **P<0.01. 
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Table 3.1: dCt and - fold change values for Wt1 and Msln gene expression analysis 
data  
 
  
Sample dCt SEM - fold Change SEM 
Wt1 
OMT 2.81 0.65 12.9 4.71 
OMC 6.50 0.09 1.00 6.12x10-2 
P5 18.56 0.44 2.34x10-4 6.18x10-5 
P10 17.01 0.80 6.88x10-4 2.94x10-4 
P25 25.22 3.41 2.32x10-6 2.10x10-6 
Msln 
OMT 5.08 0.49 78.71 22.61 
OMC 11.38 0.29 1.00 0.18 
P5 9.02 0.50 5.13 1.51 
P10 9.11 0.58 4.82 1.59 
P25 7.40 0.16 15.69 1.66 
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3.4 Mesothelial cells downregulate epithelial genes with prolonged culture 
Since the MCs at P4-P24 displayed a slight but notable increase in more elongated 
cells, thus resulting in a moderate loss of the perfect characteristic cobblestone 
morphology in the OMC cultures, we wished to determine the molecular 
mechanisms that contributed towards this change. Therefore, we analyzed the 
protein expression patterns and mRNA profiles of epithelial and mesenchymal 
markers in mesothelial cells from OMC to P25.  
Epithelial cells are classically identified by their cobblestone morphology which is the 
result of a network of cellular adhesion proteins maintaining cell-cell contacts and 
polarity (see Fig. 1.1) (Knights et al., 2012). Immunofluorescence analysis for the tight 
junctional marker zonula occludens 1 (ZO1) protein revealed that the OMC expressed 
ZO1 strongly as discrete bands at the circumference of the cells (Fig 3.6A). By 
contrast, in the P4-P24 cells, ZO1 was mostly localised in a punctate fashion around 
the cell perimeter and there was increased nuclear accumulation of the protein (Fig 
3.6B-D). However, it is important to note that the punctate ZO1 pattern at the cell 
perimeter appeared very similar between P4 and P24 cells. 
Cytokeratins (CK) are intermediate filament proteins that link to desmosomes and 
are associated with maintaining the epithelial cell morphology by establishing an 
intercellular adhesive framework (Knights et al., 2012). Pan-cytokeratin 
immunolabeling revealed that cells in the OMC cultures robustly expressed CK across 
the cytoplasm (Fig 3.6E). However, this cytokeratin distribution was retracted to the 
perinuclear region in a dot-like morphology in some of the P4 cells compared to the 
OMC (Fig 3.6F). This retraction was also seen in the P12 and P24 mesothelial cells, 
respectively (Fig 3.6G and H).  
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To further quantify the effects that prolonged cell passaging had on the epithelial 
characteristics of mesothelial cells, the expression levels of a panel of epithelial 
markers were studied through qPCR.  E-cadherin-1 (Cdh1) is the major 
transmembrane protein of the adherens junctions and is required to maintain lateral 
cell-cell contacts and regulate the actin cytoskeleton (Knights et al., 2012).  Vinculin 
(Vcl) is also a component of adherens junctions and a novel regulator of Cdh1 
function (Peng et al., 2010). Expression analysis of revealed that, while in OMT the 
levels were unchanged, the passaged mesothelial cells significantly downregulated 
the relative expression of Cdh1 when compared to the OMC. This loss of expression 
was most pronounced at P10, where there was 3000 - fold reduction (P<0.05) in Cdh1 
relative expression (Fig 3.7A). Meanwhile, the P5 and P25 cells showed roughly a 300 
- fold reduction in relative expression.  
While we observed also a 3 - fold reduction in the expression of the Vcl gene, these 
changes were not significant between the assayed samples (Fig 3.7B).     
Peritoneal mesothelial cells have been reported to express cytokeratin 8 (Krt8) as an 
epithelial marker (Li et al., 2013b, Lua et al., 2016). In our study, the passaged cells 
but not the OMT gradually downregulated relative expression of the Krt8 gene with 
prolonged culture between 42 to 400 - fold between passages 5 to 25 (P<0.001), 
relative to the OMC (Fig 3.7C). The relative mRNA transcript levels of the tight 
junctional protein ZO1 fluctuated considerably between the passages and compared 
to the OMC there was no statistical change in expression despite the roughly 400 - 
fold increase in relative expression at P5 (Fig 3.7D).   
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Taken together, while the immunolabeling studies showed that the mesothelial cells 
maintained epithelial characteristics following passaging, the qPCR studies revealed 
that passaging reduced the expression levels of some but not all of the key epithelial 
markers we analyzed. The mesothelial cells, however, maintained expression of 
these genes at relatively low levels with repeated passaging.  
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Figure 3.6: Cellular localisation of epithelial markers in mesothelial cells was slightly changed with increased passage.  Mesothelial cells from 
passages 4, 12 and 24 at near confluence, and OMC (P0) 14 days after seeding were immunolabelled with ZO1 and pan-cytokeratin antibodies. 
The OMCs [A] showed strong ZO1 bands around the cell perimeter, while in the P4, P12 and P24 cells ZO1 appeared more punctate (arrowheads) 
and also localised to the nucleus [B-D]. Cytokeratin was expressed across the cytoplasm of the cells in the OMC [E]. This expression was reduced 
to the perinuclear region of the P4, P12 and P24 cells (arrowheads) [F-H]. Images are representative of at least 3 independent biological samples 
per condition.   
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Figure 3.7: Relative expression analysis of epithelial markers in cultured MCs. MCs were 
cultured to 80-90% confluence for total RNA extraction and reverse transcription and 
subsequent qPCR analysis of epithelial gene expression. [A] Cdh1 expression decreased 
nearly 2.3x104 - fold at P5 relative to OMC, and this level was maintained thereafter. [B] Vcl 
expression was roughly 3 - fold downregulated in the passage 5-25 cells (relative to OMC), 
however, this was not statistically significant. [C] Culturing and passaging significantly 
reduced Krt8 expression in the P5-P25 mesothelial cells 40-400 - fold relative to the OMC. 
[D] ZO1 relative expression fluctuated considerably between passages. Data are presented 
as a mean of n=3 biologically independent samples and normalized to two housekeeping 
 SEM. Compared against the OMC 
group, ∗∗∗p < 0.001, ∗∗p < 0.01 and ∗p < 0.05.  
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3.5 Cultured mesothelial cells changed expression of key mesenchymal 
markers    
In light of the fact that with repeated passaging the mesothelial cells downregulated 
epithelial markers, we assessed whether the cells became more mesenchymal 
throughout this process. We characterised the protein localisation and gene 
expression profiles of mesenchymal markers in OMC and in mesothelial cells at the 
three passage time points, early (P4), medium (P12) and late (P24). When 
immunolabelled with vimentin (Vim) and alpha smooth muscle actin (αSMA), OMC 
and the passaged cells (P4-P24) displayed for both markers a uniform expression 
pattern throughout the cytoplasm (Fig 3.8A-H). Interestingly the expression of αSMA 
consistently varied between cells across the populations (arrowheads Fig 3.8E-G). 
We next assessed the mRNA levels in the passaged cells (P5-P25) relative to the OMC 
to detect any changes in expression of the three mesenchymal markers Vim, αSMA, 
and Cdh2. The intermediate filament gene Vim was statistically unchanged 
throughout the passaged mesothelial cells, but expressed at 7 - fold higher levels in 
the OMT (P<0.01) (Fig 3.9A).  The expression of αSMA was 20 - fold downregulated 
in the P10-25 relative to the OMC, although this change was not statistically 
significant (Fig 3.9B). By contrast, in the OMT, αSMA transcript levels were 1000 - fold 
lower relative to the OMC (P<0.001). We were unable to detect any changes in 
relative expression of the transmembrane glycoprotein N-cadherin (Cdh-2) in the 
tested samples (P5-P25, OMT) compared to the OMC (Fig 3.9C).     
Overall these data suggest that prolonged passaging failed to change the mesothelial 
cells into a complete myofibroblastic cell type, while the initial cell dissociation 
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procedure caused the adult mesothelial cells to respond by altering the expression 
of Vim and αSMA expression levels. 
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Figure 3.8: Mesothelial cells expressed mesenchymal markers. Confluent mesothelial cells of OMC (P0) and at P4-P24 were stained with Vim 
and αSMA antibodies. Throughout passages, the MCs showed strong filamentous staining for Vim in the cytoplasm [A-D].  The expression of 
αSMA was maintained throughout culture, with some cells expressing more of the protein than others (arrowheads) [E-H].  Representative 
images of n≥3 biological samples per passage. 
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Figure 3.9: Relative expression analysis of mesenchymal markers in cultured MCs. Total 
RNA was harvested from confluent cells and used for gene expression analysis by qPCR.  [A] 
Relative expression of Vim was maintained between the cultured cells (OMC – P25) and 2- 
fold downregulated between the OMT to OMC (P<0.01) [B] In OMCs, αSMA was upregulated 
47 - fold relative to OMT (P<0.01); while statistically unchanged in the passaged cells [C] Cdh2 
mRNA expression was unchanged between cultured cells (OMC-P25). Data shown is 
representative of 3 biological replicates per passage or tissue that are normalized to GAPDH 
and β-actinhousekeeping genes. Error bar are presented as SEM. Statistics presented are 
representative of a one-way ANOVA, where the cultured cells were compared against the 
OMC group, ∗∗∗p < 0.001, ∗∗p < 0.01 and ∗p < 0.05. 
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3.6 The effect of mesothelial cell culture on the relative expression of EMT 
transcription factors  
We have so far demonstrated that the mesothelial cells in the cultured samples 
(OMC-P25) have characteristics of a ‘hybrid’ cell, expressing genes that are markers 
of both epithelial and mesenchymal cell states. While mesothelial cells in the OMT/in 
vivo also expressed both epithelial and mesenchymal markers, their levels changed 
in response to culturing the cells.  However, our data also showed that the process 
of repeated passaging seemed to contribute to the loss of epithelial characteristics.   
Previously, the ability of mesothelial cells to transdifferentiate into myofibroblasts in 
response to stress or injury has been coined mesothelial-to-mesenchymal transition 
(MMT) (Liu et al., 2015, Strippoli et al., 2016). Physiologically, MMT provides 
mesothelial cells with the ability to contribute to repair of damaged peritoneum 
through a tightly orchestrated signaling  network regulated by the transcription 
factors Snail1/2, Zeb1/2 and Twist1 (Li et al., 2013b, Hugo et al., 2011, Lamouille et 
al., 2014). However, the progression through MMT is not a fluid process, and the cells 
may reside in a spectrum of intermediate states where they gradually lose epithelial 
features while simultaneously gaining mesenchymal characteristics similar to the 
situation during EMT in other cell types (Tam and Weinberg, 2013). Therefore, our 
results suggested that the mesothelial cells during culture adopted an intermediate 
MMT (Lamouille et al., 2014, Li and Kang, 2016).   
Therefore, we next wished to explore whether in cultured mesothelial cells the loss 
of cell adhesion was associated with the acquisition of an intermediate MMT 
phenotype. For this purpose we assessed the mRNA expression levels of the 
transcriptional factors (TFs) Snail1, Snail2, Zeb1, Zeb2 and Twist1, which had 
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previously been shown to be involved in regulating the MMT transdifferentiation 
process (He et al., 2015, Horio et al., 2011, Morishita et al., 2016).  
Since the mesothelial cells of OMCs had strong epithelial characteristics, we used 
these cells as the relative control. Our analysis showed that there was no statistical 
change in Snail1 expression between the OMC and the passaged mesothelial cells, 
while it was significantly higher (30 - fold) expressed in the OMT, relative to the OMC 
(P<0.0001)(Fig 3.10A).  By comparison, there was a 4-7 - fold upregulation in Snail2 
mRNA amounts in the passaged cells (P5-P25) relative to the OMC. However, this 
change was only statistically relevant in the P10 samples (P<0.05) (Fig 3.10B).   
Both Zeb1 and Zeb2 relative mRNA expression levels were unaffected by the isolation 
and culturing procedures when compared to OMC, as there was an 11 - 20 fold 
reduction in expression between the OMC and the cultured cells (P5-P25), which was 
not statistically significant (Fig 3.10C-D).   
Our analysis showed that prolonged culturing of the mesothelial cells did not 
significantly alter the relative mRNA amounts of Twist1 in comparison to OMC (Fig 
3.10E), while Twist1 expression levels were 8000-- fold higher in the OMT (P<0.001).  
Taken together, of the classical transcriptional regulators of EMT assessed here, only 
Snail2 was significantly upregulated and Twist1, Snail1, and Zeb1/2 were maintained 
in passaged mesothelial cells when compared to OMCs.   
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Figure 3.10:  The expression of MMT-regulating TFs was altered in mesothelial cells 
throughout culture. The mRNA levels of the main MMT-inducing TFs in mesothelial cells 
were compared to the OMC by qPCR using biological triplicates. Samples were normalised to 
GAPDH and β-actin control genes. Relative [A] Snail1 expression was between 40-80 - fold 
reduced in the cultured cells but statistically not significant [B] Relative Snail2 expression was 
roughly 5-8 - fold increased P5-P25 cells.[C] Zeb1 and [D] Zeb2 relative expression was 
unchanged in the cultured cells. [E] Twist1 was 5x103 - fold significantly downregulated in 
the OMC (P<0.01). This relative decline was then maintained in the P5-P25 cells compared 
against the OMC group. MSCs were the positive control samples used to compare MMT-TF 
expression. A one-way ANOVA was used to calculate statistical significance, where ****p < 
0.0001, ***p < 0.001, **p < 0.001 and, *p<0.05 relative to the OMC.  
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3.7 Passaged mesothelial cells changed expression of TGFβ and 
corresponding TGFβ receptors in vitro  
The expression analysis of epithelial and mesenchymal markers, and MMT regulators 
in cultured omentum explants and passaged cells suggested that the cultured cells 
were passing through the MMT programme without fully differentiating into 
myofibroblasts. Therefore, we aimed to further characterize the underlying signaling 
mechanisms by assessing the expression levels of transforming growth factor-β (TGF-
β) and epidermal growth factor (EGF) and their receptors. TGF-β and EGF are known 
potent mediators of MMT and EMT induction in a number of cell types including 
mesothelial cells (Strippoli et al., 2012, Lachaud et al., 2014, Xu et al., 2009). In order 
to address whether the observed changes in cultured mesothelial cells were 
associated with autocrine or paracrine mechanisms, we assessed the relative 
expression of TGF-β, EGF and their receptors in the same samples. Our results 
showed that repeated passaging led to a significant 7 - fold reduction in the relative 
TGF-β mRNA transcripts in the P5, (P<0.001) P10 and P25 cells when compared to 
OMC (P<0.01) (Fig 3.11A), while the expression levels of TGF-β were unchanged in 
OMTs relative to OMC.  TβRI expression levels showed similar dynamics between the 
different passages as relative expression of TβRI was 5-9 - fold downregulated in the 
passaged cells (P5 P<0.001 and P10-P25 P<0.01) when compared to OMC, while in 
OMT it was expressed at similar levels (Fig 3.11B). While the expression of TβRII was 
reduced in all passaged cells, it was significantly reduced (5 - fold) only in the P10 
cells (P<0.05) (Fig 3.11C), and expressed significantly higher in the OMT.  
Our assessment of the expression levels by qPCR of the EGF ligand and its 
corresponding receptor in mesothelial cells throughout passages was only partially 
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conclusive as we were unable to detect mRNA expression of EGF and its receptor in 
the OMC and P5 cells. However, the transcripts for EGFR could be detected in P10 
and P30 mesothelial cells, and for EGF in the P30 cells (Fig. 3.11D).   
Collectively, these data indicate that placing omentum tissue explants into culture 
changes their expression profile and that the cultured mesothelial cells pass through 
MMT, possibly via the intermediate stages of MMT (M/E state). Our data further 
suggest that this complex process may be regulated by a number of growth factors 
and that TGF-β and EGF may potentially have a role in mediating these changes.  
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Figure 3.11: Expression analysis of TGF-β, EGF, and their receptors: TβRI, TβRII, and EGFR 
in passaged mesothelial cells. [A] TGF-β mRNA expression was 7 - fold reduced in P5 to P25 
passaged mesothelial cells with respect to OMCs (P5 P<0.001 and P10-25 P<0.01). [B] 
Passaging also resulted in roughly a 5-9 - fold loss in expression of type I transforming growth 
factor receptor, in the passaged cells (P5 and P25 P<0.05 and P10 P<0.01). [C] The TβRII was 
also downregulated 5 - fold in the P10 cultured cells (P<0.05) relative to the OMC. [D] We 
were unable to detect the expression of EGF and its corresponding receptor in the OMC and 
P5 cells, however, we could amplify transcripts in P10 and P30 samples. Sample genes were 
normalized to GAPDH and β-actin housekeeping genes. Averages are presented with SEM for 
error. Statistical analysis was performed using a one-way ANOVA, where samples compared 
to the OMC had a significance of ***P<0.001, **P<0.01 and *P<0.05. 
  
dCt values for EGF and EGFR in 
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3.8 Mesothelial cells expressed stem cell markers  
Even though we observed changes in mRNA expression for a range of EMT-associated 
genes, the overall phenotype of the mesothelial cells derived from adult omentum 
remained largely unchanged between the passages 5 to 25. Furthermore,  the 
cultured MCs continued to divide into high passages (P40). Therefore, we aimed to 
determine whether these characteristics were related to the expression of stem cell 
markers.  
Immunolabelling of OMC and mesothelial cells at P4, P12, and P24 for the polycomb 
repressive complex 1 (Bmi1) transcription factor revealed nuclear expression 
throughout passages (Fig 3.12A-D). Next, we performed qPCR analysis for Bmi1 
expression and observed that mRNA levels were roughly 500 - fold downregulated in 
the P5 – P10 passaged cells (P<0.05) and >1000 fold downregulated in the P25 cells 
(P<0.01) relative to the OMC (Fig 3.13A); in OMT the expression levels were also 
significantly lower than in OMT. 
We could detect a 6 - fold drop in the expression levels of Sox9 (Sex Determining 
Region Y)-Box 9) in the P5 (P<0.05) samples relative to the OMC, and a further 9 - fold 
downregulation in the P10 and P25 cells; however, changes in the latter samples 
were statistically not significant compared to OMC (Fig 3.13B). Expression levels of 
the hematopoietic stem cell marker CD34 were maintained in the early passage P5 
cells but significantly downregulated in P10 and P25 cells when compared to OMC 
(P<0.01) (Fig 3.12C), while in the OMT expression levels were also significantly lower 
(P<0.05). Finally, the mRNA expression levels of the self-renewal gene Sox2 (SYRBox2) 
were unchanged amongst all the assayed samples (Fig 3.12D).  
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Of note, we were unable to detect the expression of the pluripotent stem cell 
markers Oct4 and Nanog (data not shown), which are involved in maintaining the 
embryonic stem cell phenotype along with Sox2 (Luo et al., 2013).  
Taken together, our data indicate that OMC cells and passaged mesothelial cells 
expressed stem cell markers, which was attenuated, but not lost, throughout the 
long-term culture. Interestingly, it appears that dissection of omentum tissue into 
explants for culture induced upregulation of Bmi1 and CD34 expression.  
 
 
Figure 3.12: Mesothelial cells expressed stem cell markers. Bmi1 was detected in the 
nuclei of OMC (P0) [A], P4 [B], P12 [C], and P24 cells [D], respectively.  
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Figure 3.13 OMC upregulate Sox9 and Bmi1 expression. [A] The relative - fold change values 
for the stem cell gene Bmi1 were roughly 500 - fold downregulated in both the passaged cells 
and OMT relative to the OMC. [B] Sox9 expression was only significantly downregulated in 
the P5 cells, 6 - fold (P<0.05) relative to the OMC. [C] Meanwhile the expression of CD34 was 
up to 400 - fold downregulated in the OMT and the older passaged cells (P10 and P25). [D] 
There was no change in expression in the self-renewal marker, Sox2. Data is representative 
of 3 biological replicates with SEM bars. One-way ANOVA statistics was performed, 
comparing the cultured cells and OMT to the OMC group, *p < 0.05 and **p < 0.01. 
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 3.9 Mesothelial cells have clonogenic potential  
A feature of stem or progenitor cells is their ability to form colonies from a self-
renewing single cell.  Based on the findings that the mesothelial cells maintained the 
expression of several self-renewal stem cell genes throughout the long-term culture, 
we tested the capacity of mesothelial cells to give rise to clones. Passage 5 
mesothelial cells were serially diluted in 96 well plates and single cells were identified 
at 16 h post seeding. The limiting factor of this assay was the relatively low chance in 
successfully seeding a single cell in one well. However, we were able to generate 4 
clonal cell lines from 3 biologically distinct tissue samples. The cells were cultured for 
more than 20 passages and shared the same slightly elongated morphology as the 
mesothelial cells pre-cloning (Fig. 3.14A-D).  
The similarity of the cloned mesothelial cells to the appearance of passaged 
mesothelial cells was confirmed by immunofluorescence analysis of protein marker 
expression. Cytokeratin was localized in a punctate pattern in the perinuclear region 
of the cells (Fig 3.14E), while ZO1 appeared in a discontinuous band in the tight 
junctions (Fig 3.14F). The clonal cells also strongly expressed Vim and αSMA proteins 
(Fig 3.14G and H, respectively), and maintained nuclear expression of the 
transcription factor Wt1 (Fig 3.14I). We also detected the stem cell marker Bmi1 in 
the cloned mesothelial cells (Fig 3.14J). 
Thus, the clonogenic assay revealed that the mesothelial cells have the ability to self-
renew and give rise to colonies of daughter cells. The characterisation studies with 
immune-labelling showed that the cloned cells showed a similar distribution of 
epithelial and mesenchymal markers as the passaged cells pre-cloning. Therefore, we 
conclude that mesothelial cells in culture have unipotent progenitor characteristics.  
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Figure 3.14: The clonogenic potential of mesothelial cells. [A] Passage 5 mesothelial cells 
were serially diluted and single cells were identified 16 h post seeding. [B] The cells were left 
to grow for 7 d when distinct colonies could be seen. [C] Individual clones of mesothelial cell 
clones reached confluence by around 14 d of culture. [D] Mesothelial cell-derived clones 
were seeded into 8-well glass chamber slides and cultured to 80% confluence. Pan-
cytokeratin was localized to the perinuclear region [E], while ZO1 was expressed in a 
punctate pattern at cell-cell contacts along the cell membranes [F] in a similar fashion as the 
passaged cells.  Similarly, Vim [G] and αSMA [H] were strongly expressed throughout the 
cytoplasm. The mesothelial marker Wt1 was expressed in the nucleus [I].  The stem cell 
marker Bmi1 was also detected in the cloned cells [J]. Representative images are shown of 
experiments conducted on n=3 independent biological samples.  Scale bar 50µm.   
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3.11 Discussion  
In this chapter, we describe the successful long-term culture of mesothelial cells after 
isolation from omentum explants. These cultures were propagated to passage 40 and 
showed relatively stable population doubling times. Furthermore, they maintained a 
cobblestone-like phenotype even at the higher passages, expressed mesenchymal 
markers and maintained some epithelial and mesothelial characteristics that were 
confirmed by immunohistochemistry and qPCR. Moreover, they also expressed stem 
cell genes and displayed clonogenic potential.  
3.11.1 Long-term culture of omentum-derived mesothelial cells 
Peritoneal mesothelial cell cultures are an invaluable tool for studying the effects of 
PD solutions or various inflammatory molecules on proliferation and wound healing 
in the absence of systemic modulating factors (Lachaud et al., 2015, Yung and Chan, 
2007). Thus, in vitro studies using peritoneal mesothelial cells in combination with 
complementary in vivo studies could pave the way for translation into the clinic 
(Lachaud et al., 2015, Yung and Chan, 2007).  
A common problem faced with autologous cellular therapies is the identification of a 
reliable source of cells for harvesting at therapeutically relevant numbers and with 
minimal health impact (Lachaud et al., 2015, Yung and Chan, 2007, Asano et al., 
2005). The mesothelium lines the serous cavities and the surfaces of internal organs, 
and shows similar morphological characteristics across different sites of the serosa 
(Lachaud et al., 2015, Yung and Chan, 2007), thus offering a number of accessible 
sources for cell harvest.  
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In this chapter, we have described the generation of several mesothelial cell cultures 
from mouse omentum explants. The cultures had PDTs that stabilized at around 24 
h between passages 8 to 16 and could be propagated for over 30 passages without 
showing signs of senescence. 
Several groups have published a number of diverse techniques for the isolation and 
culture of mesothelial cells from different tissues sites (Yung and Chan, 2007). 
Trypsinization is the most widely accepted protocol for harvesting mesothelial cells 
from whole omentum, tunica vaginalis, or general body cavity (Zhou and Yu, 2016, 
Asano et al., 2005, Hjelle et al., 1989). Other protocols included scraping the serous 
membrane off snap frozen organs and the isolation of cells from spent PD effluents 
(Jiang et al., 2010, Chen and Chen, 2012). However, contamination with other cell 
types, including fibroblasts (including myofibroblastic mesothelial cells), adipocytes, 
endothelial and inflammatory cells has been described as a major limiting factor that 
often required further sorting using mesothelial specific makers (Chen and Chen, 
2012, Yung and Chan, 2007, Zhou and Yu, 2016).  
Both human and rodent-derived mesothelial cells share similar phenotypic 
characteristics following isolation (Yung and Chan, 2007, Zhou and Yu, 2016). They 
often take 5 – 7 days post seeding of 3 – 5x103 cells/ cm2 for successful monolayer 
formation (Yung and Chan, 2007, Zhou and Yu, 2016, Chen and Chen, 2012). Similar 
to our findings, during the propagation of mesothelial cell cultures, the cells adopted 
an elongated multipolar morphology, and once confluent, the polygonal morphology 
was restored (Chen and Chen, 2012, Hjelle et al., 1989). However contrasting to our 
findings, the primary mesothelial cells showed a limited life span in culture based on 
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the observations that their polygonal phenotype was only maintained up to the third 
passage, and become senescent by the 6th passage (Yung and Chan, 2007, Zhou and 
Yu, 2016). Culturing on matrix components (collagen/ gelatin) or plastic alone did not 
attenuate premature senescence in mesothelial cells (Chen and Chen, 2012, Hjelle et 
al., 1989).   
Here, we have not characterized the mechanisms that contributed to maintaining the 
mesothelial cell cultures for prolonged periods, in vitro. However, a study by Ksiazek 
and colleagues showed in human omentum-derived mesothelial cells, that early 
senescence was associated with oxidative stress-induced DNA damage in non-
telomeric DNA regions (Ksiazek et al., 2007). Furthermore, exposing young 
mesothelial cell populations that did not contain senescent cells to conditioned 
medium from senescent mesothelial cells resulted in the reduced growth and the 
induction of senescence-associated beta-galactosidase expression (Ksiazek et al., 
2008).  
3.11.2 Mesothelial cells downregulate key mesothelial and epithelial characteristics 
with prolonged passage  
The cobblestone morphology of the cultured mesothelial cells was present but less 
pronounced in the passaged cells relative to the mesothelial cells directly 
surrounding the omentum explants. Although we were able to detect key 
mesothelial, epithelial and mesenchymal markers within our passaged cell samples, 
the distribution and gene expression levels were altered in the passaged cells relative 
to the OMCs.  
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The mRNA amounts of the mesothelial makers Wt1 and Msln showed opposing 
responses to repeated passaging. Wt1 significantly decreased in the passaged cells 
while Msln increased in the higher passages. Wt1 deletion in the epicardium of 
developing hearts failed to affect Msln expression (von Gise et al., 2011), while Wt1 
knockout in the mesothelium that lines the forming liver severely reduced the 
expression of Msln, hampering embryonic mesothelial cell differentiation (Onitsuka 
et al.). These results suggest that both Wt1 and Msln play different roles in regulating 
the mesothelial cell state depending on the tissue context.  
Wt1 is a zinc finger transcription factor that in development regulates the 
maintenance of the mesothelial cell phenotype in a number of mesodermal tissues 
(Que et al., 2008, Chau and Hastie, 2012). In adult pleural mesothelial cells the loss 
of Wt1 induced a mesenchymal transition and increased migration and contractility 
through Smad2 signalling  (Karki et al., 2014). Therefore, the downregulation in both 
Krt8 and Cdh1 that we observed in the passaged cells could be linked to the loss of 
Wt1.  
Although we were able to detect the expression of ZO1 and pan-cytokeratin, their 
protein distribution was altered. ZO1 was detectable by IF in a punctate manner 
around the cell perimeter and also accumulated in the nucleus of the passaged cells. 
Furthermore, pan-cytokeratins showed perinuclear re-organisation in the passaged 
cells, while the mesenchymal markers were unchanged relative to the omentum 
explants.  
ZO1 functions as an adaptor, linking the tight junctions to the actin cytoskeleton 
(Knights et al., 2012, Georgiadis et al., 2010). In vitro studies have shown that the 
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shuttling of ZO1 to the nucleus is inversely related to the extent of cell-cell contacts 
and degree of their maturity. Specifically, nuclear ZO1 translocation is increased 
under pro-migratory conditions (such as exposure to EMT-inducing growth factors) 
and during phases of proliferation (Benezra et al., 2007, Gottardi et al., 1996).  
Intermediate filament organization is associated with migration and invasive capacity 
of a cell. In general, the loss of cytokeratins through phosphorylation and the gain of 
vimentins is associated with increased migration and is a characteristic of MMT/EMT 
(Kalluri and Weinberg, 2009, Kim et al., 2015). The phosphorylation of Krt8 and 18 in 
pancreatic and gastric cancer cells through MEK-ERK, JNK and p38 signalling  cascades 
was shown to induce their perinuclear accumulation and consequently enhanced the 
migration capacity of these epithelial tumour cells (Busch et al., 2012, Beil et al., 
2003, Kim et al., 2015).  
Collectively, the passaged mesothelial cells show changes in key epithelial marker 
distribution that are associated with MMT, transdifferentiation.   
3.11.3 Repeated passaging of mesothelial cells alters the MMT programme 
Due to the changes in the overall epithelial organization and expression in the 
passaged cells, we sought to profile the overall expression patterns of key MMT 
mediators and downstream transcriptional regulators in the cultured cells. It is 
important to note that for the majority of markers analyzed the OMT and the OMC 
shared similar expression characteristics, and the changes seemed to occur between 
the explants and the passaged cells.  
While we observed a decline in the expression of the TGF-β ligand and its 
corresponding adaptor signaling receptor (TβRI), we noted an upregulation in the 
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expression of EGF and EGFR and increased Snail2 expression. This suggested that 
Snail2, and possibly also EGF and EGFR, induced a less epithelial state of the 
mesothelial cells.   
Mesothelial cells derived from adult livers shared a number of characteristics seen in 
the mesothelial cells of this study. With culturing the liver-derived cells lost epithelial 
features and upregulated the mRNA expression of the EGFR (Li et al., 2013b).  
Stimulation with EGF has been reported to induce MMT in uterine-derived 
mesothelial cells by upregulating Snail1/2 and Twist1 protein and mRNA expression 
(Lachaud et al., 2013). However, whether there is a link between the loss of Wt1 and 
the gain in Snail2 in mesothelial cells is still not known. A study by Takeichi and 
colleagues reported an increase in Snail2 expression following Wt1 deletion in the 
developing epicardium, which in turn promoted EMT (Takeichi et al., 2013).  
The loss of Wt1 and the gain in EGF, EGFR and Snail2 mRNA transcripts; together with 
the reduced expression of epithelial genes in the passaged cells shows that the 
mesothelial cells have adopted a more mesenchymal intermediate MMT phenotype.  
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3.11.4 Mesothelial cells show clonogenic potential and express stem cell genes  
The mesothelial cells in this study demonstrated an ability to proliferate over many 
passages, and seeding density was not a limiting factor in their propagation.  We, 
therefore, wanted to test the clonogenic potential of the passaged mesothelial cells. 
The mesothelial cell clones generated shared similar morphological and phenotypical 
characteristics as the parent cells, which is similar to the behavior to MSCs clones (da 
Silva Meirelles et al., 2006). This was in contrast to clones generated from KSCs 
derived from mouse neonatal kidneys, and from human keratinocyte stem cells:  
KSCs gave rise to clonal lines with different renal phenotypes and characteristics, and 
the keratinocytes showed alteration in Krt19 expression, organelle number, and cell 
cycle distribution (Dong et al., 2003, Fuente Mora et al., 2012).  
Based on the observation that the mesothelial cells showed clonogenic potential we 
analyzed the expression of a number of stem cell genes over prolonged culture. 
While the OMC showed the highest expression of key stem cell genes Sox9, CD34, 
and Bmi1, we noted no changes in the self-renewal gene Sox2.  However, the role 
that these stem cell genes have in the mesothelial cells requires further analysis.  
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3.12 Chapter conclusions  
In summary, the data presented in this chapter show that the process of culturing 
and passaging mesothelial cells slowly induces a less epithelial-like state and that 
prolonged culturing promotes changes in the overall gene signature. Comparison 
with the gene expression profile of KSCs isolated from neonatal pup’s and MSCs stem 
cell marker expression showed some similarity. However, we also observed 
characteristics of stem or progenitor cells due to their clonogenicity and expression 
of a range of stem cells markers. This led us to ask whether the presence of these 
stem cell genes was an indicator for multi-lineage differentiation capacity in the 
mesothelial cells and if age was a contributing factor. These aims are addressed in 
Chapter 4.  
Furthermore, we aimed to understand the molecular mechanisms that regulate the 
mesenchymal-intermediate phenotype that we observed in the cultured cells. 
Therefore, we asked whether paracrine effects played a role in these processes; 
these studies are described in Chapter 5.   
In conclusion, the mesothelial cells seemed to maintain some mesothelial associated 
characteristics following their isolation and repeated passaging relative to the OMC. 
The cells displayed clonogenic potential and expressed stem cell markers, even in the 
higher passages. However, they underwent changes that led them to a more 
mesenchymal- intermediate (M/E) phenotype. 
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Chapter 4: Analysis of the 
multi-lineage potential of 
mesothelial cells 
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4.0 Introduction and aims 
The results from the previous chapter suggested that passaging affected the overall 
phenotype of the cells, whereby the mesothelial cells downregulated Wt1 along with 
epithelial genes; however, the mesenchymal characteristics were largely unchanged 
even with prolonged culturing.   In addition, we had observed that the stem cell genes 
Sox9, Bmi1 and CD34 were upregulated in the OMC relative to OMT, but then 
downregulated in the passaged cells, and that the mesothelial cells demonstrated 
clonogenic potential around passage 5. These findings led us to hypothesize that the 
cultured mesothelial cells may possess progenitor cell characteristics.  
The mesothelium is derived from the embryonic mesoderm and the mesothelial cells 
are renowned for their ability to differentiate along the mesodermal lineages 
(Lansley et al., 2011). Specifically, mesothelial cells derived from rat omentum or 
human pericardial cavity were demonstrated to differentiate along the osteogenic 
and adipogenic lineages in vitro (Lansley et al., 2011). Furthermore, the mesothelial 
cells have also been demonstrated to contribute to the repair of injured peritoneum 
and liver tissues via the process of MMT (Li et al., 2013a). Recently, the omentum has 
been shown to ameliorate kidney associated pathologies (Garcia-Gomez et al., 2014). 
Specifically, in a 5/6 nephrectomy rat model of renal injury, the progression of 
chronic kidney disease (CKD) was slowed in the remnant kidney after attachment of 
omentum explants. The rats had reduced plasma creatinine and urea nitrogen levels 
and improved creatinine clearance compared to the renal ablation control group 
(Garcia-Gomez et al., 2014). However, the exact mechanisms behind this 
regeneration remain to be fully characterized.  
119 
 
The Unbekandt and Davies recombinant kidney ex vivo culture model is an invaluable 
tool for studying the nephrogenic potential of labeled cells in a controlled 
environment due to the easy recombination step (Unbekandt and Davies, 2010).  
Nephrogenesis is a tightly orchestrated process characterized by the sequential 
appearance of three excretory organs; the pronephros, mesonephros and the 
metanephros (Uhlenhaut and Treier, 2008). The metanephros becomes the 
permanent kidney and its development starts at embryonic day (E) 10.5–11 when 
GDNF released from the metanephric mesenchyme (MM) binds Ret on the Wolffian 
duct and induces ureteric bud (UB) invasion into the MM (Krause et al., 2015, Rak-
Raszewska et al., 2015, Uhlenhaut and Treier, 2008). At E11.5 the MM induces UB 
branching through bifurcation to give rise to the collecting duct system. Branching 
morphogenesis is induced by HGF, FGF, GDNF, and EGF signaling through Ret, while 
signaling mediators BMP4, Slit2 and Robo2 inhibit ectopic branching (Krause et al., 
2015, Rak-Raszewska et al., 2015). The UB undergoes roughly 10 cycles of branching 
in mice to give rise to a collecting duct system that channels the urine to the bladder 
(Krause et al., 2015, Rak-Raszewska et al., 2015). During this process, the 
mesenchyme surrounding the UB undergoes mesenchymal to epithelial transition 
(MET) and differentiates into mature nephrons (Krause et al., 2015, Rak-Raszewska 
et al., 2015, Uhlenhaut and Treier, 2008). This differentiation process takes place in 
morphogenetic stages where renal vesicles mature into a comma- then S-shaped 
bodies until they finally connect to the collecting duct (Krause et al., 2015, Rak-
Raszewska et al., 2015, Uhlenhaut and Treier, 2008). Figure 4.1 highlights the key 
events and signaling molecules involved in kidney development.  
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Figure 4.1. A schematic summarizing mammalian kidney development. A) Kidney development ensues over 3 stages, the pronephros, 
mesonephros and the metanephros. Metanephros is formed following the invasion of the UB through the release of GDNF from the MM. GDNF 
production and signalling is upregulated by Osr1, Wt1, Pax2 and Sall1 transcription factors. Meanwhile Slit2 and Robo2 attenuate UB budding by 
inhibiting GDNF production. B) UB branching is induced by a number of growth factors (EGF, FGF and HGF) that act on the Ret receptor. At the 
tips of the UBs the MM condenses and a heterogeneous pool of CITED1, Six2, Pax2, Wnt4 expressing stem cells aggregate. Signalling through 
Wnt9b induces the Wnt4 expressing cells to undergo MET and nephron formation occurs. C) The main stages of mouse nephron development 
stages are outlined. Micrographs were taken from (Rak-Raszewska et al., 2015). 
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While the mesothelial cells have demonstrated a plasticity; studies, however, have 
not verified if this multi-lineage capacity along mesodermal lineages is affected by 
cell passage where the mesothelial cells may lose their plasticity as they age in 
culture. In this chapter, we aimed to test this by exposing mesothelial cells from 
various passages to adipogenic, osteogenic inducing conditions and to an ex vivo 
forming nephron. 
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4.1 Mesothelial cells express mesodermal and metanephric mesenchyme 
markers.  
The mesothelium is of mesodermal origin and arises from the lateral plate mesoderm 
in the peritoneal cavity, situated close to the intermediate mesoderm, which 
contributes to the kidneys. Initially, we were interested in screening OMC and 
passaged mesothelial cells for a number of mesoderm lineage genes to determine if 
prolonged culturing affected their mesodermal signature. Analysis of mRNA 
transcript levels of passaged cells revealed that the cells stably expressed the early 
mesoderm marker brachyury (Bra) relative to the OMC (P=0.9317) (Fig. 4.2A). 
Meanwhile, no considerable change in expression was observed for the paraxial and 
intermediate mesoderm marker forkhead box protein C2 (FoxC2) (P=0.9694), or the 
intermediate mesoderm marker odd-skipped related transcription factor 1 (Osr1) 
(P=0.1234) (Fig. 4.2A). However, we could not detect the expression of the Wnt3a or 
Wnt8a (data not shown), which are associated with primitive streak development of 
the early mesoderm and direct cells towards a hematopoietic fate (Fehling et al., 
2003, Waghray et al., 2015). Among the mesodermal genes analyzed, only expression 
levels of forkhead box F1 (Foxf1), which is expressed in the lateral 
plate/extraembryonic mesoderm, were altered with passaging (Fig 4.2B). 
Specifically, we could see a substantial increase in relative expression between the 
OMC and the P5-P25 cells (P<0.05 for the P5 and P10 cells and P<0.01 for the P25 
cells). Overall, the cultured mesothelial cells expressed Bra, Osr1, and Foxf1, markers 
of the lateral plate mesoderm, suggesting they maintained some early mesoderm 
characteristics.  
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Figure 4.2: Cultured mesothelial cells express markers of the early mesoderm. [A] 
Mesothelial cells maintained the expression of early (Bra), paraxial/intermediate (Foxc2) and 
intermediate mesoderm (Osr1) genes. [B] Foxf1 expression that is found in the lateral plate 
showed between 400 – 40,000 fold upregulation in the cultured cells relative to the OMC. 
Data are presented as a mean ± SEM for 3 independent biological replicates. A one-way 
ANOVA with Sidak post hoc analysis was used to determine statistical significance between 
the group means.   
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4.2 Mesothelial cells demonstrate multi-lineage potential in vitro.  
Since the mesothelial cells expressed early mesodermal markers, our next aim was 
to assess their differentiation capacity along the mesodermal lineage across different 
passages in vitro. Initially, the mesothelial cells were seeded at a high density for the 
differentiation assays; however, the cells reached confluence within 3 d post seeding 
and by 5 d formed a tightly-packed sheet which detached from the plate. Therefore, 
the mesothelial cells were seeded at 1000 cells/cm2 (d 0), treatment for 
differentiation started the following day (d 1), and lasted until 14 d. We included 
murine MSCs as a positive indicator of differentiation for osteogenesis and 
adipogenesis.  
In the presence of osteogenic inducing media (MCs growth medium supplemented 
with β-glycerophosphate, dexamethasone, and ascorbic acid), the P5-P26 
mesothelial cells (Fig. 4.3D-E) and the MSCs (Fig. 4.3F) responded robustly by 
generating calcium deposits. To further confirm differentiation, we analyzed the 
gene expression of the osteoprogenitor marker alkaline phosphatase (Alpl), the 
osteoblast marker osteonectin (Sparc), and odontogenic differentiation marker 
dentin matrix protein I (Dmp1) in treated cells relative to untreated passage matched 
cells. Sparc has been shown to promote mineralization during bone formation , while 
Dmp1 has a crucial role in the mineralization of bone and dentin (Teti et al., 2015). In 
response to osteogenic stimuli, the mesothelial cells at P5 and P13 expressed higher 
levels of Sparc  transcripts when compared to untreated cells; at P13, this increase 
was significant (P=0.0115) (Fig. 4.3G).  By contrast, expression levels for Sparc were 
unchanged in P26 cells between treated and untreated cells. We also observed a 
step-wise increase until P13 in the relative expression of Dmp1, although not 
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statistically significant. Moreover, the expression was unchanged in treated cells at 
P26 when compared to the controls (Fig. 4.3H). Analysis of Alpl showed that the 
transcript could not be detected in treated and non-treated mesothelial samples, 
while it could be amplified in the differentiated MSCs (data not shown).   
           
           
           
           
           
           
Figure 4.3 Mesothelial cells demonstrate osteogenic potential. Mesothelial cells 
passages 5, 13 and 26 were seeded into 6-well plates and either treated with osteogenic 
inducing medium or in full growth medium for 14 d. The samples were stained with the 
alizarin red S dye to detect calcium mineralisation. In P5 and P13 mesothelial cells [A-B] 
and MSCs [C] not treated in osteogenic medium, the strong orange dye failed to develop. 
Calcium deposits were detected in P5 and P13 mesothelial cells [D and E] and P21 MSCs 
[F] that were cultured in osteogenic medium. Analysis of relative gene expression for 
Dmp1 [G] and Sparc [H] revealed that they were mostly up-regulated in the lower 
passages, with a 6-fold change for Sparc expression at P13 (P=0.0115). Data is 
representative of 3 biological replicates for each condition.  
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Following adipogenic culture conditions, we could detect lipid droplet formation 
using Oil Red O dye staining in the stimulated P5, P13, and P26 mesothelial cells and 
in the MSCs, but not in the untreated cells (Fig. 4.4A-C and not shown). Visual 
inspection indicated that more lipid droplets accumulated in the P5 cells than in P13 
cells (Fig. 4.4D-E), but in both MC passages the cells were more dispersed when 
compared to the MSCs (Fig 3F). We, therefore, characterized this apparent 
adipogenic differentiation process further by quantifying relative transcript levels of 
markers for adipogenesis in the cells.  We assayed the samples for the expression of 
peroxisome proliferator-activated receptor gamma (PPARγ), a master regulator of 
adipogenesis (Siersbaek et al., 2010), and found it significantly upregulated in 
stimulated P5 (P=0.0064), but not in P13 and P26 cells (Fig. 4.4G). We also detected 
fatty acid transport protein 1 (Fatp1) expression in the stimulated mesothelial cells. 
This gene product is involved in regulating fatty acid uptake in adipocytes (Lobo et 
al., 2007). Overall, while we observed an increase in expression following stimulation 
at P5, there were large variations between the biological samples; however, this 
increase was lost in stimulated MCs at P13 and P26, with levels dropping below those 
in control MCs (Fig. 3H). The glucose transporter type 4 (Glut4), is an insulin-regulated 
glucose transporter that is primarily located in adipose tissues (Huang and Czech, 
2007). We were unable to detect expression of this gene in the mesothelial cells but 
could amplify the mRNA in the stimulated MSCs (data not shown).  
Taken together, these data indicate that mesothelial cells cultured up to P13 
generally maintained the ability to respond to osteogenic inducing cues, while the 
potential to respond to adipogenic cues was attenuated past passage 5.    
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Figure 4.4. Mesothelial cells demonstrate adipogenic potential. Mesothelial cells from 
various passages and MSCs were seeded and stimulated in adipogenic inducing medium for 
14 d. Lipid vacuole accumulation was detected using Oil Red O staining and could be seen in 
passage 5 and 13 [D-E] mesothelial cells, and in P21 MSCs [F]. Mesothelial cells [A-B] and 
MSCs [C] cultured in control medium failed to stain for fat droplets. A 3.7-fold increase in 
PPARγ expression was detected at passage 5 (P=0.0064) [G], while a non-significant increase 
in relative Fatp1 expression was observed [H]. In MCs of P13 or P26, levels were either 
reduced or not significantly increased. Images are representative of 3 independent biological 
replicates for the mesothelial cells and averages for fold change in expression for qPCR 
analysis.  
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4.3. Assessing the potential of mesothelial cells to integrate into kidney 
structures using an ex vivo embryonic chimeric kidney rudiment assay. 
As shown earlier, the mesothelial cells maintained the expression of early mesoderm 
markers during culturing. However, their differentiation capacity along the 
osteoblast and adipocyte lineages was limited by passage. Based on their 
mesodermal lineage and the fact that the omentum could alleviate CKD, we 
wondered if they mesothelial cells could contribute to nephrogenesis and if this 
plasticity was passage limited. To do this we decided to use an ex vivo kidney 
rudiment assay which ,under appropriate culture conditions, takes advantage of the 
ability of the stem and progenitor cells present in the kidney rudiment to re-organize 
themselves into early collecting duct systems, nephrons, and stroma. This technique 
gives rise to structures that resemble whole kidney rudiments, however, they lack a 
single collecting duct tree (Davies, 2015).  
The experimental design comprises the aggregation of dissociated labeled 
exogenous cells with dissociated metanephric cells through gentle centrifugation. 
The chimeric pellets were then cultured on an air-media interface throughout the 
experiment, however, for (Batchelder et al., 2015)the first 24 h the pellets were 
treated with Rho-associated protein kinase (ROCK) inhibitor to protect them from 
apoptosis related to anoikis (Davies, 2015). Finally, the samples were collected at 4 d 
and 7 d to assess overall renal structural development and integration of exogenous 
cells. 
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 4.3.1 Optimising conditions for mesothelial cell labeling  
In order to assess the potential of mesothelial cells to integrate into kidney structures 
ex vivo, we first needed to establish a suitable labeling technique that imparted the 
strongest fluorescence signal and had limited impact on cell viability. A lentivirus-
based GFP labeling method had been previously established in our lab, which was 
followed by FACs sorting to yield cells with continuously stable uniform fluorescent 
protein expression (Ranghini et al., 2013).  By contrast, cytoplasmic and membrane 
dyes carry several advantages over other labeling techniques for single cell 
monitoring in in vivo and ex vivo studies (Progatzky et al., 2013). These labeling 
procedures usually consist of a simple, robust method for uniform cell staining. 
However these probes used for the labeling of cells can have cytotoxic effects or 
exert unintended modification in cell function if not properly optimized (Progatzky et 
al., 2013).  
Therefore, we compared the lentivirus approach with two transient labeling dyes 
(CFDA SE and PKH67) in order to identify the cell dye that would stably label the 
mesothelial cells without signs of cytotoxicity or signal fading over several population 
doublings, while ideally allowing early, medium and late passage MCs to be assessed. 
CFDA SE is a colorless, non-fluorescent cytoplasmic dye that upon entry into the cell 
through passive diffusion is deacetylated by esterases into the fluorescent CFSE 
(carboxy-fluorescein succinimidyl ester).  The fluorescent dye–protein complexes 
that form in cells are retained for up to 8 cell divisions and are equally passed onto 
the daughter cells (Progatzky et al., 2013, Thayer and Wong, 2016). PKH67 is a 
carbocyanine fluorescent dye that adducts to the lipid bilayer of cell membranes 
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through its aliphatic carbon tail. It has an estimated in vivo fluorescence half-life of 
up to 100 days (Progatzky et al., 2013, Nagyova et al., 2014).  
We were able to successfully label mesothelial cells between passages 5-10 using 5 
µM CFDA SE (Fig. 4.5A) and 1 µM PKH67 (Fig. 4.5B). GFP-lentivirus transduction of 
mesothelial cells was performed by another member in the lab and kindly gifted. 
Passage 6 mesothelial cells were used at the start of the labelling protocol, however, 
an 88% GFP-labelled population of cells was only achieved at passage 20 after several 
rounds of FAC sorting (Fig. 4.5C).   
To monitor the fluorescence stability of the two dyes over time and its dilution with 
increasing cell population doubling, labelled mesothelial cells were monitored over a 
course of 7 days. The labelled cells were also compared against GFP-transduced cells 
and unlabelled cells. The fluorescent signals emitted from the probes and GFP-
protein were quantified through FACS (Fig. 4.6A-C). The intensity of the CFDA SE was 
the brightest at day 0, however, the fluorescent signals released by both PKH67 and 
CFDA SE dyes declined at a relatively similar rate (Fig. 4.6D). Both probes were 
brighter and more uniform throughout the 7 day period than the autofluorescence 
emitted by unlabelled cells. In contrast to this, the GFP-transduced cells had a stable 
signal intensity, throughout.   
Taken together the CFDA SE and PHK67 probe kits carry the advantage over GFP 
transduction due the ease of uniformly labelling the mesothelial cells in a short space 
of time, which is convenient for using lower passage cells.  
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Figure 4.5 Mesothelial cells were labelled with either dye-probes or transduced with GFP.  
Adherent mesothelial cells were labelled with CFDA SE 5 µM [A] or PKH67 1 µM [B] or 
transduced with GFP-lentivirus [C]. While both the CFDA SE and the GFP had cytoplasmic and 
nuclear localization, PKH67 displayed a punctate staining pattern. Images were taken at 1 s 
exposure for the 488 nm channel of live cells, 1 h post labelling. Scale bar 50 µM.   
 
4.3.2 Embryonic kidney ex vivo culture 
Before we co-culture the labelled mesothelial cells into the re-aggregated 
metanephros, we first wanted to demonstrate that the process of disaggregation and 
reaggregation of the rudiment cells allowed for the development and reorganisation 
of embryonic kidney structures. We were able to detect Wt1 and sine oculis 
homeobox homolog 2 (Six2) expression in the whole embryonic rudiments (eControl) 
following 7 d of culture;  both proteins have important roles in the condensing 
mesenchyme that give rise to the nephrons, while Wt1 continues to be expressed in 
the developing nephrons (Fig. 4.7A-E). Pax2 positive regions represented induced 
MM, but it is also found in the UB (Fig. 4.7J-l). Megalin+ proximal tubules were also 
detected in the whole organoids (Fig. 4.7M-O), and laminin/ PNA (peanut agglutinin) 
positive staining was found localised to the basement membranes surrounding the 
forming nephrons and UBs (Fig. 4.7J - Q). 
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Figure 4.5 Analysis of the fluorescence signal intensity of CFDA SE-, PKH67- and GFP- labelled cells. Low passage mesothelial cell were 
incubated in suspension in either 5 µM CFDA SE for 30 mins or in 1 µM PKH67 for 3 mins. The fluorescence intensities of the labelled cells were 
measured on day 0 [A], day 3 [B] and day 7 post labelling [C], using the FL1-H channel. Unlabelled Control cells were also included. [D] Over the 
course of 7 days the intensity of the fluorescence signals imparted by both linker-kits declines, while the GFP signal is stably expressed although 
less brightly.  
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The process of dissociation followed by reformation as tightly compressed pellets of 
E13.5 rudiments (rControls) did not impart any negative consequences on structural 
development of the metanephric mesenchyme and nephrons (Fig. 4.8).  We were 
able to detect megalin expressing proximal tubules (Fig. 4.8A-F) and Wt1 expressing 
MM across the pellets by 7 d in culture (Fig. 4.8G-L). Staining with PNA (Peanut 
agglutinin) also labelled the outer surfaces of tubules (Fig 4.8M).  
Since the culture conditions and the dissociation process did not hinder the 
formation of early nephron structures, we moved on to co-culturing the labelled 
mesothelial cells with the metanephric cells in chimeric kidney rudiments.  
4.3.3 GFP-labelled cells maintained the signal most consistently in chimeras 
throughout culture 
Preliminary studies using the GFP-labelled mesothelial cells had shown that the 
optimal seeding ratio of mesothelial cells to kidney rudiment cells was 1:10. This 
allowed for an even distribution of mesothelial cells throughout the pellet by the end 
of the experiment without their overgrowth (not shown). We were interested in 
analysing the integrative potential of low and high-passaged cells; of which the two 
dyes could achieve this. We also the P20 GFP-labelled MCs for comparison. 
Passage 5 – 10 cells were labelled with either the CFDA SE or the PKH67 and 
subsequently added to the single metanephric cell suspension. While P22 – 32 GFP 
labelled cells were used to test the effects of high passage. Mesothelial cell 
distribution in the re-aggregated rudiments was intermittently monitored at days 1, 
4 and 7 (Fig. 4.9). We could easily detect the cells 24 h post seeding in all 3 conditions 
(CFDA SE-, PKH67- and GFP-labelled MC-containing re-aggregated chimeric 
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rudiments). We observed a clear reduction in signal intensity by day 4 in rudiments 
containing PKH67-labelled cells (Fig. 4.9A-C), and by day 7 in those containing CFDA 
SE-labelled cells (Fig. 4.9D-F). These results confirm the findings from the FACS 
analysis on signal intensity of the differently labelled cells over time. All 3 labelling 
techniques shared similar ring-like structures that were most prominent at day 4.  
Interestingly, the chimeric rudiments containing GFP-mesothelial cells had a more 
compacted morphology (Fig. 4.9G-I) as opposed to the rudiments containing dye-
labelled cells (Fig. 4.9A-F).  
The incorporation of GFP-labelled mesothelial cells into the re-aggregated rudiments 
was performed on 12 separate occasions with a total of 108 GFP chimeric rudiments 
successfully cultured. In all those accounted instances there was an even distribution 
of GFP mesothelial cells with prominent ring-like structures across the pellets. In the 
cases of the CFDA-SE and PKH67 probe kits, each of the labelling and incorporation 
procedures was performed on 3 independent occasions with roughly 12 pellets each. 
While all labelling techniques did show similar pellet formation, using the GFP+ 
mesothelial cells was the only condition in which the signal was maintained 
throughout the culture period. Since the signal from the probes was still detectable 
at 4 d, we preceded to use this technique to monitor the effects of early passage on 
mesothelial cells integration potential and metanephric development.  
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Figure. 4.7 Whole embryonic rudiment show expression of key kidney markers. Whole 
embryonic kidney rudiments (eControl) were harvested from E13.5 embryos and cultured 
for 7 days, on a media-air interface. The samples were immunostained for a range of 
functional and structural markers, including markers for condensed mesenchyme Wt1 and 
Six2. Early podocyte precursors were also detectable through Pax2 and Wt1 labelling. 
Megalin staining detected proximal tubule structures, while laminin and PNA were found 
surrounding the basement membrane of the developing nephrons and UBs. Representative 
images of n≥3 independent biological samples. Scale bar 50 µM.  
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Figure 4.8. E13.5 re-aggregated rudiments form renal structures. Murine kidney rudiments 
(rControl) were isolated from E13.5 mice and dissociated in trypsin for 10 mins, before being 
re-aggregated and cultured as 2x105 cells/ pellet for 7 d. The rControl samples displayed 
characteristic kidney development features during the ex vivo culture period, such as megalin 
expressing proximal tubule structures [A-F], and condensing mesenchyme and developing 
nephrons depicted through Wt1 staining [G-L]. PNA staining also detected the outer surfaces 
of forming tubules [M].   
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Figure 4.9. Labelled mesothelial cells can be identified in the chimeric rudiments. Re-
aggregated kidney rudiments containing mesothelial cells labelled with PKH67 [A-C], CFDA 
SE [D-F], and GFP [G-I], were imaged at 1, 4 and 7 d post seeding.  Distinct loop-like structures 
of mesothelial cells (white arrows) were most prominent at day 4, however, as fluorescence 
progressively declines in the dye-labelled cells, becoming less visible. In GFP-labelled 
rudiments, the population and arrangements of the cells remained comparatively more 
pronounced.  All chimeric rudiments were captured at 488nm wavelength following a 500 
ms exposure time.  
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4.3.4 PKH67 and CFDA SE dyes transferred to neighbouring embryonic kidney cells 
As shown in the previous section, the labelled mesothelial cells distributed 
throughout the re-aggregated chimeric rudiments and were still detectable by the 
end of the experiment. Accordingly, we wanted to address if these cells could 
integrate into the developing nephron structures. Therefore, samples were 
harvested at days 4 and 7 in order to assess the potential contribution of the cells as 
the chimeric rudiments increased in size and matured over time.      
After 4 days of co-culture, the rudiments appeared to have developed structures 
similar to control rudiments. This indicated that mesothelial cells did not exert an 
inhibitory effect on the rudiment development. Furthermore, laminin staining 
revealed that the chimeric rudiments contained the different stages of nephron 
development, including renal vesicle (Fig. 4.10B), S-shaped (Fig. 4.10F-G) and tubule 
elongation of the S-shaped bodies (Fig. 4.10B). Pax2 expression was seen in UB 
epithelium surrounded by a laminin-positive basement membrane (Fig. 4.10A-C). 
PECAM is a marker of endothelial cells and was located in close proximity to an S-
shaped body (Fig. 4.10E-H). However, we were unable to identify the PKH67 labelled 
mesothelial cells, as the dye seemed to have leaked from the mesothelial cells and 
appeared to have been taken up by the neighbouring metanephric cells. 
140 
 
Figure 4.10: PKH67-labelled mesothelial cells in chimeric rudiments after 4 days ex vivo culture. The chimeric rudiments show features 
characteristic of nephron development, as shown by immunofluorescence for Pax2/ laminin staining of forming nephrons and UB branches. The 
presence of the renal vesicle [blue arrows], S-shaped [yellow arrows] and tubule elongation [pink arrows] are revealed through PKH dye uptake 
by embryonic cells [D, H]. Endothelial networks were detected in the chimeric rudiments by immunolabelling for PECAM [E-H]. PKH67-labelled 
mesothelial cells were not clearly identifiable as the dye appeared to have dissociated from the cells [C, G].  
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Although PKH67 had leaked from the mesothelial cells, this did not seem to affect the 
development of the nephron structures over time, as we could see numerous comma-shaped 
and renal vesicle structures, populated with Pax2 positive cells, after 7 days of culture (Fig. 
4.11A-D). Similarly, a population of Six2 and Wt1 expressing cells were maintained in the 
induced metanephric mesenchyme, suggesting cap mesenchyme structures (Fig. 4.11E-H).  
Similarly to PKH67, the CFDA SE-labelled MCs that were cultured for 7 days in the chimeric 
rudiments were also not identifiable since the dye appeared to have dissociated from the cells 
(Fig. 4.11). Importantly, we observed that the CFDA SE dye had consistently negatively 
impacted chimeric rudiment nephrogenesis in all the independent experiments performed. 
This was because the number of observed kidney structures appeared reduced and Wt1 
positive structures were undetectable (data not shown). However, we still were able to detect 
Pax2 expressing cells (Fig. 10I-L) and endothelial network development (Fig. 4.11M-O).   
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Figure 4.11 PKH67 and CFDA SE-labelled mesothelial cells in chimeric kidney rudiments after 7 days 
of ex vivo culture. Mesothelial cells P5-10 were labelled with the two dyes and co-cultured in the 
chimeric rudiments for 7 days. Both dyes disappeared from the mesothelial cells and the PKH seemed 
to spread throughout the rudiments. Nevertheless, the formation of nephron structures was 
maintained [A-D, I-J] and Six2 progenitors were unaffected [E-H], as shown by immunofluorescence. 
Endothelial networks could be detected using PECAM immunofluorescence [M-O].  
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4.3.5 Mesothelial cells integrated into embryonic kidney rudiments, ex vivo 
Our results have so far demonstrated that the inclusion of mesothelial cells in the chimeric 
rudiments allowed the formation of normal nephron structures including cap mesenchyme, 
proximal tubules, and comma-shaped bodies. However, it still remained unclear whether the 
mesothelial cells had a supporting role in nephron development. Since the two cell dyes had 
proven to be of little use as markers of mesothelial cells in the rudiment assay, we turned to 
the GFP-labelled mesothelial cells that had been transduced with the lentivirus. MC-
containing re-aggregated chimeric rudiments were cultured for 4 and 7 days and analysed by 
confocal microscopy for marker expression and GFP+ MC localisation. As mentioned before, 
due to the approach followed to generate the GFP-labelled mesothelial cells, they were at 
P22-32. We never observed any differences in rudiment development with the use of either 
P22 cells or P32 cells (Fig. 4.9G-I).  
After 4 days of culture within the embryonic rudiments, the GFP-labelled mesothelial cells 
were well dispersed within the rudiment and found localised mostly around developing 
structures. This was in contrast to the previously observed inhibitory behaviour of other cell 
types tested in chimeric rudiments in our group, where the cells formed a cap at the top of 
the rudiment (unpublished results of Santeramo et al and Kuzma-Kuzniarska et al., 2012).  
By confocal microscopy, it became clear that the ring-like GFP+ structures noted earlier (Fig. 
4.9H-I) were the result of the mesothelial cells arranged around the developing nephroi (Fig. 
4.12). Immunofluorescence showed that the MC-GFP labelled cells were localised in the 
proximity of Pax2 (Fig. 4.12A-D), Wt1 (Fig. 4.12E-G), Six2 (Fig. 4.12G-I) and megalin expressing 
structures (Fig. 4.12J-L).  
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Given that the mesothelial cells were found throughout the day 4 chimeric rudiments close 
to developing renal structures, we wanted to further explore this interaction at a later stage. 
We observed that the prolonged culture of the GFP-MCs in the chimeric kidney rudiments for 
7 days did not impart any negative consequences on the development of nephron structures 
(Fig. 4.13). Immuno-detection revealed expression of Pax2 in the UB and in early MM 
condensates, Six2 in the induced MM and of Wt1 in pre-tubular aggregates, proximal parts of 
the renal vesicle and the forming glomerulus which confirmed that the developing nephrons 
could mature in the presence of the mesothelial cells (Fig. 4.13A-I). However, we could not 
locate any GFP-mesothelial cells inside either comma- or S-shaped bodies or in the UB tips 
(Fig. 4.13D-F). 
The proximal tubules were identified through Megalin, a multi-ligand receptor that is found 
expressed in the proximal domains of the nephron. PNA was also used to identify the 
basement membranes of developing nephrons and UBs. The GFP-labelled cells were found in 
the zones of the proximodistal axis of the forming nephrons; arranging around the tubular 
structures and directly abutting the basement membranes (Fig. 4.13J-O).  
Overall, GFP-labelled mesothelial cells demonstrated integrative potential in the chimeric 
nephrons and allowed for the formation of embryonic kidney structures. However, we could 
not see evidence of dedifferentiation.  
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Figure 4.12 GFP-labelled mesothelial cells in chimeric kidney rudiments after 4 days ex vivo culture. 
The mesothelial cells were found located around the forming cap-mesenchyme [A-I] and the proximal 
tubules [J-L].   
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Figure 4.13 Mesothelial cells are found throughout the developing kidney rudiment, 7 days post 
culture. GFP-positive mesothelial cells were found arranged around the UB like Six2 expressing 
structures [A-C]. They were also found located around Wt1 expressing s-shaped bodies of forming 
nephrons [D-F] and around Pax2 positive condensing mesenchyme [G-H]. [D-L], (arrowheads denote 
co-localisation). The mesothelial cells appeared to be attached to the basement membrane of the 
megalin-labelled proximal tubules [arrows, G-I] and PNA-positive structures [M-O].  
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4.3.6 Mesothelial cells showed alignment to forming endothelial networks in chimeric 
rudiments.  
PECAM as a marker of endothelial cells is an adhesion molecule. It has been shown that 
endothelial progenitors are recruited through the secretion of VEGF to the forming S-shaped 
bodies during nephrogenesis (Vaughan and Quaggin, 2008). We were able to visualise 
complex capillary-like networks throughout the developing embryonic kidneys that were 
cultured for 4 (Fig. 4.14A) and 7 days (Fig. 4.14B) ex vivo. Interestingly, the re-aggregation 
process maintained the pool of endothelial progenitor cells, and complex capillary like-
networks were formed across the entire rudiment plane (Fig. 4.14C). However, these PECAM-
positive endothelial networks were located only in the top two-thirds of the re-aggregated 
rudiments. We found that the presence of the GFP-positive mesothelial cells did not have any 
negative consequences on the orchestration of the endothelial tube networks (Fig. 4.14D, E). 
Interestingly, the mesothelial cells showed alignment to the endothelial tubes (Fig. 4.14E-F), 
and higher magnification clearly demonstrated that the mesothelial cells had aligned directly 
with the endothelial tubes (Fig. 4.14G-I).  
 
  
148 
 
 
Figure 13: GFP-mesothelial cells showed alignment to PECAM-positive endothelial networks in the 
chimeric rudiments. Developing endothelial networks were detected in eControl rudiments that were 
cultured for 4 days [A] and 7 days [B] ex vivo. PECAM positive networks were also detected in the 
rControl samples that were cultured for 7 days [C]. GFP-labelled mesothelial cells showed alignment 
to endothelial networks following 7 days culturing [D-F]. The mesothelial cells aligned directly with the 
PECAM positive endothelial tubes [G-I].   
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4.3.7 Gene expression profiling of GFP-mesothelial cells isolated from the chimeric 
rudiments after 7 days of ex vivo culture.  
Since we could not observe MCs that had integrated into developing nephron structures, or 
robustly expressed nephron markers, we aimed to determine whether we could detect 
changes to the gene expression profile of the cells after 7 days of exposure to a nephrogenic 
environment. Therefore, we isolated the GFP-positive mesothelial cells 7 days post-culture 
through FACS and analysed the gene expression profile for key kidney markers against 
passage matched un-challenged GFP-mesothelial cells. From among the list of assayed kidney 
markers (table 4.1), we could detect the expression of Wt1, Wnt6, Wnt4, FGF7, Notch2 and 
Sdf1 genes (Fig. 14A) in the mesothelial cells although the relative change in gene expression 
was not statistically significant following exposure to the nephrogenic environment.  
The metanephric organoid system is a rich source of growth factors and so we aimed to 
determine the effect of the chimeric rudiment on mesothelial cell morphology, in particular, 
MMT signature. Our data showed that the mesothelial cells cultured in the chimeric 
rudiments were triggered to undergo MMT through the up-regulation of MMT transcription 
factors Snail1 (7 fold), Zeb1 (>1000 fold) and Twist1 (100 fold). Vim a marker of mesenchymal 
cells was also 500 fold upregulated in the stimulated GFP mesothelial cells (Fig. 14B). 
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Kidney Structure Marker 
General epithelial 
Krt8 
ZO1 
Cdh1 
Vcl 
Msln 
Ureteric Bud 
Wnt6 
Ret 
Pax2 
AqpII 
Metanephric Mesenchyme 
Wt1 
Gdnf 
Pax2 
Sall1 
Eya1 
Bmp7 
Vim 
Distal tubule Wnt4 
Proximal Convoluted Tubule 
  
Notch2 
Pax2 
Podocytes 
Wt1 
Cxcl12/ CD10 
Stromal cells Cxcl12/ CD10 
 
Table 4.1: List of genes involved in embryonic kidney development that were studied for their 
expression in mesothelial cells, post chimeric rudiment stimulation.  
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Figure 14: Mesothelial cells respond to the nephrogenic environment. GFP-labelled mesothelial 
cells were isolated by FACS following 7 day ex vivo culture in chimeric rudiments, and analysed for 
relative expression of embryonic kidney [A] and EMT genes [B] by qPCR. Wt1, Wnt6, and Wnt4 
were increased following stimulation, while the markers of the stromal compartment, FGF7, 
Notch2 and SDF1 were decreased. [B] The mesothelial cells isolated from the chimeric kidney 
rudiment (KRA) stimulated to undergo both EMT and MET as epithelial genes ZO1, the 
mesenchymal marker Vim and the EMT-TF Snail1, Zeb1 and Twist1 were significantly up-regulated 
relative to the unstimulated GFP-mesothelial cells from the same passage. [C] Key regulators of 
embryonic kidney development were only found expressed in the eControls and not in the 
stimulated or un-stimulated mesothelial cell populations. Data is presented as means ± SEM for 3 
independent replicates.  
 
** 
Chimeric kidney rudiment 
Control 
Chimeric kidney rudiment 
Control 
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4.4 Discussion 
In this chapter, we evaluated the effects of repeated passaging on the capacity of mesothelial 
cells to differentiate along the adipogenic, osteogenic mesodermal lineages, and their ability 
to contribute to nephrogenesis using the metanephric organoid system. While mesothelial 
cells expressed a number of early mesoderm markers consistently throughout culture, their 
differentiation capacity into osteoblasts and adipocytes was limited by cell passage. In the 
chimeric kidney rudiment, the mesothelial cells did not impart negative effects on 
metanephric development. Rather they aligned around the laminin/ megalin positive 
developing proximal tubules and PECAM expressing endothelial networks. Although we did 
see GFP-mesothelial cells wrapped around Wt1+ forming S-shaped bodies, Six2+ induced 
mesenchyme and mesenchymal Pax2 expressing domains around the UBs, the mesothelial 
cells were never found within these forming structures. Ultimately, the presence of 
mesothelial cells within this organoid environment did not stimulate the cells to differentiate 
into embryonic kidney cells, while it promoted the cells to undergo MMT. 
4.4.1 Multilineage potential of mesothelial cells   
An important parameter of stemness is potency, in other words, the stem/ progenitor cells 
can produce multiple differentiated cells. The multilineage capacity of mesothelial cells has 
previously been reported in rat and human pleural mesothelial cells. Lansley and colleagues 
showed that stimulated mesothelial cells underwent MMT during differentiation into 
osteoblast and adipocyte cells (Lansley et al., 2011). In this chapter, we were able to confirm 
the multilineage differentiation of mouse omentum-derived mesothelial cells into osteoblast-
like and adipocyte-like cells following appropriate stimulation. Induction with the osteogenic 
medium resulted in the accumulation of calcium deposits that reacted with the alizarin red S 
dye. However, quantification of mRNA amounts for key osteoblast markers revealed that the 
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osteogenesis differentiation potential was only retained up to passage 13 as the higher 
passage cells failed to significantly respond. Moreover, stimulation with adipogenic inducing 
medium resulted in lipid vacuole accumulation, however, significant upregulation of the key 
adipogenic marker PPARγ was limited to the passage 5 cells only.  
The effects of increased time in culture and reduced differentiation potential has been 
reported in MSCs and haematopoietic stem cells. MSCs from both animal and human sources 
showed reduced osteogenic, adipogenic and the chondrogenic potential with increased 
donor age or/ and cell passage (Kretlow et al., 2008, Elkhenany et al., 2016, Alves et al., 2010, 
Rossi et al., 2007, Chambers et al., 2007). However, osteogenesis and chondrogenesis were 
more affected by ageing than adipogenesis, regardless of source (Kretlow et al., 2008, 
Elkhenany et al., 2016, Alves et al., 2010). Accumulation of DNA double-stranded breaks and 
the respective reduced ability to activate the non-homologous end joining repair pathway 
with successive passaging was associated with reduced MSCs multi-lineage potency (Hare et 
al., 2016, Alves et al., 2010, Elkhenany et al., 2016). Haematopoietic stem cells also 
demonstrated reduced function that was associated with increased DNA damage and 
epigenetic modification (Chambers et al., 2007, Rossi et al., 2007).  
In conclusion, the mesothelial cells in this study demonstrated multilineage differentiation 
potential, however, this was limited by mesothelial cell passage. Further investigations are 
however required to see if there are an accumulation of DSB with passaging, and whether this 
reduces the plasticty of the mesothelial cells in our culture system. . In light of this, 
mesothelial cells for regenerative medicine purposes should only be expanded and used for 
a limited number of passages.  
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4.4.2 Cell labelling techniques for monitoring the renogenic potential of mesothelial cells ex 
vivo 
As another means of testing the relative plasticity of mesothelial cells along mesodermal 
lineages, we extended our work to co-culturing the cells in an embryonic kidney organoid 
culture system. This ex vivo approach to kidney development has been used to assess the 
renogenic potential of a number of progenitor and stem cell types (Kuzma-Kuzniarska et al., 
2012, Ranghini et al., 2013, Rak-Raszewska et al., 2012, Little and Takasato, 2015, Takasato et 
al., 2014).  
However, first, we needed to select a labelling method suitable for long-term detection with 
limited side effects on both the exogenous mesothelial cells and host embryonic kidney cells. 
For this we employed 3 labelling techniques; the CFDA SE, PKH67 and GFP lentiviral 
transduction.  
According to our adipogenesis and osteogenesis results, mesothelial cells showed passage 
related changes in their differentiation capacity. The low transduction efficiency of the GFP-
lentivirus in mesothelial cells meant several rounds of FAC sorting and expansion were 
required to achieve an 88% GFP-positive population of cells by P20. On the contrary, the CFDA 
SE and the PKH67 dye labelling techniques rapidly and uniformly labelled P5-10 mesothelial 
cells to which they were directly incorporated in the chimeric kidney development model.  
The initial fluorescence monitoring studies in mesothelial cell monolayers revealed that the 
CFDA SE gave the brightest initial fluorescent intensity and throughout the 7 d culture period 
the signal dropped to an intensity that matched the GFP+ mesothelial cells. While the PKH67 
gave a brighter signal that the GFP labelled cells, its fluorescence signal was lost by 7 d culture. 
To counteract this problem we decided to stop the chimeric co-culture study at 4 d, where 
the signals for PKH67 was still above cellular autofluorescence.  
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Detailed analysis of the chimeric rudiments showed that while we were able to visualize 
embryonic kidney structures in the rudiments when cells were labelled with PKH67 or GFP 
lentivirus, the chimeric pellets that contained the CFDA SE labelled mesothelial cells seemed 
to show a perturbed development of renal structures.  There appeared to be less Pax2- and 
laminin-containing structures and Wt1- compartments were not detectable in the CFDA SE 
harbouring chimeric pellets. Furthermore, we were unable to detect the labelled mesothelial 
cells. Our previous analysis of the PDT of mesothelial cells showed an average doubling time 
of 32 h in P5-10 cells. Since the CFDA SE dye has been reported to be visualized for up to 8 
consecutive cell divisions, by 7 d the mesothelial cells should still be traceable (Wang et al., 
2005). During this study, we labelled the mesothelial cells directly before incorporating them 
in the chimeric rudiment. The CFDA SE is known to passively enter cells and form random 
covalent links with free amines found on cellular proteins (Wallace et al., 2008). However, 
during the first 24 – 48 h the unbound dye can still escape from the cell (Wang et al., 2005, 
Wallace et al., 2008). Therefore it is possible that the unbound CFDA SE dye escaped from the 
mesothelial cells and was taken up by neighbouring metanephric cells or remained in the 
intercellular spaces. It is known that the CFDA SE is toxic at high doses (Wang et al., 2005, 
Wallace et al., 2008). Which could explain why there was the poor and disrupted development 
of kidney structures. It is, however, important to note that the relative toxicity varies between 
cells as it is dependent on cell size and esterase content (Wang et al., 2005, Wallace et al., 
2008).   
While the PKH67 containing pellets showed embryonic structural development that 
resembled the rControls and eControls, also with this dye we failed to detect the mesothelial 
cells. Instead, it appeared that the dye had transferred across to neighbouring embryonic cells, 
as we could visualize S-Shaped renal structures. The PKH dye transfer to neighbouring cells 
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has been previously reported in in vitro co-cultures, were unlabelled GP293T fibroblasts 
acquired red fluorescence from the HL-60 cells labelled with PKH26 (Lassailly et al., 2010). 
Studies have suggested that dye transfer can occur through the exchange of lipid components, 
uptake of PKH-labelled exosomes and if the labelled cells are dead (Li et al., 2013a, 
Christianson et al., 2013, Franzen et al., 2014).  
Labelling mesothelial cells with GFP did not result in signal deterioration over the course of 
the 7 d culture period. Furthermore, metanephric structural development could also occur in 
the presence of the GFP+ mesothelial cells, indicating that GFP transduction was the better 
method to enable long-term ex vivo tracking of mesothelial cells. There are numerous reports 
describing the use of labelling cells with GFP lentivirus for long-term monitoring of migration 
and distribution in vivo. Tao and colleagues showed that the potency capacity of human 
umbilical cord-derived mesenchymal stem cells to differentiate into osteoblasts and 
adipocytes following stimulation was unaffected by labelling with either PKH26 or GFP-
lentivirus (Tao et al., 2014). Similar to our findings, the PKH26 fluorescence intensity was lost 
after a few passages, while the GFP+ cells maintained their signal (Tao et al., 2014).  
In conclusion, GFP-lentiviral transduction was shown to be the better labelling method for 
long-term detection of mesothelial cells in the ex vivo chimeric rudiment. This is albeit the 
fact that this technique had the lowest efficiency for labelling the cells, which in turn meant 
we could not assess the possible nephrogenic potential of the lower passage mesothelial cells.  
4.4.3 Analysis of mesothelial cell renogenic potential  
(Kuzma-Kuzniarska et al., 2012, Ranghini et al., 2013, Rak-Raszewska et al., 2012)Using the 
chimeric kidney rudiment assay, we were able to co-culture P22-32 GFP+ mesothelial cells in 
the chimeric rudiments at a ratio of 1:10, using a total of 200,000 cells. Over the course of the 
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7 d culture period and in the presence of the mesothelial cells we could see the adaptive self-
organization of key embryonic structures, namely UBs, MM, forming nephrons and PECAM 
expressing endothelial tubules. The mesothelial cells in both 4 d and 7 d cultures could be 
seen enfolded around the Wt1-, Six2- and Pax2- expressing condensed mesenchyme, in a 
loop-like formation. The GFP-cells could also be found outside the laminin/ megalin and PNA 
proximal tubule compartments. However, the GFP-cells did not engraft into the forming 
nephrons, the condensing MM or the UBs. Analysis of FAC sorted GFP-cells that had been co-
cultured in the chimeric rudiments for 7 d, confirmed this as the cells had failed to express or 
upregulate key metanephric markers. Rather, in response to cues from developing chimeric 
rudiments, the GFP-cells showed hallmarks of MMT through the expression of the Twist1, 
Zeb1, Snail1 transcription factors and Vim.  
Contrary to our findings, the co-culture of human and mouse MSCs in the chimeric organoid 
system was detrimental to nephrogenesis despite the fact that these cells expressed the renal 
markers Osr1, Sall1, Lim1 and Gdnf prior to incorporation (Kuzma-Kuzniarska et al., 2012). In 
some regions of rudiments which contained quantum dot labelled cells, there was a complete 
absence in Wt1-expressing MM (Kuzma-Kuzniarska et al., 2012). By contrast, mouse ESC that 
were directed to differentiate and express mesodermal marker Bra, showed integration into 
UBs, proximal tubules and forming glomeruli (Rak-Raszewska et al., 2012). Furthermore, 
those labelled cells that had integrated into proximal tubules were functional, as they could 
transport labelled anionic molecules from the interstitium into the proximal tubules (Rak-
Raszewska et al., 2012). An alternative cell type to ESCs for kidney regeneration are amniotic 
fluid stem cells (AFSCs) (Perin et al., 2007). Human AFSC were demonstrated to integrate into 
renal vesicles and comma- and S-shape bodies following co-culture in the chimeric rudiments 
for 10 d (Perin et al., 2007, Siegel et al., 2010). Furthermore the AFSCs showed hallmarks of 
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differentiation as they expressed ZO1, claudin, and GDNF (Perin et al., 2007). Overall, our data 
suggest that the older passage mesothelial cells have a rather low renogenic potential in the 
chimeric kidney rudiments.  
Another pertinent finding was the presence of PECAM positive endothelial networks in the 
eControl, rControl and chimeric rudiments. In addition, the GFP-cells could be seen aligning 
to the forming endothelial networks.  
Ex vivo metanephric development is halted at the stage of glomerular development, due to 
the lack of a blood supply (Rak-Raszewska et al., 2015). Contained within the in vivo forming 
kidneys is a pool of endothelial progenitor cells, and by E13.5 most of the vascular branches 
are perfused while at E15.5 the smaller-calibre peripheral vessels become also show blood 
flow (Rymer et al., 2014). However, it seems for the renal vasculature to form ex vivo, the 
chimeric rudiments need to be exposed to the correct environment (Xinaris et al., 2012, Rak-
Raszewska et al., 2015). Xinaris and colleagues used a novel technique where E11.5 rudiments 
were re-aggregated, cultured for 5 d ex vivo, following which they rudiments were treated 
with VEGF for 4 h before being transplantation under the kidney capsule of athymic rats 
(Xinaris et al., 2012). This promoted the vascularization from donors which in turn aided 
glomerular maturation and function (Xinaris et al., 2012).  
We cannot comment on whether the endothelial networks observed in the re-aggregation 
and chimeric rudiments were functional or if the glomeruli would have developed further, as 
no further exploratory tests were conducted.  Furthermore, while the mesothelial cells 
aligned to the endothelial networks, they did not seem to increase vascularization nor inhibit 
it. It has been previously demonstrated that uterine-derived mesothelial cells had the capacity 
to transdifferentiate via MMT into functional vascular smooth muscle-like cells following 
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stimulation with EGF, in vitro. It remains to be certified whether or not the chimeric rudiment 
stimulated mesothelial cells did in fact display this plasticity.   
4.5 Conclusion  
Overall we were able to show that the mesothelial cells possess a multi-lineage capacity along 
the osteogenic and adipogenic lineages; however this was limited to the early passages. 
Furthermore, GFP lentiviral transduction was the optimal technique for the long term 
monitoring of cells. Moreover, in the chimeric rudiments, the mesothelial cells did not disrupt 
metanephric structural development. Despite this, we only saw hallmarks of MMT and not 
signs of differentiation into embryonic kidney cells in the mesothelial cells after co-culture. 
There is a possibility that this may be attributed to the fact that we were only able to track 
the older passaged cells which we had previously asserted as being less potent. While we 
failed to observe quantifiable differences in re-aggregated and chimeric kidney rudiments, 
the mesothelial cells could possibly have a role in supporting the development of the 
rudiments, as they are known to secrete an array of growth factors and ECM proteins which 
could contribute to nephrogenesis (Herrick and Mutsaers, 2004).  
The results from this chapter and the previous one led us to ask whether EGF and or TGF-β 
were the growth factors that modulated the changes observed in the passaged mesothelial 
cells and through want signalling pathway. Furthermore, we aimed to address the roles of 
Zebs and Snail2 transcription factors involvement in modulating the cells MMT status.  
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Chapter 5: TβRI and EGFR 
antagonists block mesothelial 
migration through ERK5-
dependent mechanisms. 
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Introduction and aims  
In the previous chapters, we have shown that adult omentum-derived mesothelial cells in 
culture represented a ‘hybrid’ cell type, expressing both epithelial and mesenchymal features. 
During long-term culture, the adult mesothelial cells down-regulated the expression of 
epithelial markers and maintained mesenchymal characteristics when compared to cultured 
omentum explants. Further analysis of key MMT regulators and recognised inducers showed 
that with increasing time in culture, Snail2 and EGF and its corresponding receptor were up-
regulated. These results suggested that mesothelial cells in culture adopted a more 
intermediate phenotype within the MMT spectrum. However, the cells never fully 
transdifferentiated into myofibroblasts.    
Physiologically, MMT is activated in response to injury in the adult (Li et al., 2013b). 
Mesothelial cells lose their basolateral polarity and gain a more migratory capacity, for 
example, to aid in wound repair; of note, this process is usually reversible (Li et al., 2013b). 
However, the prolonged exposure to PD fluids that contain glucose degradation products 
(GDP) as a result of exposing the fluids to heat, generates advanced glycation end-products 
(AGE), together these degradation products induce a proinflammatory response and cause 
the cells of the mesothelium to undergo complete transdifferentiation resulting in debilitating 
fibrosis or sclerosis (Abelardo Aguilera, 2013).     
Free floating mesothelial cells have been demonstrated to contribute to the recovery of 
peritoneal membranes in rat testis through implantation and proliferation (Foley-Comer et 
al., 2002a), however approaches to utilise this technique to aid peritoneal repair have not 
been successful as the mechanisms that regulate MMT are not fully understood (Strippoli et 
al., 2016). 
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MMT is regulated by a number of growth factors and cytokines secreted in an autocrine and 
paracrine manner (Strippoli et al., 2016). While TGF-β is regarded as a master molecule of 
MMT both in vitro and in vivo, mediating this process through Smad-dependent and -
independent mechanisms (Fig. 1.4) (Decologne et al., 2007, Li et al., 2016, Li et al., 2013b), 
EGF has been recently attributed as an inducer of MMT in human and rodent mesothelial cell 
(Lachaud et al., 2014, Lachaud et al., 2013). TGF-β-induced MMT has been linked with the 
activation of the Smad, PI3K, Akt/mTOR, JNK and MAPK signalling  pathways (Javelaud and 
Mauviel, 2005, Liu et al., 2008, Strippoli et al., 2015), suggesting that the downstream 
signalling  effectors of MMT are activated in a context specific manner and potentially through 
a synergistic convergence of multiple growth factors or cytokines (Li et al., 2016, Strippoli et 
al., 2016). Western blot analysis of downstream signalling effectors in P7 mesothelial cells 
identified potential candidates involved in regulating the MMT transdifferentiation process. 
Specifically, we could detect the expression of EGFR, phosphorylated serine/threonine kinase 
ERK1/2, ERK5 and pSmad 2/3 (Fig. 5.1). These results suggest that EKR1/2, EKR5, and Smad2/3 
were activated as part of signalling through TGF-β and EGF. The expression of EGFR protein 
in the P7 mesothelial cells (Fig. 5.1), which corresponded with the observation of transcript 
expression from Chapter 3, further supported this hypothesis. 
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Figure 5.1: Mesothelial cells expressed intracellular proteins downstream of TGF-β and EGF 
signalling. Whole-cell lysates were isolated from P7 mesothelial cells that were cultured in 
standard growth medium. The lysates were resolved on a 4-12% Bis-Tris gel. We were able to 
detect the EGFR, pERK5, pSmad2/3 and pERK1/2 within the cells. Arrows indicate the expected 
band size for the proteins of interest.  
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Based on these results, we aimed to further analyse the potential convergence of the EGF and 
TGF-β signalling pathways in regulating MMT in the mesothelial cells, as EGF is a known 
mediator or MEK5 and MEK1/2. To address this question, we tested the role of these growth 
factors and their respective receptor inhibitors in regulating the migratory behaviour of 
mesothelial cells in an in vitro wound healing assay (tables 2.2 and 2.1 respectively). 
Furthermore, we studied any changes in the localization of MMT associated markers and the 
expression patterns at gene and protein levels in the mesothelial cells that were challenged 
in the wound healing assay.  We also attempted to dissect the downstream signalling cascades 
and transcription factors involved in regulating the migratory behaviour of the MCs in the 
wound healing assay, in order to determine at which level there was a convergence of these 
two signalling cascades. Finally, we analysed the receptiveness of the various mesothelial cell 
‘states’ (OMC – deemed more epithelial and the passaged mesothelial cells, intermediate 
mesenchymal) to undergo MMT in response to the growth factors and inhibitors. 
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5.1 TGF-β and EGF growth factors influence the phenotype of OMC mesothelial 
cells with a variable potency 
5.1.1 The TGF-β receptor I (TβR-I) inhibitor LY364947 preserved the epithelial-like 
phenotype in OMC mesothelial cells  
To explore whether cultured mesothelial cells maintained the intermediate MMT phenotype 
through TGF-β autocrine or paracrine-induced signalling  loops, we first turned to OMC 
culture to analyse the response of either TGF-β cytokine or the small molecule TβRI inhibitor 
(LY364947, here called TβRi) (Hong et al., 2014) for 48 h. The samples were then 
immunolabeled with the tight junctional complex marker ZO1 and the myofibroblast marker 
αSMA in order to detect any changes in the MMT state mediated by these inhibitors and 
growth factors.  
The OMCs were initially cultured in 10% FCS containing a medium for 5 d, before being serum 
starved for 24 h to be treated with the experimental conditions. Previous efforts in culturing 
the explants directly in low serum medium post dissection yielded poor long-term outcomes 
as explant attachment was reduced, and mesothelial cells failed to sufficiently grow out from 
the few attached explants (data not shown).  
In the low serum control group, we could confirm a mixed population of mesothelial cell 
morphologies in the OMC cultures, which is not surprising since after 5 d in full growth 
medium both mesenchymal, αSMA+ and epithelial cells have been previously described 
(Kawaguchi et al., 2007). Within the small sub-confluent islands of mesothelial cells, we could 
detect discrete bands of ZO1 at points of cell-cell contact. However, some of these cells also 
co-expressed αSMA (Fig 5.2A-D). In addition, some mesothelial cells adopted a larger flatter 
morphology expressing brighter αSMA staining and nuclear accumulation of ZO1, which is 
indicative of a more mesenchymal-like phenotype. By comparison, TGF-β stimulation of OMCs 
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induced the mesothelial cells to transdifferentiate into larger, flatly shaped cells uniformly 
expressing αSMA stress fibres throughout the cytoplasm and nuclear accumulation of ZO1 
(Fig 5.2E-H). The TβRI inhibitor re-established the epithelial-like phenotype of the mesothelial 
cells with strong ZO1 accumulation at the cell-cell contacts (Fig 5.2I-L).  
Taken together, the data revealed that TGF-β could induce the transdifferentiation of the 
mesothelial cells into more myofibroblastic cells. This was supported by the observation that 
treatment of OMCs with the TβRI inhibitor resulted in the re-establishment of an epithelial 
phenotype in the outgrowing mesothelial cells.   
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Figure 5.2: TGF-β induced mesothelial to mesenchymal transition in OMCs. Established OMC 
explants were incubated for 48 h with TGF-β or inhibitors respectively, and immunolabeled for MMT 
markers. [A-D] The control OMC (1% serum) cultures showed a mixed population of mesothelial cells 
with epithelial-like, ZO1 expressing islands (arrowheads) and αSMA-only, mesenchymal-like 
characteristics. [E-H] The OMC stimulated with TGF-β adopted a mesenchymal-like phenotype, with a 
flatter, longer fibroblastic shape, and strong αSMA expression. [I-L] The treatment with the TβRI 
inhibitor caused mesothelial cells to strongly express ZO1 tight junctional bands associated with 
epithelial characteristics.  Images are representative of n=2. Images D,H and L were digitally enlarged.  
50 µm 
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5.1.2 EGFR inhibitor maintained hybrid cell phenotype in OMC mesothelial cells  
As with the previous set of omentum explants, the cultures were left to attach for 5 d to allow 
the mesothelial cells to migrate out as an epithelial sheet. Next, the samples were serum-
starved before being either stimulated with EGF or inhibited for 48 h with a selective EGFR 
tyrosine kinase inhibitor (PD153035, from now on called EGFRi) (Guan et al., 2016), a highly 
potent and selective non-competitive MEK inhibitor (PD184352, MEKi) (Wang et al., 2014) 
and a selective MEK5 and ERK5 inhibitor (BIX02189, MEK5i) (Amano et al., 2015) . 
Subsequently, the samples were immunolabelled with the epithelial and mesenchymal 
markers ZO1 and aSMA.  
In the presence of EGF, some of the mesothelial cells growing out of the explants 
differentiated into elongated αSMA-expressing myofibroblasts. However, this process was 
not uniform as pools of epithelial-like cells expressing ZO1 at tight junctional bands were also 
present (Fig 5.3E-H). The presence of the EGFRi also resulted in epithelial, ZO1-expressing 
islands that were surrounded by αSMA-expressing myofibroblasts (Fig 5.3I-L). Both the 
MEK1/2 and the MEK5 inhibitors impacted OMC survival, therefore we could not analyse the 
cells for ZO1 or αSMA expression (data not shown).  
Taken together the data suggests that EGF was a less potent mediator of MMT in the OMCs 
compared to TGF-β.   
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Figure 5.3: EGF induces MMT changes in some explant derived mesothelial cells. Established OMC 
explants were stimulated or inhibited with EGF growth factor or inhibitors, respectively, for 48 h. The 
samples were then immunolabelled for ZO1 and αSMA. [A-D] The control treatment group had a 
mixed population of mesothelial cells expressing either tight ZO1 junction complexes (arrowheads) or 
αSMA-expressing fibroblastic cells. [E-H] Some of the mesothelial cells that had been stimulated with 
EGF adopted a flatter longer fibroblast shape, with strong αSMA staining. [I-L] The treatment with 
EGFR inhibitor maintained the mixed pool of epithelial and mesenchymal cell morphologies.  Images 
are representative of n=2 biological independent samples. 
50 µm 
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5.2 Stimulation in TGF-β and EGF for 48 h does not induce complete MMT in 
passaged mesothelial cells  
5.2.1 Protein expression analysis in response to TGF-β and EGF in passaged mesothelial cells 
In the previous experiments, we showed that TGF-β, and possibly EGF, had an effect on the 
transdifferentiation of mesothelial cells from OMC, therefore we wanted to determine 
whether TGF-β and EGF also induced the passaged mesothelial cells (P10-P25) to undergo full 
MMT by acquiring complete mesenchymal characteristics and losing epithelial features. To 
address this question, we assessed the effect of these growth factors on the localisation of 
key epithelial and mesenchymal protein markers.    
Serum-starved mesothelial cells (P10-P25) were stimulated in 1% FCS growth medium 
containing either 50ng/ml EGF or TGF-β for 48 h, followed by immunolabelling with ZO1 and 
αSMA, respectively. The images for all the samples were captured at the same exposure time 
to gain a qualitative and semi-quantitative assessment of protein expression.  
The tight junctional marker ZO1 was difficult to detect at the cell-cell contacts in the 1% FCS 
control group (Fig 5.4B-C), which is contrary to the mesothelial cells sub-cultured in full 
growth medium (Fig 3.6B-D). Meanwhile, the mesenchymal marker αSMA was unaffected by 
the low serum conditions (Fig 5.4A-C). Cells that had been stimulated with either EGF or TGF-
β showed brighter αSMA staining (Fig 5.4D and G) relative to the low serum control group. 
Furthermore, stimulated cells, particularly those treated with EGF, expressed little to no ZO1 
at the cell-cell junctional contacts (Fig 5.4E and H). Taken together, mesothelial cells cultured 
in low serum show some but very little ZO1 expression and stimulation in either EGF or TGF-
β reduces this further. Therefore suggesting MMT progression.   
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Figure 5.4: EGF and TGF-β induce some MMT changes in passaged mesothelial cells. Passaged 
mesothelial cells were stimulated for 48 h in EGF or TGF-β and immunolabeled for ZO1 and αSMA. [A 
- C] Cells in the 1% serum group expressed αSMA weakly, however, ZO1 was absent from the cell-cell 
contacts. [D - F] EGF-treated cells expressed αSMA uniformly in the cytoplasm, while ZO1 was not 
localised to the cell borders. [G - I] The passaged cells that were stimulated in TGF-β showed no ZO1 
localisation at the cell-cell junctions and strong αSMA staining. Images were taken at 846.6 ms 
exposure for 594 channel and 2 s exposure for the 488 channel. Images shown are representative of 
n=2  
  
50 µm 
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Through western blot analysis, we could show that the stimulation with TGF-β and EGF did 
not significantly alter the expression of the MMT associated markers αSMA (Fig 5.5B), ZO1 
(Fig 5.5C), and Snail2 (Fig 5.5D). Moreover, western analysis of the Ras/MAPK signalling 
pathway showed that EGF and TGF-β increased the expression of ERK1/2 and ERK5 levels in 
mesothelial cells, without changing the overall phosphorylation (Fig 5.5). This suggests that 
these growth factors stimulate the activation of these MAP kinases in mesothelial cells. 
Whether ERK1/2 and ERK5 have a role in mediating MMT in mesothelial cells needs further 
clarification.  
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Figure 5.5:  MAPK signalling  in mesothelial cells treated with EGF and TGF-β [A] Mesothelial cells were treated for 48 h in TGF-β or EGF (50ng/ml) following 
which the cells were lysed and protein extract. Samples were resolved on a 4-12% Bis-TRIS membrane. Signal intensities of the bands were quantified and 
phosphorylation revealed no significant changes for αSMA [B], ZO1 [C], and Snail2 [D] expression, or for [E] ERK1/2 and [F] ERK5 phosphorylation. However, 
stimulation increased overall total protein expression of these signalling molecules. All samples were normalized against β-actin loading control and ERK 
phosphorylation was calculated as [(pERK/ β-actin) / (tERK/ β-actin)]. Data representative of n= 2 biologically distinct replicas.  
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5.2.2 Response in migratory behaviour of mesothelial cells after TGF-β or EGF stimulation 
During insult induced by bio-incompatible agents or injury to the serosa, mesothelial cells can 
undergo MMT to gain migratory features of mesenchymal cells in order to assist with wound 
healing (Lee and Ha, 2007). Therefore, the ability of cytokines to regulate MMT could affect 
cell infiltration and cell aggregation at the site of the injury. Therefore, we next assessed the 
effects of TGF-β or EGF stimulation on the migration capacity of cultured mesothelial cells in 
an in vitro scratch assay. 
Passaged mesothelial cells (between passages 10 and 16) were serum deprived for 24 h in 1% 
FCS medium. The cells were then stimulated with TGF-β or EGF for 48 h. Their ability to close 
the scratched area was analysed over a 24 h period in the presence or the absence of 
mitomycin C (10 μg/ml). Mitomycin C (MMC) is a potent DNA cross-linker and was used in 
order to assess the gap closure rate in the absence of cell proliferation (Liu et al., 2009) (Fig 
5.7).  
By 12 h, the percentage gap closure had reached 80% in the TGF-β stimulated conditions, and 
roughly 70% in cells stimulated with EGF (Fig 5.6), and full gap closure was seen by 24 h in all 
conditions that lacked MMC (Fig 5.6). In comparison to the control low serum group, the TGF-
β stimulated cells showed a 1.8 fold faster rate of gap closure at the 4 h point, however by 12 
h the rate of gap closure had attenuated to 1.4 fold compared to control cells (Fig 5.6A).  On 
the other hand, stimulation with EGF slowed the rate of gap closure by 2.3 fold at the 4 h 
point, relative to the control cells (Fig 5.6A).  Statistical significance was noted between the 
EGF and TGF-β growth factors at the 4 h point, where TGF-β induced a faster rate of migration 
by 4 fold when compared to EGF stimulation (P<0.05) (Fig 5.6A). 
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In the presence of MMC, we could not detect any significant changes in the percentage gap 
closure rate between the samples (Fig 5.6B).     
Overall, stimulation with TGF-β for 48 h in the absence of MMC, showed the fastest rate of 
gap closure at 4 h and 12 h. Significance, however, was only noted at 4 h where the TGF-β 
induced faster migration relative to EGF stimulation. In the absence of cell proliferation, the 
migration rates between the treated and untreated groups were unaffected. Taken together, 
we showed that TGF-β and EGF-induced some changes in ZO1 localization and increased 
expression of ERK1/2 and ERK5, yet complete transdifferentiation into myofibroblasts was 
not achieved. This could due to the fact that the cells needed longer exposure to the growth 
factors for full MMT progression. 
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Figure 5.6 Stimulation with EGF or TGF-β growth factors for 48 h fails to change the rate of gap 
closure. Mesothelial cells (P10 -25) at 80% confluence were serum deprived for 24 h, before being 
stimulated for 24 h with either EGF or TGF-β in the presence or absence of mitomycin C (MMC+/-). 
They were then scratched and the medium was replaced. The cell wounds were imaged at 0, 4, 12 and 
24 h post wounding. [A] In the absence of MMC, the cells showed a 4 fold faster rate of migration at 
4 h post-scratch induction after stimulation with TGF-β when compared to the EGF stimulation 
(P<0.05). However, by 12 h the percentage wound closure was similar between all the groups. [B] In 
the presence of MMC the mesothelial cells showed a similar rate of wound closure between all groups. 
Data is representative of 2 biological replicas. A one-way ANOVA followed by a Sidak post hoc was 
performed to determine significance between the groups where # = P<0.05 compared to the EGF 
treatment group. Scale bar 200 µm.  
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5.3 TGF-βRI and EGFR inhibitors rescued the expression of ZO1 in the mesothelial 
cells and slowed the rate of mesothelial cell migration in an in vitro wound healing 
assay  
The previous sections had shown that stimulation with TGF-β or EGF caused the mesothelial 
cells to show reduced expression of ZO1 at cell contacts and increased overall ERK1/2 and 
ERK5 expression. We next sought to determine the effects of long-term inhibition of the TGF-
β and EGF signalling pathways on the expression and localization of epithelial and 
mesenchymal-related markers. Following a 48 h culture period in 5-20 µM of either LY364947 
(TβRi) or PD153035 (EGFRi), the mesothelial cells were fixed and immunolabeled with ZO1 
and αSMA. Sample images were captured at the same exposure time to more accurately 
examine the effect of the inhibitors on protein localization.  
The cells exposed to low serum only showed strong αSMA stress fibre expression and weak 
ZO1 expression (Fig 5.7A-C). In comparison, mesothelial cells treated with an escalating range 
of doses between 5-20 µM of TβRi showed brighter levels of αSMA and more restored ZO1 
expression, especially in the higher doses, relative to the 1% FCS only group (Fig 5.7D-L). 
Treatment with EGFRi seemed to also increase the localisation the tight junctional protein 
ZO1 at the cell-cell contacts in a punctate manner (Fig 5.7M-U). However, the restoration of 
ZO1 in response to EGFRi seemed less pronounced when compared to the TβRi treatment 
group.   
Overall, inhibiting signalling through TβRI and EGFR seemed to restore ZO1 expression at the 
cell contacts while simultaneously increasing the expression of αSMA. Suggesting that the 
cells had adopted an intermediate E/M state within the MMT spectrum.  
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Figure 5.7: Blocking TGFb and EGF signalling with TβRi (LY364947) and EGFRi (PD153035) rescued ZO1 expression and increased αSMA in mesothelial cells. 
P10-25 mesothelial cells were inhibited for 48 h in TβRi and EGFRi, respectively, and immunolabelled for ZO1 and αSMA. [A-C] Cells of the low serum control 
group expressed αSMA, while ZO1 expression was absent from cell contacts. [D-L] After incubation with doses of between 5-20 µM TβRi, mesothelial cells 
upregulated the expression of αSMA and ZO1 in a dose-dependent manner. ZO1 was found localised to the cell borders in a punctate pattern (arrowheads). 
[M-U] Incubation with EGFRi resulted in faint punctate ZO1 localisation at the cell-cell junctions (arrowheads) and bright αSMA staining. Images were taken 
at 846.6 ms exposure for 594 channel and 2 s exposure for the 488 channel; a representative of n=2. 
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Since we have shown that the inhibition of TGF-β and EGF signalling resulted in the 
upregulation of both epithelial and mesenchymal markers, it was important to assess whether 
the inhibitors had an effect on the rate of mesothelial cell migration in the scratch assay. The 
passaged mesothelial cells were seeded at 4x105 density/ well and left to attach overnight. 
They were serum deprived for 24 h following which they were inhibited for a period of 24 h 
in 5-20 µM TβRi (LY364947) (Fig 5.8) or EGFRi (PD153035) (Fig 5.9). The monolayers were 
subsequently scratched and fresh medium supplemented with inhibitors was re-added. The 
migration rates were assayed in the presence or absence of MMC over a course of 24 h.   
Mesothelial cells treated with TβRi in the absence of MMC showed a dose-dependent 
response in migration into the wound area. At 4 h post wound generation, the mesothelial 
cells treated with TβRi had a 1.5-1.9 fold reduced rate of migration relative to the control cells. 
However by 12 h the TβRi-treated cells had closed the wound space 1.3-1.5 fold faster relative 
to the control cells (P<0.01 for the 20 µM treatment) (Fig 5.8A).    
During the time course of the wound closure in the presence of MMC, the highest inhibitor 
concentration led to a significant reduction in the closure rate throughout the study. Overall, 
the wound closure rates were reduced in a dose-dependent manner over control conditions 
(Fig 5.8B).   
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One way ANOVA: 12 h P= 0.0008 and 24 h P= 0.0244 
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Figure 5.8 Inhibition of TβRI for 48 h attenuates the rate of gap closure. Mesothelial cells between 
P10 -25 were serum deprived for 24 h, before being treated with TβRi for 24 h in the presence or 
absence of mitomycin C (MMC+/-). Following which the monolayer was scratched and the wounds 
were imaged at 0, 4, 12 and 24 h. [A] Under MMC- conditions, the mesothelial cells had attenuated 
the rate of gap closure at 4 h between 1.5 to 1.9 fold relative to the low serum group. Paradoxically, 
the percentage wound closure by 12 h was 1.2-1.5 fold faster (P<0.01 in the 20 µM treatment). [B] 
Under MMC+ conditions, the mesothelial cells attenuated the rate of gap closure in a dose-dependent 
fashion. At 4 h the rate of wound closure was roughly 4 fold slower in the 10 and 20 µM treatments 
(P<0.01). By 24 h the rate was 1.5 fold lower (P<0.05) at the 20 µM dose. Data is representative of 2 
biological replicas. A one-way ANOVA was used to determine statistical significance between the 
groups where ** = P<0.01, and *** =P<0.001 when compared to the 1% FCS only group. Scale bar 200 
µm. 
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Next, we examined the rate of gap closure of mesothelial cells in the presence of the EGFRi 
(Fig 5.4.2A). In the absence of the MMC, the rate of wound closure was attenuated over time 
relative to the low serum control cells, as the percentage of wound closure was roughly the 
same between the EGFRi-treated and untreated cells. By 12 h the rate of cell migration had 
dropped by 1.7 and 2.1 fold in the 10 and 20 µM dose treatments, respectively, however, this 
difference was not statistically significant (Fig 5.9A). In the presence of MMC, the rate of cell 
migration into the open wound in response to EGFRi stimulation was also slower relative to 
the control. Initially, the rate of migration across all doses of EGFRi was similar at both 4 h and 
12 h since migration was attenuated 3 fold (P<0.01 at 12 h). However, by 24 h the gap closure 
rate showed a dose-dependent response since EGFRi at 10 µM attenuated gap closure by 1.33 
fold, and at 20 µM the gap closure rate was 1.9 fold reduced (P<0.01) (Fig 5.9B).  
In summary, the temporary inhibition of signalling through TβRI and EGFR in the absence of 
cell proliferation attenuated mesothelial cell motility in a dose-dependent manner.  
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Figure 5.9 Inhibition of EGFR for 48 h attenuates the rate of gap closure. Mesothelial cells were serum 
starved for 24 h in 1% FCS medium. This was followed by a 24 h period of treatment in the EGFR 
inhibitor (PD153035). A scratch was formed in the centre of the monolayer and medium was replaced. 
Samples were imaged at 0, 4, 12 and 24 h. [A] The mesothelial cells 12 h post wounding in the MMC- 
conditions showed a dose-dependent attenuated wound closure of 1.7 fold at the 10 µM dose and 
2.11 fold slower closure at the 20 µM dose relative to the control group. [B] In the MMC+ condition 
the rate of mesothelial cells migration into the gap was most attenuated at 4 and 12 h post wounding, 
showing a 3 fold reduced migration relative to the control cells (P<0.01). By 24 h the percentage gap 
closure was 1.9 fold slower in the 20 µM PD153035 treated cells (P<0.01). The data presented is 
representative of 2 biological replicas, and a one-way ANOVA test was used to determine statistical 
significance where P<0.01, *** =P<0.001 and ****=P<0.0001 compared to the 1% controls. Scale bar 200 
µm. 
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5.4 Inhibition of MEK5 and ERK5 gave rise to two distinct groups of cells that 
corresponded to the different MMT states.  
So far we showed that stimulation by especially by TGF-β led to an increase of phosphorylated 
ERK1/2 and ERK5 in mesothelial cells, while both EGF and TGFb inhibition resulted in 
upregulation of ZO1 and decrease in migratory behaviour. Next, we aimed to determine if 
ERK5 and ERK1/2 played a role in mediating MMT. While ERK1/2 has been previously 
documented to induce MMT in mesothelial cells, the role of ERK5 signalling  in mediating 
epithelial cell migration and transdifferentiation remains largely disputed and not well 
characterised, especially in mesothelial cells (Jin et al., 2016, Strippoli et al., 2015, Liang et al., 
2015, Komaravolu et al., 2015, Badshah et al., 2014). Recent work on keratinocytes 
demonstrated that EGF-induced EMT was mediated through the ERK5 – Snail2 signalling  
cascade (Arnoux et al., 2008).  
Our previous efforts to analyse the MMT status in the OMC explants following the inhibition 
of MEK1/2 and MEK5 for 48 h were not successful as the small molecule inhibitors induced 
cell death. In fact, treatment with PD184354 (a small molecule inhibitor of MEK, MEKi) 
induced cell death in the OMC-derived mesothelial cells just 2 h post treatment (data not 
shown).  With this in mind, we decided to assess the impact of MEKi, BIX02189 (MEK5 
inhibitor, MEK5i), and XMD8-92 (ERK5 inhibitor, ERK5i) on MMT and migration in mesothelial 
cell cultures using a range of doses.  
Our preliminary tests using the inhibitors showed that even at a low dose (5 µM) MEKi 
negatively impacted on mesothelial cell proliferation and survival with most cells dying by 24 
h (P<0.0001) (Fig 5.10). Treatment with 5 µM ERK5i resulted in a 55% loss in cell viability by 
24 h, while by 48 h the cell viability was reduced to 62% relative to the 1% FCS controls 
(P<0.001 and P<0.01), respectively. Finally, 5 µM MEK5/ERK5i showed a delayed onset of 
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cytotoxicity in the mesothelial cells, as we noted a 35% drop in relative cell viability by 48 h 
(P<0.05).  
 
Figure 5.10: Inhibition of MEK5 and ERKs 1/2 and 5 are essential for mesothelial cell survival. Serum-
starved mesothelial cells were treated with 5 µM of MEK5/ERK5i, ERK5i or MEKi. Cell cytotoxicity was 
assayed using the CCK-8 kit at 0 h, 24 and 48 h post treatments. MEK5/ERK5i showed a delayed onset 
of cytotoxicity in mesothelial cells since a significant difference was only detectable at 48 h. ERK5i 
reduced cell viability by 55% at 24 h and 62% by 48 h, while MEKi was most potent and induced 
complete cytotoxicity by 48 h. Data is representative of n=2 biologically independent samples. A One-
way ANOVA determined statistical significance, where *=P<0.05, **=P<0.01, ***=P<0.001 and 
****=P<0.0001.    
Cytotoxicity effects of MEK and ERK inhibitors on MCs 
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Since MEKi showed a high degree of cytotoxicity, we decided to concentrate on MEK5i and 
ERK5i in order to determine the role of ERK5 and MEK5 on MMT using ZO1 and αSMA 
immuno-detection. We also aimed to test the effects of lower doses of these small molecule 
inhibitors to circumvent the cytotoxic effects seen in the 5 µM dose.  
With immunolabeling, we were able to detect a spectrum of coexisting cells passing through 
the MMT programme since these cell populations would have otherwise been masked by 
whole cell lysis techniques that generate population average data.  
In the absence of inhibitors, cells of the control group expressed αSMA and very little ZO1, as 
shown before (Fig 5.11A-C). When the mesothelial cells were exposed to a range of 
MEK5/ERK5i doses between 1.25 and 5 µM, they exhibited an increase in ZO1 abundance 
overall relative to the low serum group (Fig 5.11D–L). However, there was a mixed population 
of cells that expressed either ZO1medium / αSMAlow (white arrow) or ZO1medium / αSMAhigh 
(yellow arrow), consistent with the MMT spectrum where the cells seem to exist in the 
intermediate state.   
Treatment with ERK5i for 48 h also increased the expression of ZO1 at the cell-cell contacts; 
furthermore, we were able to see a similar spectrum of cells going through MMT. However, 
the mesothelial cells seemed to express less ZO1 at the cell borders even in the higher doses 
when compared to MEK5/ERK5i (Fig 5.11M-U).  
  
189 
 
 
Figure 5.11: Treatment in MEK5/ERK5i and ERK5i gave rise to a spectrum of MMT cell states.  Mesothelial cells between P10 and P25 were inhibited for 48 
h in MEK5/ERK5i and ERK5i, respectively, and immunolabeled for ZO1 and αSMA. [A-C] Low serum controls expressed high αSMA and weak ZO1. [D-L] 
Inhibition with doses between 1.25 - 5 µM MEK5/ERK5i yielded a mixed population of cells that expressed αSMAlow /ZO1medium (white arrowheads) or αSMAhigh 
/ZO1medium (yellow arrowheads). [G-I] Inhibition using ERK5i resulted in a similar but less pronounced population of cells with mixed expression of MMT state 
markers. Images were captured at 846.6 ms and 2s exposure times for 594 and the 488 channels for n=2.  
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5.5 Inhibition of MEK5 attenuates that percentage gap closure rate of passaged 
mesothelial cells in an in vitro wound healing assay.  
Encouraged by the findings that MEK5 and ERK5 inhibitors led to an upregulation of the 
epithelial marker ZO1 in a spectrum of MMT cells, we aimed to explore whether MEK5 played 
a role in mesothelial cell migration in a scratch assay. Mesothelial cells treated with MEK5i 
and without MMC for 48 h showed a decreased gap closure rate over the first 12 h when 
compared to control cells (Fig. 5.12A). Specifically, by 4 h the migration rate was 1.6 fold 
slower in the 1.25 µM and 2.5 µM MEK5i treated cells relative to the control group. The 
migration rate of was slightly more attenuated by 12 h, falling to 1.8 fold in 1.25 – 5 µM dose 
treatment (Fig 5.12A). However, these findings were not statistically significant. In the 
absence of cell proliferation, mesothelial cells treated with MEK5i showed a reduced rate of 
cell migration at 12 h. Specifically, at this time point, the rate of wound closure depended on 
the dose of MEK5i as wound closure was reduced by 1.7 fold in the 2.5 µM condition, and by 
2.5 fold in the 5 µM dose (P<0.01 and P<0.001 respectively) (Fig 5.12B).   
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Figure 5.12 Treatment with MEK5i for 48 h attenuated the percentage gap closure in the passaged 
mesothelial cells MEK5 signalling was inhibited for 48 h in mesothelial cells with and without MMC, 
and gap closure was imaged at 0, 4, 12 and 24 h post wounding. [B] Mesothelial cells 4 h post wounding 
in the MMC- conditions showed on average a 1.6 fold decreased the rate of percentage gap closure in 
MEK5/ERK5i-treated cells when compared to the control group. The rate of gap closure was slightly 
more attenuated by 12 h at 1.8 fold. [C] When cell proliferation was removed following MMC 
treatment, the rate of gap closure was most attenuated at 12 h in a dose-dependent fashion. 
Treatment with 2.5 µM MEK5/ERK5i slowed the wound closure by 1.7 fold and treatment with 5 µM 
of the inhibitor attenuated gap closure 2.5 fold, (P<0.01 and P<0.001 respectively). Means were 
calculated from 2 biologically distinct samples. A one-way ANOVA determined statistical significance 
where ** = P<0.01 and *** =P<0.001 relative to 1% FCS group. Scale bar 200 µm. 
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5.6 Long-term inhibition of TβR1 and EGFR decreases ERK5 activation  
In the previous sections, we demonstrated that the inhibition of TβRI, EGFR signaling , and 
MEK5 reduced wound closure rate and increased accumulation of ZO1 at cell-cell contacts. 
We, therefore, wanted to see if ERK5 phosphorylation was affected by diminishing signalling 
through EGFR and TβRI. Whole cell lysates of mesothelial cells treated with various inhibitors 
were isolated and resolved on an SDS-Page gel (Fig 5.7.1A). Analysis of the band intensity in 
comparison to control cells showed that treatment with the inhibitors did not significantly 
alter the expression levels of the MMT markers, αSMA, and ZO1, even though we noted an 
increase in ZO1 expression (Fig 5.7.1B-D). ERK5 phosphorylation was 6 fold down-regulated 
following TβRi treatment, 17 fold downregulated in the EGFRi-treated cells, and 2.3 fold 
down-regulated in the ERK5i-treated cells (P<0.05) (Fig 5.21F).  
While we could not demonstrate that the following stimulation with either EGF or TGF-β MMT 
transdifferentiation. We did, however, show that the inhibition of TGF-β and EGF signalling 
slowed the rate of mesothelial cell migration, increased ZO1 localization at cell contacts and 
reduces ERK5 activation in the passaged mesothelial cells. Which suggests that these factors 
do have a role in mediating MMT in a paracrine fashion. Table 5.1 summarizes the key findings.  
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Figure 5.13 TGF-β and EGF show convergence at the level of ERK5. [A] Mesothelial cells treated for 48 h in the various inhibitors were lysed and 
the proteins were resolved on a 4-12% Bix-TRIS membrane. We could not detect statistically significant changes in [B] αSMA, [C] ZO1, [D] Snail2 
expression following treatment with inhibitors relative to 1% FCS controls. [E] Inhibition of ERGR, TβRI MEK5 and ERK5, down regulated ERK5 
phosphorylation between 5 -45 fold in mesothelial cells. [F] ERK1/2 phosphorylation was 6 fold down regulated between the TβRi and EGFRi 
treatment. All samples were normalized to β-actin loading control and ERK phosphorylation was calculated as [(pERK/ β-actin) / (tERK/ β-actin)]. 
Data presented as means of 2 biologically distinct replicas. Statistical analysis was calculated using a one way ANOVA followed by post hoc Sidak 
multiple comparisons test, where *=P<0.05, relative to the 1% FCS; #=P<0.05 was relative to TβRi. 
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TABLE 5.1: SUMMARY OF OBSERVED CHANGES IN PASSAGED MESOTHELIAL CELLS 
FOLLOWING EXPOSURE TO THE SMALL MOLECULE INHIBITORS, RELATIVE TO 1% FCS 
Treatment ZO1 at cell-
cell contacts 
αSMA expression Migration rate ERK5  
phosphorylation 
TΒRi 
(LY364947) 
++++ stronger 
Dose-dependent 
attenuation 
 
↓ 
EGFRi 
(PD153035) 
+ stronger 
Dose-dependent 
attenuation 
 
↓↓ 
MEK5i 
(Bix02189) 
+++ 
 
αSMAhigh/low 
expressing cells 
Dose-dependent 
attenuation 
No change 
ERK5i 
(XMD8-92) 
++ 
 
αSMAhigh/low 
expressing cells 
 
N/A ↓ 
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5.7 Transient Zeb1 and Zeb2 knockdown decrease mesothelial cell migration and 
increases ZO1 accumulation at cell edges.  
A number of transcription factors have been implicated in modulating mesothelial cell 
transdifferentiation, and our analysis showed upregulation in Snail2 and Zeb1 mRNA 
expression levels with repeated passaging and following stimulation in the kidney rudiments, 
respectively. Thus, we aimed to further explore the role of these transcription factors in 
mesothelial cell migration capacity and expression of key MMT markers, by targeting them 
with siRNA. We achieved a transient knockdown range of between 60 – 75% in our cells, 
relative to the mock-treated samples (Fig 5.8.1). Through immunolabeling, we could detect 
increased ZO1 expression at the plasma membrane cell edges, following knockdown of Zeb1, 
Zeb2 or both, when compared to the mock controls (Fig 5.8.2A-L). However, transient Snail2 
silencing failed to increase the tight junctional localization of ZO1 (Fig 5.8.2M-O). Meanwhile, 
there was a uniform distribution of the mesenchymal marker vimentin in the transfected cells 
compared to the mock samples (Fig 5.8.2A-O).  
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Figure 5.14 Relative Knockdown levels following siRNA transfections. Mesothelial cells were seeded 
and left to reach 80% confluence before transfection with siRNA or mock for 6 h. Following the 48 h 
knockdown period, the RNA was harvested and gene knockdown levels were calculated relative to the 
mock. We could achieve on an average a 70% knock-down in target genes. Data representative of N=2 
biological independent samples.   
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Figure 5.15 Silencing Zeb1 and Zeb2 increased the ZO1 expression at cell junctions. Seeded mesothelial cells were left to reach 80% confluence 
before being transfected with siRNA against Zeb1, Zeb2, Zeb1+2, Snail2 or mock. Following a 48 h knockdown period, the cells were immunolabeled 
with ZO1 and Vim, markers of MMT. [A-C] Mock-treated cells expressed Vim strongly throughout the cell cytoplasm, and ZO1 weakly at cell-cell 
junctions. Mesothelial cells transfected with siZeb1 [D-F], siZeb2 [G-I] or both [J-L] showed increased accumulation of ZO1 at cell-cell contacts. [M-
O] siSnail2-treatment failed to increase ZO1 distribution. Vim expression was consistent between samples. Images were captured using consistent 
exposure times of 846.6 ms for the 594 and 2 s for the 488 channels for n=2.  
 
199 
 
It is well recognized that a feature of MMT is the gain of a migratory capacity. To this 
end, we performed a wound-healing assay in cells treated with siZeb1, siZeb2 or both. 
Our results showed that cell migration was markedly reduced over a 24 h period in 
siZeb1-, siZeb2- or siZeb1-siZeb2- transfected cells when compared with cells 
transfected with mock vectors. By 6 h, the migration rate of the siZeb1 transfected 
cells was 4 fold slower (P=0.0253) compared to the mock group. Moreover, the rate 
of cell migration further dropped to 7 fold by 24 h (P=0.0466) (Fig 5.8.3D-F, P). 
Transient Zeb2 silencing slowed the rate of cell migration 2 fold by 6 h (P= 0.0405) 
and 3 fold by 24 h (P<0.0001) (Fig 5.8.3G-I, P). Dual silencing of the Zeb transcription 
factors decreased the overall migration rate, however, there was no additive effect 
(Fig 5.8.3J-L, P). At 6h, there was a 3 fold reduced migration rate (P=0.0288) following 
Zeb1+2 silencing and at 24 h the migration rate was 2 fold slower than the mock 
treated cells (P=0.0009). On the other hand, the transient knockdown of Snail2 did 
not significantly alter the rate of mesothelial cell migration into the wound (Fig 
5.8.3M-O, P). These results show that Zeb1 and Zeb2 are more potent at inducing 
MMT in the cultured mesothelial cells. 
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Figure 5.16 Mesothelial cells transfected with siZeb1, siZeb2 or both showed a reduced gap 
closure rate. Mesothelial cells at 80% confluence were transfected with siRNA or treated 
with mock for 6 h. The cells were left for 48 h for effective gene knockdown, before being 
serum deprived and scratched. Images were taken at 0, 6 and 24 h. Representative images 
of [A-C] Mock, [D-F] siZeb1, [G-I] siZeb2 ls, [J-L] Zeb1 and Zeb2, and [M-O] siSnail2 treated 
mesothelial cells. [P] The wound closure rate was attenuated in the siZeb treated samples 
compared to the mock. Gap closure means were generated from n=2. Scale bar 200 µm. 
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5.8 Discussion 
In this chapter, we demonstrated in the omentum explants that TGF-β and EGF 
signalling mediated MMT progression. Moreover, blocking signalling in the passaged 
mesothelial cells through TβRI, EGFR, and MEK5 small molecule inhibitors, inhibited 
cell migration in a dose-dependent fashion. Through western blotting, we could show 
diminished ERK5 phosphorylation following treated with TβRi and EGFRi; suggesting 
that TGF-β and EGF activate ERK5. While we could not detect significant changes in 
protein and mRNA ZO1 expression, there was increased accumulation at the cell-cell 
contacts in the inhibitor-treated groups. Finally, the transient knockdown of Zeb1 
and Zeb2 transcription factors, but not of Snail2, perturbed cell migration and 
increased ZO1 accumulation at cell junctions. Overall, we failed to detect complete 
differentiation through the MMT programme after stimulation with TGF-β and EGF 
in our passaged cells, however, our results showed that mesothelial cell migration 
capacity could be mediated through ERK5 signalling.  
5.8.1 EGF, TGF-β, and MMT  
MMT is a complex stepwise process regulated by a web of signalling pathways that 
are context specific. In the adult, MMT is associated with repair, and if disrupted, 
gives rise to fibrosis and cancer. Understanding the underlying mechanisms is key to 
uncovering therapeutic targets.  
Over the course of this study, we demonstrated that with repeated passaging the 
mesothelial cells lost some epithelial features, but failed to differentiate into fully 
myofibroblastic cells. We associated these alterations with progression through the 
MMT process and aimed to determine if these changes were regulated in cultured 
mesothelial cells through the paracrine effects of the known MMT mediators, EGF, 
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and TGF-β signalling. The mesothelial sheets that surrounded the omentum explants 
showed characteristics indicative of MMT, through the increased expression of αSMA 
and decreased the presence of ZO1 epithelial cell clusters following stimulation with 
50 ng/ml of either EGF or TGF-β for 48 h. The contrary was seen in the cultures 
treated with the small molecule TβRI inhibitor and to a lesser extent with the EGFR 
tyrosine kinase inhibitor.  
Interestingly, stimulation of passaged mesothelial cells with either of these factors 
for the same length of time did not alter the expression of ZO1/ αSMA at protein or 
mRNA levels compared to the low serum group (mRNA data not shown); this was 
consistent with the migration studies. Although we did observe a slight reduction in 
ZO1 localization at cell contacts by IF. Yet, to some extent, we could reverse MMT in 
the passaged cells by inhibiting receptor mediated signalling , which resulted in 
attenuated mesothelial cell migration in a dose-dependent manner, and increased 
ZO1 expression at cell-cell contacts. These results suggested that EGF and TGF-β also 
regulate MMT in the passaged cells, but it may be possible that the mesothelial cells 
required longer periods of stimulation for full MMT progression and myofibroblast 
differentiation.  
TGF-β is a known inducer of MMT. Nasreen and colleagues demonstrated 
myofibroblastic conversion of pleural mesothelial cells following 96 h exposure to 
TGF-β and increased haptotactic migration to a concentration gradient of TGF-β 
exposure (Nasreen et al., 2009). However, a number of other studies have 
determined that TGF-β by itself is not enough to elicit full MMT in vitro (Yáñez-Mó  
et al., 2003, Strippoli et al., 2008, Strippoli et al., 2012). Co-stimulation of omentum-
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derived mesothelial cells with TGF-β and IL-β for 48 h was shown to mediate robust 
myofibroblast conversion, compared to TGF-β only (Yáñez-Mó  et al., 2003, Strippoli 
et al., 2008, Strippoli et al., 2012).  
Instead of stimulating with a defined subset of growth factors and cytokines, other 
studies have instead resorted to supplementing the mesothelial cell full growth 
medium that contained 5-10% FCS with the stimulant of interest (TGF-β or EGF), to 
induce MMT (Kawaguchi et al., 2007, Lachaud et al., 2014, Lachaud et al., 2013, Li et 
al., 2013b).  
Similar to the behavioural characteristics of omentum-derived mesothelial cells 
following culturing, adult liver derived mesothelial cells have been reported to 
undergo MMT differentiation by losing basolateral polarity and Krt8 mRNA 
expression upon culturing and passaging (Li et al., 2013b). Through qPCR, the cells 
were shown to express both TGF-β and increasing amounts of EGFR with culturing, 
the authors stimulated these cells for 4 d in either of these factors in 10% FCS 
containing medium to determine their impact on the MMT state (Li et al., 2013b). 
Their results revealed that TGF-β was more potent than EGF in mediating 
myofibroblastic conversion in culture, through the increased expression of Vim, 
αSMA and collagen 1 and decreased ZO1 genes (Li et al., 2013b). The use of the small 
molecule inhibitor specific for TβRI (SB431542) reversed these changes (Li et al., 
2013b). These findings were consistent with their in vivo work where the conditional 
deletion of TβRII in mesothelial cells decreased MMT transdifferentiation in CCL4 liver 
injury model (Li et al., 2016).  
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The stimulation of omentum explants with EGF has been previously documented. 
Kawaguchi and colleagues reported that the integrity of the epithelial-like 
mesothelial sheet was maintained in serum-free medium following 5 d of culture; but 
lost in 10% FCS-containing medium (Kawaguchi et al., 2007). Stimulation in serum-
free medium supplemented with 40 ng/ml of EGF was not enough to promote 
significant myofibroblastic conversion (Kawaguchi et al., 2007). Moreover, Lachaud 
and colleagues demonstrated the full MMT spectrum and complete 
transdifferentiation into vascular smooth muscle cells in both mouse uterine and 
adipose tissue derived mesothelial cells, over the course of 15 d stimulation (Lachaud 
et al., 2013, Lachaud et al., 2014). The authors reported that the full MMT process 
was only achieved in high glucose medium containing 20-50 ng/ml EGF, 10% FCS 
medium and 1 ng/ml hydrocortisone (Lachaud et al., 2013, Lachaud et al., 2014).   
Overall, TGF-β and EGF are modulators of myofibroblastic differentiation of 
mesothelial cells in culture. However, for complete MMT progression in vitro, there 
must be a synergistic convergence of multiple ligands which in the majority of cases 
remain unidentified in the serum used as a supplement (Chen and Chen, 2012). 
Therefore, the alterations in the epithelial and mesothelial characteristics seen in our 
own system are likely due to the presence of serum. We had previously attempted 
to subculture both the omentum explants and the passaged cells in low serum (1% 
FCS) growth medium, however, both the explant cells and the passaged cells could 
not be sustained for longer than 6 d. Furthermore, substituting 1% FCS with 
Advanced™ medium slowed the growth characteristics of the passaged cells, 
whereby they needed >6 d to reach confluence. This finding suggested that serum 
contains some factors that are key for the survival of mesothelial cells in culture.   
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5.8.2 The role of ERK5 in MMT 
The MMT process can be promoted through Smad and Smad-independent signalling 
cascades in mesothelial cells. Several groups have published the involvement of 
Smad2/3, ILK/ERK1/2 P38 MAPK, Akt/PI3K, JNK signalling  in MMT after stimulation 
with TGF-β and EGF (Jin et al., 2016, Lachaud et al., 2014, Li et al., 2016, Li et al., 
2013b, Strippoli et al., 2010, Strippoli et al., 2015).  
In this chapter, we aimed to better characterize the intracellular signalling cascades 
involved in MMT modulation following EGF and TGF-β stimulation. Treatment of 
passaged mesothelial cells with either TGF-β or EGF for 48 h elevated the expression 
of the phosphorylated forms of ERK1/2 and ERK5 and the total levels of these 
proteins. Moreover, targeting TGF-β and EGF signalling with small molecule inhibitors 
showed the opposite effect. While we could not detect changes in overall ERK1/2 
phosphorylation, we could observe a decline in the relative phosphorylation of ERK5 
following treatment with TβRi (LY364947), EGFRi (PD153035) and ERK5i (XMD8-92). 
Furthermore, inhibition of MEK5/ERK5 in the passaged cells also attenuated relative 
mesothelial migration in the scratch assay and increased ZO1 accumulation at cell 
contacts. This suggests that TGF-β and EGF signalling regulates migration and ZO1 
localization through ERK5.  
TGF-β and EGF have been reported to mediate the loss of epithelial phenotype and 
gain in migratory capacity through ERK5; in vitro and in vivo. Indirect inhibition of 
ERK5 via the MEKi (BIX02189) in lung epithelial cells and fibroblasts perturbed TGF-β 
induced ECM production and Smad3 acetylation in vitro and impeded bleomycin-
induced lung fibrosis in vivo (Kim et al., 2013).  TGF-β also stimulated the 
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phosphorylation of ERK5 in podocytes, increasing the expression of P-cadherin and 
αSMA, while simultaneously reducing barrier function (Badshah et al., 2014). Not 
only did BIX02189 reverse these changes, it also attenuated the wound closure rate 
(Badshah et al., 2014).  
EGF is an established activator of ERK5 (Arnoux et al., 2008). Human keratinocytes 
treated with EGF showed increased phosphorylated ERK5 that coincided with 
increased levels of Snail2 mRNA. Stable knockdown of ERK5 using shRNA decreased 
motility, and Snail2 mRNA expression in HaCaTs and keratinocytes (Arnoux et al., 
2008). Furthermore, the loss of ERK5 resulted in disrupted desmosome organisation 
along with a gain in a compact epithelial-like morphology (Arnoux et al., 2008).  
Although the data presented in this chapter is preliminary, the work suggests that 
ERK5 plays a role in regulating ZO1 organisation and motility of mesothelial cells, 
which has not been previously reported.   
5.8.3 The role of Zeb1/2 in MMT 
The Zeb family of transcription factors are essential players in the modulation of 
myofibroblastic differentiation in a number of epithelial cells. In our ex vivo kidney 
rudiment, the GFP-labelled mesothelial cells had significantly elevated Zeb1 mRNA 
expression following the 7 d co-culture period. However, both Snail2 and Zeb1/2 as 
modulators of myofibroblast conversion in mesothelial cells are not widely 
characterised. In this chapter, we showed for the first time that the transient 
knockdown of Zeb1/2 attenuated mesothelial cell migration for longer periods of 
time in comparison to Snail2 knockdown. Furthermore, treatment with siZeb1/2 
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increased ZO1 accretion at cell contacts, implying that Zeb proteins also play a role 
in MMT progression.  
Previously, it has been shown that the complete reversal of the TGF-β induced EMT 
programme in mouse mammary gland cells required the inhibition of both TβRI 
(SB431542) and RhoA Kinases (Y27632). In turn, this inhibition blocked Zeb1/2 
induced mesenchymal gene expression and stabilized epithelial structures, 
respectively (Das et al., 2009). Furthermore, shRNA-mediated knockdown of Zeb1/2 
in TGF-β stimulated cells restored Cdh1 expression, even though inhibition by ROCK 
was required to stabilize cortical actin (Das et al., 2009). 
Furthermore, in response to treatment with TGF-β, Zeb1 was upregulated and was 
able to promote EMT in MDCK cells by downregulating the expression of its 
antagonizing miRNA, miR-200, while the removal of TGF-β stimulation restored the 
epithelial state (Gregory et al., 2011). Therefore suggesting, that these factors 
regulate each other in a negative feedback loop that ultimately acts as a molecular 
switch to modulate the existence of the E, M and E/M states (Fukuda et al., 2016, 
Gregory et al., 2011). 
However, a number of reports have indicated the existence of a further layer of 
control for Zeb function via a Snail/miR-34 loop (Fig 5.17) (Jolly et al., 2015a, Zhang 
et al., 2014). In these computational modules it was suggested that the Snail/miR-34 
switch acts as a buffer, preventing the activation of EMT from transient signals but 
itself not inducing complete EMT (Jolly et al., 2015a). This, in turn, regulates the 
Zeb/miR-200 loop that is associated with the existence of the 3 EMT states (Jolly et 
al., 2015a). In other words, the Snail loop instigates Cdh1 repression while Zeb is 
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needed for its complete inhibition (Jolly et al., 2015a, Zhang et al., 2014). This is 
further supported by work, which described that a complete EMT reversal was 
achieved only when both the EMT-inducing signal and Zeb are suppressed (Das et al., 
2009, Zhang et al., 2014).  
Overall, the data suggests that Zeb transcription factors play an integral role in 
mesothelial MMT plasticity; however, its exact role in maintaining the intermediate 
MMT state requires further investigation.  
 
 
Figure 5.17 Computational models showing the bistable dynamics of TGF-β induced EMT. 
[A] The Snail1-miR-34 loop is postulated to regulate Zeb function in EMT. The arrows signify 
activation, and blunted lines denote inhibition. [B] Computational dose-response EMT curves 
show the different response of cells starting with different EMT phenotypes that are treated 
with increasing (blue line) and decreasing (purple line) concentrations of exogenous TGF-β. 
Overall the figures illustrate bistable dynamics of EMT that have also been confirmed in 
MCF10A cells. Adapted from (Jolly et al., 2015a, Zhang et al., 2014). 
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5.9 Chapter conclusions 
In this chapter, we attempted to address on multiple levels the regulatory 
mechanisms that control the altered morphology we have observed in cultured 
mesothelial cells over passages. Our results indicate that paracrine TGF-β and EGF 
signalling , through MEK5/ERK5 signalling , had a role in regulating mesothelial cell 
migration and ZO1 distribution Not only so, but we also demonstrated a role of 
Zeb1/2 in MMT. However, in our experimental models, we were unable to 
manipulate the signalling pathways such that a fully induced MMT or complete 
reversal could be achieved. We postulate that for full MMT transdifferentiation to 
occur, the mesothelial cells should be exposed to a more sustained signal from 
multiple growth factors/ cytokines that act in a synergy to mediate myofibroblastic 
conversion. Whereas silencing the autocrine/ paracrine signalling cues and Zeb 
mediate transcriptional regulation should induce the cells to transition back into a 
more epithelial phenotype. This chapter certainly set up the basis for more 
experimental work into uncovering the regulatory networks involved in inducing and 
maintaining the intermediate state of mesothelial cells in the MMT process.  
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Chapter 6: General 
discussion and future 
directions 
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6.0 Final discussion 
Regenerative medicine therapies aim to revolutionize the therapeutic approaches for 
the alleviation of diseases that result from failing organs, by replacing the damaged 
or aged cells with healthy functioning ones (Liu et al., 2016, Herrick and Mutsaers, 
2007). Currently, adult stem cells show the greatest promise as a primary source of 
cells for regenerative applications as they do not carry the risk of teratoma formation, 
they are free from ethical concerns and confer low immunogenicity (Liu et al., 2016).  
Mesothelial cells carry regenerative capacity through their ability to be recruited into 
the wounded area, transdifferentiate and secrete of a plethora of signalling 
molecules that mediate inflammation, fibrosis and angiogenesis (Kanda et al., 2014, 
Kitamura et al., 2014, Mutsaers et al., 2015). Together with the availability of a 
number of practical autologous sources, mesothelial cells are ideal candidates for the 
regeneration and preservation of the mesothelium. Current promising strategies for 
the alleviation of fibrosis and adhesions are carried out through direct mesothelial 
cell transplantation or cell sheet engineering (Bertram et al., 1999, Kanda et al., 2014, 
Kitamura et al., 2014, Lachaud et al., 2015). This treatment option requires the 
transplantation of a large cell volume and sometimes, multiple rounds are required 
for an effective therapeutic outcome (Kanai et al., 2014). As a result, the harvested 
mesothelial cells have to be expanded for prolonged periods of time, of which the 
effects are ill-defined. Mesothelial cell morphology is also a limiting factor associated 
with autologous transplantation since the transplantation of more fibroblast-like 
mesothelial cells was shown not alleviate peritoneal adhesions or thickening 
(Kitamura et al., 2014). Therefore, we aimed to address the effects of long-term 
culture on mesothelial cell characteristics, MMT status, and progenitor properties.  
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In this thesis, we established mesothelial cell cultures derived from the adult murine 
omentum for over 30 passages and showed relatively stable PDTs. However, 
repeated passaging caused the mesothelial cells to downregulate some epithelial 
features (table 6.1). The cultured mesothelial cells displayed progenitor 
characteristics through the expression of stem cell markers, their clonogenicity and 
differentiation capacity, however, the latter was confined to cells up to P5-P13. Using 
a chimeric kidney rudiment assay, we demonstrated that the presence of mesothelial 
cells allowed embryonic structures to form. Finally, we showed that mesothelial cell 
migration, a facet of the MMT process, was regulated through via MEK5/ERK5 
through EGF and TGF-β signalling.  
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Table 6.1: A summary of the changes in genes expression and protein localization seen with 
repeated passaging. In this thesis we showed alterations in the expression of a number of 
mesothelial and epithelial markers, suggested that the mesothelial cells resided in the 
intermediate phase of the MMT spectrum.  
 
 
Expression Expression Distribution Expression Distribution 
 
Genes OMT OMC Passaged Cells 
M
e
so
th
e
lia
l 
Msln +++ + 
Poor/ non-
specific 
++ Membranous 
Wt1 +++ +++ Nuclear +/- Nuclear 
Ep
it
h
e
lia
l 
Cdh1 + + -- +/- -- 
Krt8 ++ + 
Diffuse 
cytoplasmic 
staining 
+/- Perinuclear 
ZO1 + + 
Strong 
bands at 
cell 
contacts 
+/- 
Disrupted at 
cell 
membranes 
and nuclear 
accumulation 
M
e
se
n
ch
ym
al
 
αSMA + +++ 
Prominent 
stress fibres 
+++ 
Prominent 
stress fibres. 
Difference 
between 
intra- 
mesothelial 
populations 
Vim +++ +++ 
Diffuse 
cytoplasmic 
staining 
+++ 
Diffuse 
cytoplasmic 
staining 
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6.1 Mesothelial cell morphology and phenotype are dependent on length of 
culture 
The use of simple epithelial-like mesothelial sheets seems a promising therapeutic 
avenue for the alleviation and treatment of debilitating adhesions and fibrosis 
induced by surgery and peritoneal dialysis respectively (Kawanishi et al., 2013, Kanai 
et al., 2014, Inagaki et al., 2015). The techniques can be categorized into (i) 
harvestable cell sheets generated on thermoresponsive cell culture dishes that in 
response to lower culture temperatures, forces the release of intact cell monolayers 
along with underlying ECM for cell sheet engineering purposes.  (ii) Classical static 
cell-seeding approaches (Lachaud et al., 2015). In rodent models, these techniques 
often require the use of a large volume of cells over a small area (~5x105 cell/ cm2) 
(Inagaki et al., 2015, Asano et al., 2005). Previous reports describing the 
establishment of mesothelial cell cultures from rodent and human sources reported 
morphological changes associated with senescence by passage 6 (Yung and Chan, 
2007, Zhou and Yu, 2016). Contrary to these reports, in this study, we showed that 
the isolated mesothelial cells from murine omentum could be propagated long term, 
with PDTs ranging between 20 – 40 h. Therefore our method for isolating autologous 
mesothelial cells offers an option for the long-term culture of cells, which is a 
prerequisite for the expansion of the appropriate cell number for transplantation.  
6.2 Mesothelial plasticity is affected by passage 
It remains unclear whether the ‘perfect’ epithelial cobblestone phenotype is 
associated with plasticity and if it is necessary for the repair and regeneration of the 
serosa. Therefore, we next attempted to address the effects of time in culture on 
mesothelial plasticity. We could report clonogenic potential in P5 cells (although 
older P25 were not examined), a reduction in the expression of a number stem cell 
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genes in the passaged cells (P5-P25) compared to the OMC, and the ability to 
differentiate along the adipocyte and osteoblast lineages up to P5 and P13, 
respectively. The capacity of mesothelial cells and indeed the mesothelium to 
differentiate along the mesodermal lineages and to contribute to the repair of 
damaged tissue has been previously documented (Chau and Hastie, 2012, Lachaud 
et al., 2014, Lachaud et al., 2013, Lansley et al., 2011, van Tuyn et al., 2007). In light 
of this, we exposed the mesothelial cells to a developing chimeric kidney organoid 
system. While we struggled to effectively trace the lower passage cells, we could 
report that in higher passage cells, the mesothelial cells maintained the ability to 
undergo MMT in response to the nephrogenic challenge and key embryonic 
structures could develop in the presence of the GFP-labelled cells. This suggested 
that the grafting of the higher passage cells indeed does not exhibit damaging effects 
on neighbouring cells.  
6.3 TGF-β and EGF signalling, potential targets for reversing passage 
induced changes 
Within our culturing system, we observed changes that correlated with the 
progression of the mesothelial cells through the MMT programme. We wondered if 
these changes were mediated by paracrine mechanisms based on the presence of 
certain growth factors in the culture medium. Our initial qPCR analysis showed 
upregulation in EGFR expression with culture, a known mediator of MMT (Lachaud 
et al., 2014, Wang et al., 2015). Furthermore, we also decided to study TGF-β related 
signalling, as it is a well-established master molecule of MMT (Zolak et al., 2013, Karki 
et al., 2014, Strippoli et al., 2015). By targeting the both the EGF and TGF-β signalling  
pathways at the level of the tyrosine kinases, we noted attenuated migration 
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capacity and improved ZO1 distribution at the cell-cell contacts in a dose-dependent 
fashion. However, it remains to be clarified if sustained use of the pharmacological 
inhibitors to preserve the epithelial characteristics in higher passage cells would 
indeed result in maintenance of the associated plasticity seen in the lower passage 
cells. Studies that characterised the effects associated with age/ passage on MSC 
potency, demonstrated that the differentiation capacity of MSCs and haematopoietic 
stem cells was dependent on the accumulation of DNA damage (Alves et al., 2010, 
Chambers et al., 2007, Elkhenany et al., 2016, Kretlow et al., 2008). Which suggests 
that MMT transdifferentiation and differentiation along adipocyte and osteoblast 
lineages may be regulated and affected by different mechanisms.  
6.4 Future directions 
In this thesis, we attempted to address the effects of long-term culture on the 
characteristics of mesothelial cells, specifically their stem/progenitor status and 
transdifferentiation potential. We could show that the omentum explant-derived 
cells could be sustained in culture long term, yet a prominent and not addressed 
observation was the reduced Wt1 mRNA expression seen in the passaged cells.  
Wt1 is a multifunctional zinc finger transcription factor that has been reported to 
regulate apoptosis, proliferation, differentiation and mRNA processing (table 6.2) 
(Shandilya and Roberts, 2015). These distinct functions are thought to be brought 
about by the various Wt1 isoforms (Shandilya and Roberts, 2015). Of the 36 identified 
isoforms, 4 are abundantly expressed and arise from two independent splicing events 
at the exon 5 with 17 amino acids and the KTS site found between exons 9 and 10 
(Shandilya and Roberts, 2015, Kramarzova et al., 2012).  
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Table 6.2: A summary of the functions that the various Wt1 isoforms have been shown 
mediate in adult cells. 
 
In our preliminary data, we could also see a passage dependent loss of expression in 
the various Wt1 isoforms (Fig. S1). In an attempt to address the role of the different 
Wt1 isoforms had in maintaining the epithelial cell state, we transfected the cells 
with linearized GFP containing plasmids for the 4 main isoforms and initiated 
selection for stable transfection with blasticidin (Fig. S2). Unfortunately, we were 
unable to establish the mesothelial Wt1 expressing lines, due to the transfection 
protocol needing further optimisation. Addressing the function of these isoforms 
during the MMT process in mesothelial cells could further our understanding of the 
role Wt1 has on the physiology of mesothelial cells. 
Another observation made was the dependence of mesothelial cell potency on 
passage. However, in the chimeric kidney rudiment, we could not assert if lower 
passage cells could contribute to nephrogenesis. Since the original transfections 
Wt1 variants Splicing events Function 
Wt1A Exon 5- / KTS-  Increases tumour size, dissemination, VEGF 
expression and decreases survival rates in a 
mouse ovarian cancer model (Yamanouchi et 
al., 2014).  
 Promotes ovarian cancer cell migration and 
invasion, in vitro (Jomgeow et al., 2006).  
 In mammary epithelial cells it acts as a tumour 
suppressor by regulating p21 expression 
(Burwell et al., 2006). 
Wt1B Exon 5+ / KTS-  Induced apoptosis through the transcriptional 
repression of the EGFR in osteosarcoma cells 
(Haber et al., 1996) 
Wt1C Exon 5- / KTS +  Inhibits apoptosis induced by anticancer 
antibiotic by promoting homologous 
recombination mediated DNA repair (Oji et al., 
2015).  
Wt1D Exon 5+ / KTS -  Induces EMT in mammary epithelial cells 
(Burwell et al., 2006). 
218 
 
were performed in our lab, a new more efficient technique has been established that 
results in >90% GFP+ expression within 1 sorting event. This technique would mean 
the lower passage mesothelial cells labelled with GFP could be co-cultured in these 
re-aggregated rudiments, and analysed for their potential to transdifferentiate into 
kidney cells  
It also remains to be established if the passaged mesothelial cells in this study that 
showed reduced epithelial features could contribute to the regeneration of the 
damaged peritoneum, in vivo. One way to address this question would be through 
the use of cell sheet engineering   
One way of addressing this could be to culture the passaged mesothelial cells in the 
presence or absence of EGFR and TβRI inhibitors in order to induce their epithelial 
state, although the length of culture prior to coating on matrices would still require 
further optimising.  
6.5 Conclusion  
The use of mesothelial cells in regenerative medicine applications is expanding 
rapidly. However, there still exists a number of unsolved issues that require 
addressing for such therapies to reach the clinic. In our hands, it appears that 
mesothelial cells that are expanded for shorter lengths of time are potentially a more 
useful source of cells for regenerative applications. Although, the effects of long-term 
culture on human omentum-derived mesothelial cells still needs to be addressed. 
Specifically, the molecular mechanisms that mediate these culture-induced changes, 
which could be targeted for pharmacological intervention to reverse, correct, or 
prevent these changes.  
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Supplements 
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Figure S1: Repeated passaging results in the loss of Wt1 isoforms. OMT and P5 and P25 
mesothelial cells RNA was harvested and reverse transcribed for qPCR analysis of Wt1 isoform 
expression. With prolonged culturing, the mesothelial cells show reduced overall Wt1 expression 
relative to the OMT (P=0.0006, P5, and P=0.0042, P25). Wt1A was >1X104 fold downregulated at 
P5 (P=0.0013) and was not detectable at P25. Isoforms Wt1C and Wt1D were not detectable by 
qPCR in the P5 and P25 samples. Meanwhile, there was not change in relative expression of Wt1B 
between the passaged cells and the OMT.  Samples were normalised to Gapdh and β-actin 
housekeeping genes. Data shown is averages from 2 biologically independent samples.  
  
** 
** 
*** 
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Figure S2: Mesothelial cell transfection with Wt1 isoform plasmids. Wt1 plasmids for the 
various isoforms were kindly gifted by Dr. Peter Hohenstein. [A] The plasmids were linearized 
AhdI restriction enzyme. [B] Passage 10 mesothelial cells were seeded 8x104 cells/ well in a 
12 well dish and left to attach overnight. The mesothelial cells were transfected with 2 µg of 
DNA per well for 6 h in OptiMEM medium containing 2 µl of lipofectamine 2000.  The cells 
were left to recover overnight before being split 1:10. Once the cells had attached selection 
was initiated by culturing the transfected cells in growth medium containing 2 µg/ml 
blasticidin. Images were taken 1-week post transfection.  
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